Risk factors for Type 2 Diabetes Mellitus : Metabolic Syndrome, Insulin Resistance and Primary Prevention by Hydrie, Muhammad Zafar Iqbal
 
Risk factors for Type 2 Diabetes Mellitus: 
Metabolic Syndrome, Insulin Resistance 
and Primary Prevention. 
 
Muhammad Zafar Iqbal Hydrie 
Supervisor: 
Professor Akhtar Hussain 
Co-supervisor: 
Professor Abdul Basit 
 
University of Oslo 
Faculty of Medicine 
Institute of Health and Society 
Department of Community Medicine 
Section for International Health 
 
Doctoral Thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Muhammad Zafar Iqbal Hydrie, 2012 
 
 
Series of dissertations submitted to the  
Faculty of Medicine, University of Oslo 
No. 1269 
 
ISBN 978-82-8264-171-5 
 
 
All rights reserved. No part of this publication may be  
reproduced or transmitted, in any form or by any means, without permission.   
 
 
 
 
 
 
 
 
Cover: Inger Sandved Anfinsen. 
Printed in Norway: AIT Oslo AS.  
 
Produced in co-operation with Unipub.  
The thesis is produced by Unipub merely in connection with the  
thesis defence. Kindly direct all inquiries regarding the thesis to the copyright  
holder or the unit which grants the doctorate.   
 
  
Acknowledgment 
 
I am deeply grateful to my principal supervisor Professor Akhtar Hussain for his patience, 
expert guidance, encouragement and support during my study period in Oslo. I also owe my 
sincere heart felt gratitude to Professor Abdul Basit, my local supervisor and mentor for 
having firm belief in me and for his valuable support and guidance through out my career. 
This work would not have been possible without the support and contribution of a great 
number of people. I would like to thank all of my colleagues in Pakistan who helped me in 
the studies and supported me during the study period. I would like to thank all the 
participants and volunteers for their contribution, and special thanks to my research team 
who helped during the study. I would also like to thank all my co-authors for their 
contribution to my publications.    
I would also like to acknowledge the Norwegian State Education Loan Fund through the 
Quota Programme and the department of International Health, University of Oslo for the 
financial support that has enabled me to take up this programme. I also thank the 
Norwegian Research Council for funding my research.  
I have enjoyed working with the people at the Department of International Health and 
special thanks to my teachers Prof. Gunnar Bjune and Prof. Johanne Sundby for their 
valuable inputs. I would like to thank Ragnhild Beyrer, Line Løw, Vibeke Christie and other 
staff members of the department for their kind help and cooperation during my stay. I 
would also like to thank my classmates here in Norway, friends and relations for their well 
wishes towards me  
I am indebted to my wife for her constant cooperation and support during my time of study 
here. It was a difficult time for her and I appreciate her efforts to take care of the family in 
my absent as well as having to put up with me during this stressful period.  
I am grateful to the encouragement and constant support of my sister during my study. My 
mother’s inspiration and prayers helped me to look forward and words of wisdom of my 
father has helped me during my study. 
 
 
 
 
 Abstract 
Aims:  
The purpose of the study was to identify the extent of metabolic syndrome on the basis of 
ATP III and IDF definition in subjects aged 25 years and above from an urban population of 
Karachi. Also to see the association of risk factors related to diabetes and metabolic 
syndrome in this population. And finally to prove the hypothesis of intervention effect on 
the onset of type 2 diabetes in a high risk urban population and evaluate the rate of 
conversion of IGT to diabetes by these interventions in this population.  
Methods:
The epidemiological survey was designed to see the prevalence of metabolic syndrome and 
its risk factors among 500 randomly selected households in Lyari, an urban area within 
Karachi city in 2004 . We generated a computerized random sample of the households from 
among the 85,520 households in Lyari Town. There were 11 union councils in Lyari Town 
where the samples were taken and each union council had equal opportunity to be 
represented in the sample selection. We expected approximately 1000 adult men and 
women 25 years and above in the households selected in Lyari Town. If members of a 
household that had been selected refused to consent to household interviews, we knocked 
on the third door to the right of that house and seeked consent there. Out of the 85,520 
households, 532 households were randomly selected and 867 adults ш25 years old 
consented to take part in the survey; 363 of these subjects gave blood samples. 
The second study was a primary prevention trial which was started in the city of Karachi in 
2006. It was a prospective randomized clinical trial (RCT) to assess the effect of intervention 
for 18 months on high risk subjects. Nearly 2000 suspected high risk cases identified by a 
questionnaire were to be invited to participate. Considering 30% IGT cases in high risk 
individuals around 600 were expected to have IGT based on OGTT. The IGT cases were then 
randomly allocated on three different arms, two preventive groups and one control group, 
all with 200 participants (one of the preventive arms included metformin 500mg twice 
daily). An estimated 5000 people attended the diabetes prevention lectures and visited the 
screening camps and around 2300 people filled in the high risk questionnaire only 1825 
were identified as high risk. Of these 1739 high risk subjects undertook a standardized oral 
glucose tolerance test (OGTT) and 317 subjects were identified as having impaired glucose 
tolerance (IGT group) and were randomized into the three groups. 
Results: 
The prevalence of diabetes was 9.4%, whereas 5.6% had impaired fasting glucose (abnormal 
glucose tolerance 15%). The prevalence of metabolic syndrome according to the IDF 
definition and modified ATP III criteria was 34.8% and 49%, respectively. Inclusion of 
modified waist circumference and specific body mass index (BMI) cut offs for Asians might 
have helped in this increased prevalence of the metabolic syndrome. 
Dietary data about  specific food items was available for 867 adults. Participants also 
completed a health and lifestyle questionnaire and 363 subjects provided fasting blood 
samples for glucose and lipids. Dietary intake was assessed by a questionnaire to identify 
consumption of 33 specific food items and the dietary patterns categorized into 6 food 
groups was assessed by cluster analysis. Five dietary patterns were identified through 
cluster analysis. Cluster 1 had the lowest proportion of persons with metabolic syndrome 
i.e. 42.7% while cluster 2 had the highest percentage of metabolic syndrome subjects 
(56.3%) (p=0.09). Consumption of fat and calorie dense foods was significantly higher 
among highest risk group (cluster 2) compared to lowest risk group (cluster 1) (p = 0.0001). 
The consumption of food groups containing fruit, milk and meat was also more than twice in 
high risk compared to low risk group (p = 0.0001). Even within the same population there 
are marked differences in dietary patterns and these apparently contribute to the risk of 
developing metabolic syndrome. 
Insulin Resistance (IR) was defined at 75th percentile cut off of insulin levels (9.25 U/mL) 
and HOMA-IR (1.82). The 25th percentile cut off was used for defining IR in QUICKI (0.347) 
and McAuley Index (6.77).  
 
In the second study which was the primary prevention trial 273 subjects out of 317 subjects 
completed the study giving a compliance rate of 86%. A total of 47 incident cases of 
diabetes were diagnosed during the study. The overall incidence of diabetes was 4 cases per 
1000 person-months with the incidence of diabetes as 8.6 cases in the control group, 2.5 
cases  in the Life Style Modification (LSM) group and 2.3 cases per 1000 person-months in 
the LSM+drug group.  
Conclusion:
In the first study we observed high prevalence of metabolic syndrome irrespective of the 
definition applied in this urban population. This may call for immediate action such as 
preventive measures to halt the accelerating risk of diabetes and CVD which is leading to a 
possible unparalleled rise in the cost of health care and human suffering. 
 
To initiate a preventive program we need to make dietary changes within the population 
and we found marked differences in dietary patterns which were apparently contribute to 
the risk of developing metabolic syndrome in the same population. Dietary pattern studies 
will help elucidate links between diet and disease and contribute to developing healthy 
eating guidelines. 
 
A common approach towards managing subjects with metabolic risk factors which could 
help physicians would be able to identify IR cases earlier and defining IR reference values 
identified from simple indirect methods would be of value in such cases. However larger 
population based studies are needed to further define and validate the cutoff values defined 
for insulin resistance in our population.  
 
The primary prevention study was initiated after we had some baseline information from 
our first epidemiological study and it showed that lifestyle intervention had a major impact 
in preventing diabetes among IGT subjects in this region. However, addition of drug in the 
intervention did not show any improved results. Resource constrain societies are challenged 
with the additional burden of diabetes cost on their already ailing economy and such 
lifestyle intervention approach would be of benefit in such communities. Therefore, we 
recommend that lifestyle modification advice and follow-up should be incorporated in 
primary health care.  
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1 Chapter 1. Introduction 
1.1 Pakistan – Country Profile 
The Islamic Republic of Pakistan was founded in 1947. East Pakistan (now Bangladesh) 
seceded in 1971. Since independence there have been several military coups. The last was in 
1999, when the chief of army staff, Pervez Musharraf, became the chief executive of 
Pakistan. Mr Musharraf resigned as army chief in November 2007 and stood down as 
president in August 2008. The general election that took place in February 2008 resulted in 
a new coalition government led by the Pakistan People's Party and the Pakistan Muslim 
League (Nawaz); the latter  party withdrew from the government in August 2008 (1). 
Pakistan is a poor and underdeveloped country. A brief overview of the country is given 
below: 
1.1.1 Geography: 
The country is located in South Asia, bordering the Arabian Sea, between India on the east 
and Iran and Afghanistan on the west and China in the north. Geographic coordinates are 30 
00 North and 70 00 East.  Land area is 769,095 sq km. Population is 150 million according to 
2007 official estimates. Pakistan is divided into four provinces, namely Sindh, Baluchistan, 
Punjab and North-West Frontier Province (NWFP) recently renamed Pakhtoonkowah. 
Pakistan features different types of landscape; ranging from desert in the south to high 
mountains in the north. Climate is subtropical and cold in the highlands.  
 
 
Figur 1 : Geographic Location of Pakistan 
 
1.1.2 Population Demography:   
The population of Pakistan was 150 million in 2007 according to government statistics (2). 
One third of the population lives in urban areas.  Sex ratio is 1.05 male(s)/female for the 
total population.  
Population growth rate:  1.88%  
Birth rate:    25.6 births/1,000 population  
Death rate:    6.8 deaths/1,000 population  
Life expectancy at birth for males is 64 years and for females is 68 years. 
1.1.3 People:  
The five main ethnic groups are Punjabi, Sindhi, Pashtun (Pathan), Baloch and Muhajir 
(immigrants from India at the time of partition and their descendants).  More than 95% of 
the population is Muslim. Main towns as per June 2003 estimates are Karachi: 10.1 millions, 
Lahore: 5.6 millions and Faisalabad: 2.3 millions (1).  
Languages:  Urdu is the national language. English is widespread in business circles and as a 
second language.  Time is 5 hours ahead of GMT.  
1.1.4 Education 
Education in Pakistan is mostly subsidized by the Government from primary schools to 
higher education levels in public universities. The definition of literacy is taken as over 15 
years of age and able to read and write. This level of literacy for the total population is 
48.7% while it is 61.7% for males and 35.2% for females according to 2004 estimates (2).  
1.1.5 Economy 
Pakistan’s economy depends mostly on agriculture. The GDP - per capita (PPP) of the 
country was $2,600 according to 2006 estimates, but political instability, civil unrest and the 
threat of terrorist violence have damaged the business operating environment since 2008.  
The catastrophic flooding of August-September 2010 has only heightened this dependency. 
Currency:  
Pakistan rupee (PRs); PRs1 = 100 paisa. Average exchange rate in 2009: PRs 81.7:US$1 
1.1.6 Lifestyle and Physical Activity 
Lifestyle of the people is different depending to rural and urban settings. Apart from 
household work the women in the rural areas also help their men in the fields and in looking 
after cattle. Compared to this the people in cities are exposed to a easier way of daily life. 
Pakistani people do not have a tradition of doing recreational physical exercise apart from 
the requirements of their daily work. 
1.1.7 Karachi  
Karachi is the largest and most populous city in Pakistan. The population and demographic 
distribution in the megacity has undergone numerous changes over the past 150 years. At 
the time of independence on 14 August 1947, it became the capital city of  Pakistan, with a 
population about 450,000. However, the population rapidly grew with large influx of 
refugees from neighbouring India (after the partition of British India). By 1951, the city 
population had crossed one million mark and in the following decade, the rate of growth of 
Karachi was over 80 percent. Today, the city has grown 60 times its size from 1947 when it 
became the country's first capital (3). 
Predominantly Urdu speaking, the refugees known as Muhajirs form the dominant ethnic 
group in Karachi. It is the financial and commercial capital of Pakistan; accounting  for a 
lion's share of Pakistan's revenue generation (20% of the GDP of Pakistan).  
1.2 Global Burden of Chronic Non Communicable Diseases 
While infectious diseases are still threatening people’s health, non-communicable diseases 
(NCDs) – such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes  
were responsible for 60% of all deaths globally in 2005 (estimated at 35 million deaths). 
Total deaths from NCDs are projected to further increase by 17% over the next 10 years (4). 
Low- and middle-income countries are most likely to be affected by these diseases, which 
can be prevented by modifying common risk factors such as tobacco use, unhealthy diet, 
physical inactivity and harmful use of alcohol. 
Globally, cardiovascular diseases (CVD) are the number one cause of death with an 
estimated 17 million people dying from cardiovascular disease in 2005, representing 30% of 
all global deaths. About 80% of these deaths occurred in low- and middle income countries. 
The high burden of CVD in developing countries is attributable both to the increased 
incidence of these disorders as well as the relatively early age at which they occur (5-10). 
The contribution of developing countries to the global burden of CVD in terms of disability 
adjusted years of life lost was three times higher than that of developed countries (11). 
The global prevalence of people with diabetes is 6.4%, affecting 285 million adults in 2010 
and this will increase to 7.7% with 439 million adults affected by 2030 (12). Thus between 
2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in 
developing countries and a 20% increase in developed countries (12). The greatest increase 
of 195% is projected to be in India (12,13). The last two decades has seen an explosive 
increase in the number of people diagnosed with diabetes worldwide and 75% of these are 
from the developing countries (13). Unfortunately this trend of increasing prevalence of 
diabetes and obesity is imposing a huge burden on our already fragile health-care systems 
and this is likely to increase further in the future (14,15).  Every year, 3.2 million people 
around the world die from complications associated with diabetes. Type 2 diabetes has 
become one of the major causes of premature illness and death, mainly through increased 
risk of CVD which is responsible for 80 per cent of these deaths (12,16). World Health 
Organization (WHO) projects that diabetes deaths will double between 2005 and 2030 (4).  
1.2.1 Prevalence and Global trends of Diabetes  
Diabetes mellitus is the fourth or fifth leading cause of death in most high-income countries 
and there is evidence suggesting that it is increasing in epidemic proportions in many newly 
industrialized developing countries (4,12). Complications from diabetes are resulting in 
increasing disability, reduced life expectancy and enormous health costs for every country 
making diabetes one of the most challenging public health problems in the 21st century. 
The low- and middle income countries (LMCs) face the greatest threat from the burden of 
diabetes with 70% of new incident cases developing in these countries in the future (17,18). 
Unfortunately, many countries are unaware of the magnitude and future burden due to the 
increase in diabetes and its complications on their own countries. Table 1 shows the global 
and projected burden of diabetes and IGT,within the next 20 years. 
Tabell 1:  Global Burden: Prevalence and Projections of Diabetes and IGT, 2010 and 2030 
  2010 2030 
Total world population (billions) 7.0 8.4 
Adult population (20-79 years, billions) 4.3 5.6 
Diabetes (20-79 years)   
Global prevalence (%)  6.6 7.8 
Number of people with diabetes (millions) 285 438 
IGT (20-79 years)   
Global prevalence (%) 7.9 8.4 
Number of people with IGT (millions) 344 472 
 
In addition to diabetes, Impaired glucose tolerance (IGT), a condition also referred to as 
prediabetes is a substantial risk factor for the progression to diabetes and constitutes a 
major global public health concern, both because of its strong association with diabetes 
incidence and with its association of increased risk of cardiovascular disease.  Moreover, 
microvascular complications, such as retinopathy, chronic kidney disease, and neuropathy, 
and cardiovascular disease have been associated with prediabetes (19-22). 
Looking at the global trend amongst the ten leading countries with diabetes we see that five 
of these are from Asia as shown in table 2 which is an alarming senerio for experts working 
in the region (12,23). Recently the IDF website has shown that China appears to have  
overtaken India and become the global epicentre of the diabetes epidemic with 92.4 million 
adults with the disease. 
In 2030, China will rank first with an estimated half a billion people with diabetes, followed 
by India in second place with 87 million people having diabetes (12,24).  
Tabell 2. Top 10 countries for numbers of people aged 20–79 years with diabetes in 2010 & 2030.  
 2010  2030  
 Country  No. of adults with 
diabetes (millions)  
Country  No. of adults with 
diabetes (millions) 
1 India 50.8 China 500 
2 China 43.2 India  87.0 
3 USA 26.8 USA 36.0 
4 Russian Federation 9.6 Pakistan 13.8 
5 Brazil 7.6 Brazil 12.7 
6 Germany 7.5 Indonesia 12.0 
7 Pakistan 7.1 Mexico 11.9 
8 Japan 7.1 Bangladesh 10.4 
9 Indonesia 7.0 Russian Federation 10.3 
10 Mexico 6.8 Egypt 8.6 
1.2.2 Diabetes in Pakistan 
The International Diabetes Federation estimates that there are approximately 7 million 
people with diabetes in Pakistan making it seventh among countries with the highest 
number of adults with diabetes as shown in table 2 (12). This number is predicted to 
increase between to 13.8 million by the year 2030 making it fourth amongst this list (12,25). 
These predictions are modeled upon the reported prevalence of type 2 diabetes (T2DM) in 
the national survey conducted by the Diabetic Association of Pakistan (DAP) in collaboration 
with World Health Organization (WHO) during the 1990s (26-29). The national survey was 
conducted in urban and rural areas in all the four provinces (NWFP, Baluchistan, Punjab and 
Sindh) of Pakistan using WHO guidelines for the diagnosis of T2DM and IGT in ~ 5,600 
persons above 25 years  of age. The overall prevalence of T2DM among men and women 
was reported to be 11%, with overall abnormal glucose control of around 22%.  
A summary of the results is given below in table 3.  
Tabell 3. Pakistan National Diabetes Survey 
Province Diabetes(%)        IGT(%) 
Sindh                    (Rural) 
                              (Urban) 
13.9 
16.5   
11.2 
10.4 
Baluchistan         (Rural) 
                              (Urban) 
07.5 
10.8   
07.4 
10.4 
NWFP         (Rural) 12.0 09.4 
Punjab         (Rural)  
                               (Urban) 
06.2  
13.7  
05.6 
10.3 
Overall   11.5  9.3 
 
 A higher prevalence of obesity and IGT was observed among women vs. men and a 
relatively higher prevalence of diabetes and IGT was found in younger age groups compared 
to western populations (26-29). Nearly half of the subjects did not know they had diabetes 
before the surveys, a finding also seen in other population based studies worldwide (12).  
1.3 Metabolic Syndrome (High Risk for Diabetes and CVD Epidemic)  
Over the last 3 decades, the prevalence of metabolic syndrome has been increasing steadily 
in all populations globally (30,31). Despite the debate on use of the term ‘Metabolic 
Syndrome’, its significance in helping identify subjects at high risk of developing type 2 
diabetes and cardiovascular disease (CVD) is still recognized.  
Subjects having metabolic syndrome have a 2–3 fold risk of cardiovascular disease and a five 
fold  risk of developing type 2 diabetes (32). It is estimated that nearly 20-25 per cent of the 
world’s adult population has the metabolic syndrome and they are twice as likely to die 
from a heart attack and three times likely to suffer from a heart attack or stroke compared 
with people without the syndrome (32). 
This ‘clustering’ of metabolic abnormalities that occur in an individual appear to confer a 
substantial additional cardiovascular risk over and above the sum of the risk associated with 
each abnormality (32,33). Thus more components of the metabolic syndrome that are 
evident, the higher is the CVD risk as shown in Figure 2 (34,35).   
 
Figur 2. Relative risk of CVD in normoglycemia, prediabetes and type 2 diabetes. (36) 
1.3.1 Definations of Metabolic Syndrome   
After Reaven put forward the concept of Syndrome X, many attempts have been made to 
define this clustering of risk factors for cardiovascular disease and type 2 diabetes mellitus 
with names such as “deadly quartet” and “insulin resistance syndrome” but it has finally 
been referred to as the “Metabolic Syndrome”  (36-41). 
In 1998, a WHO diabetes group first attempted to define this syndrome with insulin 
resistance and impaired glucose tolerance or diabetes as essential components, together 
with at least two other components (38).  
In 1999, the European Group for Study of Insulin Resistance (EGIR) called it insulin resistance 
syndrome and defined insulin resistance as plasma insulin levels in the upper quartile of the 
population as a primary requirement (39). Predetermined cut points for the other criteria 
were used as shown in Table 4 below.  
In 2001, the National Cholesterol Education Program, Adult Treatment Panel III (NCEP, ATP 
III) came up with a more clinical based definition for the metabolic syndrome (40). While 
insulin resistance was considered important, it was excluded from the definition. The ATP III 
criteria did not make any single factor necessary for diagnosis, but instead made presence of 
three of five factors as the basis for establishing the diagnosis; these factors being 
abdominal obesity, elevated triglycerides, reduced HDL-C, elevated blood pressure and 
elevated fasting glucose (IFG\type 2 diabetes mellitus).  
In 2003, the American Association of Clinical Endocrinologists focused again on insulin 
resistance as the primary cause behind the primary metabolic risk factors (41). Calling it the 
insulin resistance syndrome as done by EGIR, the definition included IGT, elevated 
triglycerides, reduced HDL-C, elevated blood pressure, and obesity as major criteria; while 
factors such as family history of CVD or type 2 diabetes mellitus, polycystic ovary syndrome 
and hyperuricemia were needed to make a clinical diagnosis. The decision of defining the 
syndrome was left on the clinician's judgment.  
In 2005, the International Diabetes Foundation (IDF) published its own definition, trying to 
make the diagnosis clinically simple and widely usable as possible (32). The IDF definition 
made the presence of abdominal obesity compulsory for diagnosis. Once this essential 
condition was present, at least two additional factors out of four were necessary for the 
diagnosis. The IDF definition recognized for the first time ethnic differences in the 
correlation between abdominal obesity and other metabolic syndrome risk factors (Table 4).  
Tabell 4. Previous criteria proposed for the diagnosis of metabolic syndrome  
Clinical 
measure  
 
WHO (1998)  
 
EGIR  
 
ATP III (2001)  
 
AACE (2003)  
 
IDF (2005)  
 
Insulin 
resistance 
IGT, IFG, T2DM, or 
lowered insulin 
sensitivity plus any 
2 of the following 
Plasma insulin 
>75th percentile 
plus any 2 of the 
following 
None, but any 3 
of the following 5 
features 
IGT or IFG plus 
any of the 
following based 
on clinical 
judgment 
None 
Body 
weight 
Men: waist-to-hip 
ratio >0.90; 
women: waist-to-
hip ratio >0.85 
and/or BMI 
>30 kg/m
WC шϵϰ cm in 
men or шϴϬ cm 
in women 
2 
WC шϭϬϮ cm in 
men or шϴϴ cm in 
women 
BMI шϮϱ kg/m Increased WC 
(population 
specific) plus 
any 2 of the 
following 
2 
Lipid TG шϭϱϬ mg/dl (1.7 
mmol/l) and/or  
 
TG шϭϱϬ mg/dl 
(1.7 mmol/l) 
and/or  
TG шϭϱϬ mg/dl 
(1.7 mmol/l) 
TG шϭϱϬ mg/dl 
(1.7 mmol/l)and  
TG шϭϱϬ mg/dl 
(1.7 mmol/l) or 
on TG Rx 
 HDL-C <35 mg/dl 
(0.90 mmol/l) in 
men or <39 mg/dl 
(1.01 mmol/l) in 
women 
HDL-C <39 mg/dl 
(1.01 mmol/l) in 
men or women 
HDL-C <40 mg/dl 
(1.03 mmol/l) in 
men or 
<50 mg/dl (1.29 
mmol/l) in 
women 
HDL-C <40 mg/dl 
(1.03 mmol/l) in 
men or 
<50 mg/dl (1.29 
mmol/l) in 
women 
HDL-C 
<40 mg/dl 
(1.03 mmol/l) 
in men or 
<50 mg/dl 
(1.29 mmol/l) 
in women or 
on HDL-C Rx 
Blood 
pressure 
шϭϰϬͬϵϬ mmHg шϭϰϬͬϵϬ mmHg 
or on 
hypertension Rx 
шϭϯϬͬϴϱ mmHg шϭϯϬͬϴϱ mmHg шϭϯϬ mmHg 
systolic or 
шϴϱ mmHg 
diastolic or on 
hypertension 
Rx 
Glucose IGT, IFG, or T2DM IGT or IFG (but 
not diabetes) 
>110 mg/dl (6.1 
mmol/l) (includes 
diabetes)
IGT or IFG (but 
not diabetes) 
a 
шϭϬϬ mg/dl 
(5.6 mmol/l) 
(includes 
diabetes) 
Other Microalbuminuria   Other features of 
insulin 
resistance
 
b 
a The 2001 definition identified fasting plasma glucose of шϭϭϬ mg/dl (6.1 mmol/l) as elevated. This 
was modified in 2004 to be шϭϬϬ mg/dl (5.6 mmol/l), in accordance with the American Diabetes 
Association's updated definition of IFG. 
b
 
 Includes family history of type 2 diabetes mellitus, polycystic ovary syndrome, sedentary lifestyle, 
advancing age, and ethnic groups susceptible to type 2 diabetes mellitus.  
The AHA/NHLBI statement was released later in 2005 and was popularly known as the 
modified ATP III definition, with no mandatory criteria which had to be present (42,43). One 
major change was the reduction from 110 to 100 mg/dl for the diagnosis of IFG; 
corresponding to the modified American Diabetes Association (ADA) criteria for IFG. The 
criteria of abdominal obesity was specified by ethnicity and based on the clinician's 
judgment (Table 5).  
Tabell 5. IDF and AHA/NHLBI
Comparison of diagnostic criteria for MS from the International Diabetes Federation (IDF) and 
American Heart Association (AHA)/National Heart, Lung, and Blood Institute (NHLBI)  
IDF clinical criteria for metabolic syndrome  AHA/NHLBI diagnostic criteria for metabolic syndrome  
Measure (central obesity 
plus any two of five 
other criteria constitute 
a diagnosis of metabolic 
syndrome)  
Categorical cut points  
 
Measure (any three 
of the five criteria 
below constitute a 
diagnosis of 
metabolic syndrome) 
Categorical cut points  
 
Central obesity Waist circumference 
ethnicity specific  
For South Asians: 
шϵϬ cm in men, 
шϴϬ cm in women 
Elevated waist 
circumference 
General U.S. population: 
шϭϬϮ cm (шϰϬ in.) in men, 
шϴϴ cm (шϯϱ in.) in women; 
lower cut points for insulin-
resistant individuals or ethnic 
groups (based on clinical 
judgment) 
Raised triglycerides >150 mg/dl (1.7 mmol/l) 
or on specific treatment 
for this lipid disorder 
Elevated 
triglycerides 
шϭϱϬ mg/dl (1.7 mmol/l) or on 
drug treatment for elevated 
triglycerides 
Reduced HDL 
cholesterol 
<40 mg/dl (1.03 mmol/l) 
in men, <50 mg/dl 
(1.29 mmol/l) in women 
or on specific treatment 
for this lipid abnormality 
Reduced HDL 
cholesterol 
<40 mg/dl (1.03 mmol/l) in 
men, <50 mg/dl (1.29 mmol/l) 
in women 
Raised blood pressure шϭϯϬ mmHg systolic 
blood pressure or 
Elevated blood 
pressure 
шϭϯϬ mmHg systolic blood 
pressure or шϴϱ mmHg 
шϴϱ mmHg diastolic 
blood pressure or on 
treatment for previously 
diagnosed hypertension 
diastolic blood pressure or on 
drug treatment for 
hypertension 
Raised fasting glucose Fasting plasma glucose 
шϭϬϬ mg/dl (5.6 mmol/l) 
or previously diagnosed 
type 2 diabetes 
 Fasting plasma glucose 
шϭϬϬ mg/dl (5.6 mmol/l) or 
previously diagnosed type 2 
diabetes 
 
In the IDF and modified ATP III definations it was evident that ethnicity had a role in 
influencing metabolic syndrome. Thus different ethnic backgrounds, diet and physical 
activity, population age and sex structure and levels of nutrition, all have shown to influence 
the prevalence of the metabolic syndrome (32,43). Although the precise increase in the risk 
of developing NCDs may vary depending on the population being studied, from a clinical 
viewpoint the presence of the metabolic syndrome places a person at higher risk for major 
CVD events and/or T2DM (44). Taking this in a global prespective, it then becomes not only 
a medical, but also a socio-economic need to take all steps necessary to try and prevent the 
ravages which can be caused by T2DM and CVD (11,14,44). 
1.3.2 Prevalence of the Metabolic Syndrome  
The widespread use of the different metabolic syndrome definitions has resulted in a large 
number of studies describing different prevalence rates of the metabolic syndrome.  
The prevalence of the ATP-III metabolic syndrome in the U.S. was initially reported in the 
Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). The age-
adjusted prevalence was 23.7% (45–49). The contribution of the various components was 
different among ethnic groups. Low HDL cholesterol, hyperglycemia and high triglycerides 
made a significantly greater contribution in Mexican-Americans while arterial hypertension 
was more prevalent in African-Americans. The prevalence of the ATP-III metabolic syndrome 
was updated in the NHANES 1999–2000. The age-adjusted prevalence increased from 24.1% 
to 27% (48). An increased prevalence was observed in younger women (< 40 years).  
The WHO criteria was used mostly in European cohorts (46,49). The prevalence of the WHO 
metabolic syndrome in non-diabetic subjects varied between 7 and 36% for men 40–55 
years and between 5 and 22% for women of the same age group (49).  
Associations between the metabolic syndrome, CHD, and diabetes have also been 
established by an analysis of the cross-sectional NHANES III data on adults aged >50 years 
(50). A stepwise increase in the prevalence of the metabolic syndrome was observed with 
worsening glucose tolerance, and 86% of people with diabetes had the metabolic syndrome 
(51). The prevalence of CHD was 19% in people with both the metabolic syndrome and 
diabetes versus 9% in those with neither and 7.5% in the small percentage of the study 
population that had diabetes but not the metabolic syndrome. These results suggest that for 
most diabetic patients, cardiovascular risk is related not to diabetes itself but to the 
concomitant presence of the metabolic syndrome (52). 
The currently available definitions can be used as valuable tools for studying the disease 
pattern, even these definitions include, in affected and non-affected subjects a 
heterogeneous group of cases with a broad range of relative risks for future complications, 
which need to be explored.  
Finally, the metabolic syndrome could be considered as a prime target for preventive 
medicine. Clearly, the emerging global epidemic of metabolic and vascular disease has 
significant implications for the development of population based health promotion 
strategies. Lifestyle modifications and weight loss programs are a key part of the program 
because weight loss reduces the incidence of type 2 diabetes and a large percent of the 
affected subjects had excess body weight (53). Thus preventive programs, properly designed 
need to be implemented, otherwise we will continue to treat the majority of the cases when 
they reach the steeper extreme of the road: where many present with the complications of 
the metabolic syndrome such as diabetes complications and heart diseases. 
1.3.3 Metabolic Syndrome in South Asians 
In Asia the prevalence of the metabolic syndrome is in the range of 10% to 40% (54–58).  
Insulin resistance and clustering of other proatherogenic factors (the metabolic syndrome), 
is frequently seen in South Asians and these important contributory factors for T2DM and 
CHD make South Asians more prone to develop these diseases (58-60). Insulin resistance, at 
the level of the liver and peripheral tissues, and defective glucose sensing at the b-cell are 
the central pathophysiologic determinants that together cause and predict the defining 
hyperglycemia as is evident in figure 3. All of these factors are fueled by increasing obesity 
resulting from nutritional and lifestyle transitions (61).  
 
Figur 3. Insulin sensitivity (as box plots of the M/I) 
in individuals with NGT, impaired fasting glucose (IFG), IGT, and type 2 diabetes (T2D). Asterisks indicate a significant 
difference from the NGT group (61).  
Prevalence of obesity is rising in South Asia and this important factor is associated with 
insulin resistance since a increase of over one third ideal body weight decreases insulin 
sensitivity by 40% (62). There are other factors related to insulin resistance that also 
increase susceptibility to CHD in South Asians such as high levels of proatherogenic small, 
dense low-density lipoprotein (LDL) as observed in Asian Indians (63,64).   
Studies from India shows that about one third of the urban population has the metabolic 
syndrome and consequently the prevalence of T2DM has become double during the 
previous 3 decades (57, 65-68). Around 15% of the global mortality from CVD is also 
contributed by India and preventing metabolic syndrome could make a significant difference 
in reducing this also (69). The Southall study done in UK demonstrated that despite being 
matched for age and body mass index (BMI) with Caucasians, South Asian men had higher 
waist: hip ratio, higher systolic blood pressure (BP), higher insulin levels after glucose load, 
higher triglyceride levels and lower high density lipoprotein (HDL)-levels, all suggesting a 
high prevalence of the Metabolic Syndrome (53). In addition, type 2 diabetes a CHD risk 
equivalent was present in 20% of the South Asians compared to 5% of Caucasians adding to 
the CVD risk burden (70). This only highlights the increased risk that south asians have at 
lower thresholds and by making a diagnosis of the metabolic syndrome we might be able to 
initiate lifestyle changes earlier, to reduce the risk of CVD and T2DM in this population. 
1.3.4 Metabolic Syndrome in Pakistan 
Very few studies have looked at the prevalence of metabolic syndrome in Pakistan. One 
study done in rural area of Pakistan showed that in total 40% of the subjects met the IDF 
definition while 31% met the ATP III definition of the metabolic syndrome (71). Another 
recent population based study carried out in an urban area, Karachi of Pakistan showed  
metabolic syndrome at a prevalence of 34.8% according to the International Diabetes 
Federation (IDF) definition and 49% by the modified National Cholesterol Education 
Program, Adult Treatment Panel III (NCEP ATP III) criteria (72).   
In another study done in 400 subjects at a tertiary cardiology unit in Pakistan, the 
prevalence of the metabolic syndrome according to ATP III was 44% (73). While in another 
study also done in Karachi, 46% type 2 diabetic subjects were found to have metabolic 
syndrome according to the WHO definition (74). 
1.4 Associated Factors for Diabetes and Metabolic Syndrome 
Rapid demographic and nutritional changes with increased life expectancy and more elderly 
population is occuring globally.  Most importantly, globalization of diets and consumption of 
nontraditional fast foods is taking place at a very rapid pace especially in urban areas 
(14,75). A progression of these transitions and changes in populations of many countries is 
resulting in high prevalence of non-communicable diseases such as diabetes. Looking at 
developing countries we see that rapid increase in western fast food outlets and increased 
consumption of fried snacks is taking place (61,75). Furthermore, migration from villages to 
cities is increasing in these countries resulting in nutritional imbalance, physical inactivity, 
stress, and increased consumption of alcohol and tobacco (76-79). In addition, some 
populations such as south asians are physically less active leading a increasingly sedentary 
lifestyle which has further deterimental effects on their health (80-81).   
Thus some of the modifiable and non-modifiable risk factors contributing to type 2 diabetes 
as evident from various studies are shown in table 6 below. 
Tabell 6 Modifiable and non-modifiable risk factors and associated disorders for Type 2 diabetes 
 
It is important to remember that modifiable risk factors such as overweight and obesity, 
sedentary lifestyle, unhealthy diet, glucose intolerance, alcohol consumption, and tobacco 
smoking can be targeted for prevention of disease, and by controlling these risk factors 
through population based prevention programs we can reduce the disease burden (82).   
1.4.1 Socio-demographic Factors 
These include factors such as age, sex, family history of type 2 diabetes, genetic 
predisposition, history of gestational diabetes, and ethnicity etc. All of these belong to the 
nonmodifiable risk factors for type 2 diabetes but are mentioned here because they are 
important. The risk of type 2 diabetes increases markedly with age and unfortunately the 
age of onset of type 2 diabetes has steadily decreased down into younger adults and even 
adolescents in recent decades (82).  
Also the magnitude of the differences between Caucasians and South Asians when exposed 
to same environments implies a significant genetic contribution in them (70). Thus there is 
strong evidence that South Asians have a stronger genetic predisposition to diabetes than 
other ethnic groups. People who have family members with type 2 diabetes are at greater 
risk for developing diabetes themselves as is evident from a study done in Pakistan which 
showed that 45% people with diabetes had a positive family history of diabetes (83).  
1.4.2 Overweight and Obesity 
Obesity has been identified as the single most important risk factor for Type 2 diabetes. The 
WHO estimates that there are currently 1.1 billion people who are overweight with 
estimations of over 1.5 billion by 2015 (84). Longitudinal studies have shown obesity to be a 
powerful predictor for type 2 diabetes (84-85). This is further strenghten by the fact that 
interventions aimed at reducing obesity also reduce the incidence of Type 2 diabetes. 
The average BMI value in South Asians is lower than seen in white Caucasians, Mexican-
Americans, and blacks, but unfortunately South Asians have a higher percentage of body fat 
compared to white Caucasians and blacks at this lower BMI values (57,59,70).  
Because of this increased cardiovascular risk among Asian people occuring at lower waist 
circumference compared to European populations, both the WHO and the IDF have 
adopted the definition of overweight and obesity in Asians at a BMI of 23 kg/m2 or above 
and 25 kg/m2 or above, respectively, while central obesity is defined as a waist 
circumference of 90 cm or above in men and 80 cm or above in women (59). 
1.4.3 Nutritional transition 
Work patterns changing from heavy labour to sedentary due to increase in computerization 
and mechanization, and improved transport have made an impact on human health (14). 
These sedentary changes along with easy access to fast foods and empty calories have 
resulted in increased rates of obesity and type 2 diabetes globally (44,84-86). Although it is 
difficult to collect accurate dietary data, epidemiological studies indicate that a high calorie 
and low dietary fibre intake with a high glycaemic load and low polyunsaturated to 
saturated fat ratio contribute towards developing chronic diseases such as type 2 diabetes 
and metabolic syndrome (61,867-88). Thus diet is a crucial aspect of lifestyle changes. 
South Asians consume more carbohydrates compared to Europeans and this may lead to 
hyperinsulinemia, postprandial hyperglycemia, hypertriglyceridemia and low HDL 
cholesterol levels, all of which is probably due to insulin resistance (87). Particularly in South 
Asians the increased carbohydrate and fat intake, along with decreased fiber intake likely 
contributes to obesity, the metabolic syndrome and T2DM (61,87,89). Studies have shown 
that high intake of whole grain foods or cereal fibers reduce the risk of diabetes and even 
adjustments in diet composition without weight loss could improve hyperglycemia of 
diabetes (90,91).  
1.4.4 Physical Activity and Sedentary Lifestyle 
Physical activity has decreased over recent decades in many populations, and this is a major 
contributor to the current global rise of obesity. Physical inactivity has been found to be an 
independent predictor of Type 2 diabetes in both cross-sectional and longitudinal studies 
(81,82).  
Unfortunately South Asians have been found to be more sedentary compared to other 
ethnic groups (80,92-97). Increasing sedentary lifestyle is attributed to increased 
mechanization at workplaces and in household work. Leisure-time activities have also 
shifted from outdoor play to indoor entertainment such as television and computer games 
(94). Previously adolescents playing outdoor games regularly and doing household activities 
had lower prevalence of been overweight, compared to 3 times higher in those not 
participating in outdoor games (98).  Even for equivalent degrees of obesity, more physically 
active subjects have a lower incidence of diabetes. 
1.4.5 Glucose Intolerance (IGT and\or IFG) 
Prediabetes includes the diagnostic categories of IFG and IGT, but is actually a band of 
glucose concentrations over a continuum extending from conventional NGT to overt type 2 
diabetes as shown below. 
 
Prediabetes (IFG and/or IGT) should be viewed as a preclinical state in the natural history of 
disordered glucose metabolism rather than as a distinctive clinical entity representing an 
interim condition and as a risk factor prestaging (a) the development of diabetes (increased 
risk for diabetes) and (b) an increase in cardiovascular and possibly microvascular 
complications. 
The transition from prediabetes to diabetes may take many years but can also be rapid 
(99,100). Current estimates indicate that up to 70% subjects with prediabetes eventually 
develop diabetes (101). The International Diabetes Federation estimates that some 344 
million people have IGT worldwide in 2010, the vast majority of who live in low- and middle-
income countries. By 2030, the number of people with IGT is projected to increase to 472 
million as shown in Table 1 (12). 
Studies have observed that the risk of developing diabetes as well as the incidence of 
diabetes is highest in individuals with combined IFG and IGT (Relative risk is 12-fold higher) 
as shown in figure 4 below (100-102). The average risk of developing diabetes is about 5% to 
10% per year in individuals with IFG or IGT compared with approximately 0.7% per year in 
normoglycemic individuals (102).  
 
 
Figur 4. Relative risk of developing diabetes in different categories of prediabetes.    
Reference group is those with normal glucose tolerance (defined in each study). I-IGT, isolated IGT; I-IFG, isolated IFG; 
IGT 1 IFG, combined IFG and IGT. (102) 
Diagnosing prediabetes helps to identify a segment of the population which is at increased 
risk for developing both diabetes and CVD so that interventions can be initiated. Diagnosis 
has traditionally been made by measuring blood glucose levels during either fasting or an 
OGTT.  Many high-risk subjects (pre-diabetes) have a clustering of other cardiovascular 
disease risk factors, e.g. abdominal obesity, elevated levels of total triglycerides, low levels 
of high-density lipoprotein (HDL) cholesterol and elevated blood pressure, commonly known 
as the metabolic syndrome (31,32,42).  
1.5 Follow-up studies of Metabolic Syndrome (Prediction of DM and CHD) 
Results from large, prospective studies suggest that the metabolic syndrome is an important 
risk factor for CHD and type 2 DM, and it increases cardiovascular and total mortality (103). 
A  12-year follow-up data of 2682 middle-aged finnish men showed that death from 
cardiovascular disease was 2.9–4.2 times more likely among men with metabolic syndrome 
than those without metabolic syndrome at start of study (104).   
Since detecting subjects at risk of future disease and implementing programs to reduce the 
risk of progression to disease is a fundamental objective of preventive medicine, the 
metabolic syndrome can be used as a predictor to identify subjects at high risk of developing 
CVD and diabetes. The dysglycemia of type 2 diabetes coexists with other metabolic 
abnormalities such as obesity, dyslipidemia, and hypertension, leading one to postulate that 
the increased CVD risk in subjects with prediabetes may be largely due to the coexistence of 
other metabolic syndrome components (43).   
Several studies have shown that the metabolic syndrome predicted T2DM independent of 
other factors (105–109). Lorenzo et al. showed that the odds ratio (OR) using different 
definitions of the metabolic syndrome (ATP III [OR 2.00], IDF [OR1.69]), and the World 
Health Organization (WHO) [OR 1.73]) were almost similar in predicting incident CHD 
independent of age, sex, ethnic origin, history of CHD and T2DM, non-HDL-C, smoking 
status, and family history of myocardial infarction (110). Subjects free from CHD and/or CHD 
risk equivalents, when evaluated with ATP III, IDF, and WHO definitions, were also shown to 
have similar ORs for predicting CHD. Although some studies have shown that conventional 
risk factors may also predict T2DM or CHD, it appears that the metabolic syndrome adds to 
the prediction provided by individual components (111–114). 
Sattar et al. showed strong association of the metabolic syndrome with diabetes (RR, 7.47) 
in South Asians, however, with CHD it was less strong (RR, 1.27) (112). Forouhi et al. showed 
higher cardiovascular risk in South Asians compared to white Caucasians (114). The 
awareness of ethnicity as a potential independent risk factor for chronic disease has clinical 
importance because lower thresholds would have to be considered when planning primary 
prevention strategies in certain populations.  
1.6 Intervention Epidemiology 
Importance of identifying ssubjects at high risk for developing diabetes has increased with 
expansion of  knowlegde from prevention trials  that prevent or delay type 2 diabetes using 
lifestyle modification or medication (82). The cardiometabolic risk factors, including 
increased body mass index (BMI), blood pressure, and triglycerides, which often coexist in 
subjects with IGT and IFG can be modified as shown by prevention studies.  
Most interventions targeted preventing Type 2 diabetes by achieving and maintaining a 
healthy body weight through a combination of dietary measures and physical activity in high 
risk subjects (pre-diabetes group) (82). Dietary recommendations across studies are quite 
similar, and stress reducing fat intake and increasing vegetable consumption with moderate 
calorie restriction in overweight/obese populations.  The approach used to promote 
physical activity in the interventions range from providing exercise goals and advise on how 
to increase daily physical activity, to providing weekly supervised exercise training sessions. 
Most interventions recommend a minimum of 30–40 min of moderate physical activity on 
all or most days of the week. 
 
 
  
Tabell 7 Summary of major diabetes intervention studies 
 
Clinical trials have proven that prevention of type 2 diabetes with lifestyle intervention is
possible as shown in table 7, if high-risk subjects who might benefit from preventive 
interventions are used. Identification of such subjects through invasive blood tests, such as 
the OGTT, is however not feasible at the population level.  
One approach for identifying subjects at high risk for developing diabetes is the use of 
simple non-invasive scores. Because these scores can predict risk without requiring medical 
or invasive measures, they can be easily applied to and used by the general public and offer 
potential for mass screening programs (82). These risk tools can be used to identify people 
at high risk who can be offered a lifestyle program or become the first step in a 2-step 
screening procedure in which the risk tool is used to identify people who require further 
testing (82). Thus  further blood glucose testing can be done into a reconfigured score to 
increase the accuracy of risk prediction. 
Several risk tools have been developed across different populations. The first tool for 
predicting diabetes was Finnish Diabetes Risk Score (FINDRISC), and subsequently other 
tools have been developed in different countries (82). Variables included in determining risk 
are generally similar and include age, weight (body mass index, waist circumference), 
history of hypertension and high blood glucose levels (including gestational and pre-
diabetes), and level of physical activity.  
The IDF plan for the prevention of Type 2 diabetes is based on controlling modifiable risk 
factors and can be divided into two target groups: 
ͻƉĞŽƉůĞĂƚĂŚŝŐŚƌŝƐŬŽĨĚĞǀĞůŽƉŝŶŐdǇƉĞϮĚŝĂďĞƚĞƐ͖ 
ͻƚŚĞĞŶƚŝƌĞƉŽƉƵůĂƚŝŽŶ͘ 
The high risk approach consists of  3 steps and is used in most primary prevention trials. 
However, in planning national measures for the prevention of Type 2 diabetes, both groups 
should be targeted simultaneously. In addition, it is important that all activities are tailored 
to the specific local situation based on the cultural specifications. 
Preventive measures should be particularly vigorous for those with family history of obesity, 
T2DM, or premature CHD the so called high risk population.  Overweight individuals and 
those with abdominal obesity should be actively encouraged to lose weight by lifestyle 
measures.  
Research on metabolic syndrome in South Asians should be targeted; initially to observe the  
prevalence of metabolic syndrome or high risk subjects in the community and to identify the 
associated risk factors for diabetes and CVD. The metabolic syndrome should be considered 
as a prime target for preventive medicine. The primary management goals of the metabolic 
syndrome are to reduce the risks of cardiovascular disease and diabetes burden. This can be 
followed by prospective intervention studies to ascertain the effect of intervention to 
prevent T2DM  in these high risk subjects.  
A high prevalence of the metabolic syndrome in South Asians suggests a higher risk of 
developing cardiovascular and diabetes in the future. Despite the challenges involved in 
day-to-day life, the intervention to prevent diabetes is needed in Pakistan due to increased 
inherent genetic predisposition, younger age of onset of disease, lack of capacity and 
resources to treat the condition effectively at the primary health-care level. 
Targeting subjects with IGT  for lifestyle interventions focused around increasing activity and 
altering dietary factors has been particularly effective and primary prevention trials have 
produced significant results in people at high risk of diabetes. This has also lead to 
recommendations been proposed by some for primary prevention in subjects with 
prediabetes as shown in Table 8 below.   
One of the major difficulties in translating knowledge generated by randomized clinical trials 
(RCTs) is the inability to generalize to the practice setting as they were conducted in a 
controlled environment. Attempting to translate interventions from studies into a practical 
setting of diverse nature with less funding which leads to deviations from the initial 
intervention protocols has resulted in a variety of new approaches which is a challenge for 
public health experts. 
 
 
 
  
Tabell 8: Key features of selected published recommendations on prediabetes 
 
 ADA Consensus  Statement 
(2007) 
Indian Health Services 
Guidelines for Care of 
Adults with Prediabetes 
and/or the Metabolic 
Syndrome in Clinical 
Settings (2006) 
Australian Diabetes Society 
and Australian Diabetes 
Educators Association 
Position Statement (2007) 
IFG FPG > 100 mg/dL (5.6 
mmol/L) but < 126 mg/dL 
(7.0 mmol/L) and 2-h 
plasma glucose < 200 mg/dL 
(11.1 mmol/L) 
FPG > 100 mg/dL (5.6 
mmol/L) but < 126 mg/dL 
(7.0 mmol/L) 
FPG > 110 mg/dL (6.1 
mmol/L) but < 126 mg/dL 
(7.0 mmol/L) and 2-h plasma 
glucose < 140 mg/dL (7.8 
mmol/L) 
IGT FPG  < 126 mg/dL (7.0 
mmol/L) and 2-h plasma 
glucose > 140 mg/dL (7.8 
mmol/L) but < 200 mg/dL 
(11.1 mmol/L) 
2-h plasma glucose > 140 
mg/dL (7.8 mmol/L) but < 
200 mg/dL (11.1 mmol/L) 
FPG  < 126 mg/dL (7.0 
mmol/L) and 2-h plasma 
glucose > 140 mg/dL (7.8 
mmol/L) but < 200 mg/dL 
(11.1 mmol/L) 
Who should be 
screened for  
diabetes? 
Individuals with risk factors 
for diabetes should be 
screened for prediabetes 
Annual testing of individuals 
at risk for developing  
diabetes 
Incidental detection when 
screening for diabetes 
Method of 
Screening 
FPG 
2-h OGTT if metformin 
therapy is considered 
FPG 
Optional 2-h OGTT if 
resources permit 
Incidental detection when 
screening for diabetes 
Recommended 
Treatment 
Lifestyle modification for 
IFG or IGT                   
Lifestyle modification 
and/or metformin for IFG 
and IGT and at least one of 
the following:  age <60years, 
BMI >35kg/m2,  family 
history  of diabetes in first 
degree relatives,  elevated 
triglycerides,     reduced 
HDL-C,  hypertension,  
HbA1c >6.0% 
Lifestyle changes 
Consideration of metformin 
on an individualized basis; 
depression screening and 
cardiovascular risk reduction 
also recommended 
Intensive lifestyle 
intervention for a minimum 
of 6 months before 
consideration of 
pharmacotherapy 
Follow-up Metformin treatment: 
semiannual HbA1c  
Lifestyle intervention: 
annual follow-up 
Monitor glucose values 
every 6 months  
75-g OGTT, initially 
performed annually, then 
indivudualized retesting 
every 1-3 years 
Data from American Diabetes Association. 2010 Standards of medical care in diabetes. Diabetes Care 2010;33(Suppl 1):511-61.
 
 1.7 Rationale or Statement of Problem 
Pakistan has been undergoing demographic, epidemiological and nutritional transition for 
the last few decades. Increased access to energy dense foodstuffs and reduced physical 
activity has resulted due to so called “urbanization” and “westernization”. Pakistan is also 
one of the top 10 countries with the most people with diabetes and this current state of 
affairs will take it in the top 5 countries list by 2030 (12).  
Since the metabolic syndrome is postulated to be a precurser of type 2 diabetes and CVD, it 
seems that in view of the increasing prevalence of type 2 diabetes, there will be high 
number of subjects  with metabolic syndrome in Pakistan. Although the prevelance of 
metabolic syndrome has been reported to be 44% to 46% in studies done in Pakistan, it has 
been done in cardiac and diabetic subjects (75,76). No population based epidemiological 
study had been done in the urban areas of Pakistan to find the prevalence of metabolic 
syndrome and its associations with the risk factors of T2DM and CVD. 
The current epidemiological study will help to assess the prevalence of metabolic syndrome 
in the general population and look at the associated risk factors, as well as establishing 
baseline cutoff values for insulin sensitivity. This will help in understanding the volatile high 
risk situation of future disease burden and lay the foundation for planning intervention 
studies of primary prevention of Type 2 diabetes and CVD.  
Epidemiological evidence have suggested that unless effective prevention and control 
programmes are started, the prevalence of diabetes will continue to rise globally (82). The 
collective results of primary prevention trials have showed an average reduction of 51% in 
new cases of diabetes in high risk subjects (82). Individuals usually at highest risk for 
diabetes are those having prediabetes i.e. impaired fasting glucose (IFG) andШŽƌŝŵƉaired 
glucose tolerance (IGT) . Thus identifying high risk subjects and initiating lifestyle 
intervention are important primary prevention strategies globally.  
Since diabetes is increasing at a rapid rate in Pakistan with alarming consequences, 
prevention is becoming highly relevant over here where subjects have increased inherent 
genetic predisposition and younger age at onset of disease. We lack the resources to 
effectively treat the condition at the primary healthcare level and also lack equitable access 
to healthcare for treating the complications which arises from diabetes. This makes a strong 
case for investment in diabetes prevention to reduce the future disease burden (44,72,82). 
 
1.8 Research Questions and Objectives of the Study  
  
1.8.1 Research Questions 
What is the prevalence of metabolic syndrome based upon WHO, ACE, EGIR, modified ATP 
III and IDF definition in this Pakistani population?  
What is the prevalence of diabetes and other forms of abnormal glucose tolerance in 
subjects aged 25 years and above in Karachi, Pakistan?  
What is the insulin resistance cutoffs for our population? 
What is the distribution and relationship of diet with metabolic syndrome in this 
population? 
What is the rate of conversion of IGT to diabetes? 
What effect does intervention (lifestyle modification and lifestyle modification with 
metformin) has on the onset of type 2 diabetes in an urban setting? 
 
1.8.1.1 Main Objective 
x To determine the prevalence of metabolic syndrome in a sample of adults aged 25 
years and above from an urban population of Karachi. 
 
x To observe the rate of conversion of IGT to diabetes and to observe the impact of 
intervention (lifestyle modification and combining lifestyle modification with 
metformin) on the onset of type 2 diabetes in an urban population.  
 
1.8.1.2  Specific Objectives 
More specifically, the objectives of the two studies  were to: 
Estimate and compare the differences in prevalence of metabolic syndrome based upon 
modified ATP III and IDF definition in Pakistani population.  
Estimate the prevalence of diabetes and other forms of abnormal glucose tolerance and 
association with metabolic syndrome.  
Assess the relationships of diet with metabolic syndrome and its risk in this population. 
To evaluate the impact of intervention with lifestyle modification. 
To note the usefulness of adding an insulin sensitizer (Metformin 500 mg BD ) in this 
population with lifestyle modification and register the benefits of combining them. 
 
1.9 Justification of the Study 
 
It has been noted that the features of Metabolic Syndrome may present up to 10 years 
preceding Type 2 diabetes and CVD (103-110). Especially in South Asians having a high 
prevalence of the Metabolic Syndrome may lead to a high diabetes and CVD incidence in the 
coming decade (57,58).  
The increasing prevalence of obesity in recent years along with metabolic syndrome has 
increased the risk of developing Type 2 diabetes and CVD manifold. Identifying the risk 
factors associated with Metabolic Syndrome is thus important if primary prevention 
programs for diabetes and CVD are to be planned in the future. 
The identification of risk factors especially modifiable ones would be a integral and vital part 
of public health polices on prevention as longitudinal studies have shown that reducing 
these risk factors delays or prevents the occurrence of disease in the future.  
The clustering of these risk factors in the so called “metabolic syndrome” may also provide 
the primary care physician an integrative view of linking conditions together so as to treat 
these high risk subjects much earlier.  This identification of cluster of risk factors may also 
help in identifying high risk subjects in whom intervention can be done.  
Once these high risk subjects are identified, initiating intervention in such primary 
prevention program could be initiated and culturally adapted needs in such a  pioneer 
program would be observed and documented for future health policy planning. 
Unless such culturally adapted effective primary prevention programmes are designed and 
implemented, the prevalence of diabetes will continue to rise steeply. 
The first step should be a primary prevention study of a smaller scale, the results of which 
are to be analysed and if needed modified according to local needs to initiate local or 
national health care policies. 
 
 
 
 
 
2 Chapter 2: Material and Methods  
2.1 Study Sites 
Two studies were consequently undertaken with different study designs; the first an 
epidemiological survey in one area of karachi in 2004 followed by the second, a prospective 
intervention study done between 2006-2009 in karachi.  
The first was an epidemiological survey designed to see the prevalence of metabolic 
syndrome and its risk factors among 500 randomly selected households in Lyari, an urban 
area within Karachi city in 2004 .  The second was a primary prevention study done in the 
city of Karachi from 2006-2009. It was a prospective randomized clinical trial (RCT) to assess 
the effect of intervention for 18 months on high risk subjects.   
2.2 Research Setting  
2.2.1 Epidemiological survey in Lyari town: 
The City of Karachi is divided into 18 towns as shown in figure 5 and Lyari Town is one of the 
oldest and most densely populated part of Karachi city. Lyari’s approximately 700,000 
residents form an extremely diverse community, representing almost every cultural and 
ethnic groups found in Pakistan. There is a wide spectrum of socioeconomic groups. 
2.2.2 Primary Prevention Study in Karachi city 
Karachi is the largest and most populous city in Pakistan. The City of Karachi is divided into 
18 towns and 178 union councils. Today the population of this megacity is somewhere 
around 16 million.   
1. Lyari Town, 2. Saddar Town, 3. Jamshed Town, 4. Gadap Town, 5. SITE Town, 6. Kemari Town, 7. Shah Faisal Town, 8. Korangi Town, 9. Landhi 
Town, 10. Bin Qasim Town, 11. Malir Town, 12. Gulshan Town, 13. Liaquatabad Town, 14. North Nazimabad Town, 15. Gulberg Town, 16. New Karachi 
Town, 17. Orangi Town, 18. Baldia Town. A. Karachi Cantonment (Cantt.), B. Clifton Cantt, C. Korangi Creek Cantt, D. Faisal Cantt, E. Malir Cantt, F. 
Manora Cantt.  
Figur 5: Description of the 18 towns and 6 cantonments of Karachi. 
  
Figur 6: Lyari Town 
 
Figur 7: Lyari Town 500 Households randomly selected 
2.3 Study Population 
2.3.1 Lyari Town 
We generated a computerized random sample of 500 households from among the 85,520 
households in Lyari Town as shown in figure 6. There were 11 union councils in Lyari Town 
where the samples were taken from ensuring that each union council had equal opportunity 
to be represented in the sample selection. We expected approximately 1000 adult men and 
women 25 years and above in the 500 households selected in Lyari Town as shown in figure 
7. If members of a household that had been selected refused to consent to household 
interviews, we knocked on the third door to the right of that house (while standing facing 
the door of the original house) and seeked consent there. If we were refused again, we 
knocked on the next consecutive door to the right and repeated this process until we had 
enrolled a household from the neighbourhood of the original household selected. 
2.3.1.1 Criteria for Inclusion and Exclusion 
All adults 25 years and above from the selected households who gave their informed 
consent were included in the study.  
Persons with physical or intellectual disabilities that precluded participation in the study 
were excluded and also those who had resided in the current address for less than 6 months 
before the survey. 
2.3.2 Karachi City 
Karachi is the largest and most populous city of Pakistan. All the major ethnic groups of the 
country are represented here. High risk questionnaires were distributed at the out patient 
departments of health care centres to recruit the family members of known diabetes 
subjects. Posters, banners and leaflets informing about the primary prevention program 
were distributed throughout the city. Our team of health professionels also visited different 
organizations and offices to generate awareness about our primary prevention program and 
gave awareness lectures. Diabetes screening camps were also arranged at various public 
places such as parks and community halls to create awareness about diabetes and inform 
the general public about the prevention program.  
2.3.2.1 Criteria for Inclusion and Exclusion 
Subjects over the age of 30 years who fulfilled the study criteria were included. Subjects 
having IGT and no known diabetes were included.  
Subjects with a debilitating disease or compromised condition such as cancer or hepatitis 
etc, which could be a contraindication to participate in such a trial were excluded.  
Those taking any medication which could affect their blood glucose levels such as beta 
blockers for hypertension etc, or planning to get pregnant were also excluded from the 
study. 
2.4 Sample Size 
2.4.1 Lyari Town 
In the planning phase of the study the following assumption was made by the research 
group of the epidemiological survey;  
Assuming that the prevalence of T2DM to be 11% in this population and the size of the 
population from which the study sample is to be selected (persons 25 years and above in 
Lyari Town) is 244,000. The worst acceptable result is ±1.5% from the true population value, 
thus our study would require a sample of at least 713 individuals to have 80% power to 
detect the true population value.  
Individual members within households also reserve the right to refuse participation in the 
study. Assuming a 10% refusal rate (by members within the household at the time of 
interview) and another 10% refusal rate by those who decline to provide consent for a blood 
test, we expected at least 810 individuals to participate in this study. 
Since the prevalence of metabolic syndrome is assumed to be higher than that of diabetes 
we believe this sample size would be sufficient for assessing metabolic syndrome in our 
population. 
In the field we were able to interview 867 individuals; more than the required number 
needed but only 363 individuals gave blood samples leaving us with less than the required 
numbers at the end of the study having 40 – 45% power to detect true population value.    
2.4.2 Karachi City 
For the primary prevention study nearly 2000 suspected high risk cases identified by a high 
risk questionnaire were to be invited to participate. Considering 30% IGT cases in high risk 
individuals around 600 were expected to have IGT. The IGT cases were then to be randomly 
allocated on three different arms, two preventive groups and one control group, all with 200 
participants. With an expected conversion rate of  nearly 30% T2DM in the control group (n 
= 60) and an reduction of 15-20 % in the intervention group (n = 9 -12) the sample size will 
be adequate considering ß = 0.20 and ɲсϬ͘Ϭϱ  ͘
Although an estimated 5000 people attended the diabetes prevention lectures and visited 
the screening camps and around 2300 people filled in the high risk questionnaire only 1825 
were identified as high risk on the basis of the questionairre. Of these 1739 high risk 
subjects undertook a standardized oral glucose tolerance test (OGTT) and 317 subjects were 
identified as having impaired glucose tolerance (IGT group) and were randomized into the 
three groups. 
2.5 Research Design  
2.5.1 Lyari Town 
2.5.1.1 Survey protocol and procedures 
The survey activities were conducted over a period of 6 months from July to December 
2004. A Geographical Imaging Systems (GIS), previously developed for Lyari Town with 
unique identification numbers ascribed to 85,520 households was used.  
The survey activities were divided into two phases—the household interview plus physical 
examination and blood sample collection. 
A household was defined as including all those who shared a kitchen. Five hundred 
households were randomly selected through the GIS software and maps to these 
households were generated for 9 field teams. A field team comprised of one or two medical 
students, a female health worker and a male health worker. Surveyors from the GIS teams 
worked as guides for 2-3 teams in a given area. All teams and surveyors were supervised by 
a medical doctor acting as the field coordinator.  
2.5.1.2 Household census and interview 
Twelve medical students conducted these household visits with the assistance of 8 health 
workers from Lyari Community Development Project – a local welfare organization. Once a 
household was located, medical students identified themselves to the oldest male or female 
member present and informed them of the objectives of the survey. All adults 25 years and 
older were invited to participate after providing signed consent. In case of illiterate 
participants, the consent form was read out to them and a thumb print procured in the 
presence of a household member or neighbour as witness.  
Field work entailed afternoon visits to the selected household by a field team (medical 
students and health worker), introduction to the purpose of the research study, consent, 
interviews and physical measurements (including weight, height, waist and hip 
circumference, blood pressure).  
The interviewers made a minimum of 2 visits and up to 5 visits before a household was 
classified as a non contact. Where possible, at each participating household a personal 
interview was conducted with every adult member aged 25 years and above who met the 
eligibility requirements.  
At the end of the household visit, all adults 25 years and above were asked to undertake an 
8 hour fast for blood tests (fasting blood sugar and lipid profile) that was collected at home 
on Saturday and Sunday mornings. All adults were provided with a urine collection bottle 
and asked to collect a mid-stream urine specimen for tests (pus cells, proteinuria and 
microalbuminuria) on the morning of  their blood test date.  
2.5.1.3 Questionnaire 
The adults present in each household were administered a survey form (Questionnaire) 
which consisted of 3 main parts.  
Part A collected information about the entire household and was same for all the persons 
living in a specific household. It consisted of 4 sections.  
Part B of the survey form collected information about personal and family history of the 
persons in each household and consisted of 6 sections.  
Part C collected anthropometric information about the individual persons and also lab 
reports were written in this section.  
Anthropometric data included measurements of weight, height, waist and hip 
circumference. Participants were asked to wear light clothing and take off their shoes during 
anthropometry measurements. Height was measured to the nearest cm and weight to the 
nearest 0.1 Kg. Weight was taken with a standardized scale and height with a standardized 
measuring stick. Waist circumference was measured as the mid point between the iliac crest 
and the lower margin of the ribs.  
Blood pressure was take by a medical student or doctor at least twice with 20 minute 
intervals, after ensuring that at least 30 minutes had passed since tea or tobacco were last 
consumed. A third BP measurement was taken if one or both of the first two readings were 
above the cutoffs for a diagnosis of hypertension.  
2.5.2 Karachi City 
2.5.2.1 Study  protocol  
This was a randomized clinical trial (RCT) conducted in subjects over 30 years of age who 
were diagnosed as having IGT according to World health Organization criteria (38). The IGT 
subjects were followed for a period of 18 months prospectively. Awareness about the 
primary prevention program was disseminated through posters\banners and leaflets. Our 
primary prevention team also visited different primary health care centres in the city to 
generate awareness about our primary prevention program and held diabetes screening 
camps at various public places such as parks and community halls.  
To identify subjects from the general population who may be at increased risk of developing 
type 2 diabetes, a questionnaire was asked to be filled in as the first step. This standardized 
questionnaire asking about family history (parents or siblings with  diabetes), high body 
mass index, low physical activity, age > 40 years, hypertension, high cholesterol or 
triglycerides and history of gestational diabetes or baby weighing > 3.5 Kg at birth was used 
to identify high risk subjects at this initial step. Those identified as high risk were further 
asked to undertake an Oral Glucose Tolerance Test (OGTT). Those subjects identified as 
being IGT were stratified randomly by age into three different arms to ensure equal age 
representation in all the arms of the intervention. The age stratification was 31- 40 years, 
41–50 years, 51–60 years and > 60 years into each of the three groups.  
2.5.2.2 Recruitment and Questionnaire 
A number of strategies starting with opportunistic screening at the 2 health care centres 
involved in the study was initiated. With the aim to reach a greater audience our diabetes 
prevention team arranged a series of 2-days awareness lectures at various places in the city 
by going to offices, service organizations, work factories and visiting health care centres. 
Lectures on diabetes and its prevention were delivered by the diabetes prevention team in 
local language to the audience on the first day. The audience were asked to fill in the risk 
questionnaire at the end of the first day. On the second day, screening of high risk subjects 
was done according to results of the questionnaire and all high risk subjects were invited for 
an OGTT.  
During the time that the OGTT was done, all subjects underwent a detailed anthropometric 
and medical examination as well as been asked questions about their socio-demographic, 
physical activities and dietary habits including information on quantity and quality of meals 
by a dietician and physical trainer. Weight, height, waist circumference and blood pressure 
were measured at each scheduled visit. Weight and height was measured with the subjects 
minimally clothed, without shoes, in a standing position. Waist circumference was measured 
at the mid-point between the iliac crest and the costal arch. Blood pressure was measured 
twice, 5 min apart, in a sitting position, and the average of the two was recorded. 
2.5.2.3 Intervention and Randomization 
All subjects who agreed to participate in the study were randomized into three groups. First 
group (Control Group) was given standard medical advice, second group (ILSM Group) was 
given intensive lifestyle modification advice while thrid group (ILSM+Drug Group) was given 
intensive lifestyle modification advice and metformin 500 mg twice daily. The subjects 
assigned to their respective groups were followed till the close of the study.  
The subjects in the control group were given general diet and exercise information at 
baseline and followed at subsequent visits but no specific individual counselling was done.  
The subjects in the intervention+drug group were given detailed advice about how to 
achieve the intervention goals, which included reducing > 5 % of body weight loss via diet 
control and physical exercise, total fat intake less than 30% of energy consumed, fiber intake 
of 15g/1000 kcal, and moderate exercise for minimum 30 min/day. Frequent ingestion of 
wholemeal products, vegetables and fruits, low-fat milk and meat products, and vegetable 
oils rich in monounsaturated fatty acids was recommended. The subjects had sessions with 
a dietician and physical trainer at each visit and they were individually guided and 
encouraged to increase their level of physical activity. Endurance exercises such as walking, 
jogging and cycling were recommended to increase fitness. Supervised, progressive and 
individually tailored training advice was also offered to improve the functional capacity and 
endurance of each individual. These interventions were based on reinforcing behaviour 
modification via diet change and encouraging physical activity of each subject individually. 
The subjects in the intervention+drug group were seen every 2 months by a medical doctor 
for their drug adherence apart from the intervention advice.  
2.5.2.4 Follow-up 
Reinforcement and counselling was done every 2 months in the intensive and 
intensive+drug groups with visits to the medical officer, dietician and physical trainer. While 
every 3 months the subjects in the control group were seen by the medical officer. 
2.5.2.5 Primary Outcome: 
The primary outcome was defined as developing diabetes indicated by either fasting plasma 
glucose of (> 125 mg\dl) and \or 2-hours plasma glucose of (>199 mg\dl) during 9 and 18 
months follow-up by an OGTT (38). Subjects identified as having diabetes were excluded 
from the study and given medical advice with referral to physicians for further follow-up. 
2.6 Lab Investigations: 
2.6.1 Blood and Urine Samples of Lyari Town Survey 
Specimens were collected at home on Saturdays and Sundays by five mobile teams 
consisting of two phlebotomists each. At the time of blood collection, all participants were 
asked to provide consent for blood tests for fasting blood glucose and lipid profile and urine 
for proteinuria.  
All blood samples were collected in two separate test tubes; a red cap vacutainer and green 
cap sodium fluoride tube. A total of 12 cc of blood was taken from each patient. 10 cc was 
place in the red vacutainer for analysis of Lipid profile and insulin serum levels and 
remaining 2cc was placed in the green NaF test tube for analysis of fasting glucose.  
Within 1 hour of collection the blood was centrifuged and separated. Tests were done by 
the Vitalab Selectra Analyzer for Glucose, Cholesterol, Triglycerides, HDL-Cholesterol, LDL-
Cholesterol and Insulin levels. Fasting blood glucose and lipid profile were done by GOD PAP 
method and CHOD PAP method respectively. Insulin levels were done by Elisa method.  
Urine samples were collected from the respective subject on the morning of collection. They 
were advised to keep the specimen in a cool and shaded area. Urine tests included a 
qualitative determination of proteinuria and a quantitative measurement of 
microalbuminuria. 
2.6.2 Samples of Karachi City 
All IGT subjects in the primary prevention study had fasting lipid profile, fasting insulin 
levels, OGTT and HbA1c done at 0, 9 and 18 months. At the interim 9-month visits, 
confirmation of diabetes was made with OGTT. Plasma glucose was measured using the 
glucose oxidase–peroxidase method. The fasting serum lipid profile was estimated using 
standard enzymatic procedures. HbA1c was measured by HPLC using Biorad, a procedure 
certified by the National Glycohemoglobin Standardization Program.  
2.7 Statistical analysis 
 
2.7.1 Lyari Data 
All data was recorded on forms developed using TeleForm® Version 6.01, an optical 
character recognition software. Forms were scanned and verified using TeleForm® Version 
6.01 and exported into an SQL database. Later this data was converted into the software 
package SPSS version 11.5 (Statistical Package for Social Sciences) for analysis.  
The main variables for analysis included age, gender, socioeconomic and ethnic groups, 
fasting glucose and insulin levels, lipid profile, proteinuria and microalbuminuria, 
hypertension, body mass index, waist-hip ratio, mid-abdominal circumference, smoking 
exposure and family history of disease.  Some of the other risk factors to be included in the 
analysis were physical activity and diet.  
The prevalence of metabolic syndrome was determined by simple percentages and with 
95% confi dence intervals (CIs). For group comparisons, the chi-square test was performed; 
the Student t-test was performed for continuous variables. A P value of <0.05 was 
considered statistically significant. The age-specific distribution of prevalence of metabolic 
syndrome was calculated for men and women separately and described in percentages. A 
kappa test was done to examine the agreement among the defi nitions. All P values 
presented are two tailed (Paper 1). 
2.7.1.1 Dietary data:  
Dietary consumption was assessed by a 33 food items interviewer-administered semi 
quantitative food-frequency questionnaire in the lyari town study. The food items were 
categorized into 6 major food groups: Dairy, meat, fat and sweet, cereals, vegetables and 
fruits groups. Out of the 363 subjects assessed for metabolic syndrome 362 completed the 
food-frequency questionnaire. 
We used cluster analysis to identify dietary patterns and to segregate subjects based on the 
similarity of diet. We chose food variables because we wanted to identify food patterns 
clusters. K-means cluster analysis was used to define clusters of subjects using the cluster 
analysis option in SPSS. This procedure attempts to identify relatively homogeneous groups 
of cases based on selected characteristics. 
In K-means cluster analysis, the homogeneity of cases within a cluster is measured by the 
total within-cluster sum of squares. Cluster memberships are determined by sequentially 
moving cases from one cluster to another so that the total within-cluster sum of squares is 
minimized. The algorithm requires the number of clusters to be specified prior to analysis. It 
is possible to identify seeds using information derived from previous research. Five clusters 
were defined and we investigated metabolic syndrome prevalence in each cluster and 
compared the dietary patterns of the clusters with the lowest and highest prevalence of 
metabolic syndrome (Paper 2). 
2.7.1.2 Assessing insulin resistance 
Insulin resistance was assessed in 227 normal subjects by calculating HOMA, QUICKI and 
McAuley Index indices by the following calculations: 
x HOMA-R = Insulin (Iu/ml) × glucose (mmol/l)/22.5 
x QUICKI = 1/ [log (fasting insulin) + log (fasting glucose)] 
x McAuley Index = Exp [2.63-028 ln (Insulin in Mu/l)-0.31ln (triglyceride in mmol/l). 
Characteristics of the subjects according to gender were analyzed using an independent 
sample t-test. Data was presented as quartiles of fasting insulin, HOMA-IR, QUICKI and 
McAuley index to observe the various percentiles of insulin sensitivity and determine insulin 
resistance according to defined standard protocols.   The statistical analysis was conducted 
using SPSS for Windows (version13, SPSS Inc., Chicago, IL, U.S.A.), and p <0.05 was 
considered statistically significant (Paper 3). 
 
2.7.2 Primary Prevention Study 
Mean and standard deviation are reported for continuous variables and inter-group 
comparisons were tested by two tailed ANOVA in this study. Comparison of proportions was 
by chi square analysis. The proportion of subjects developing diabetes in each group and 
their comparison was also done by chi square analysis.  
For the intervention measures, the absolute and relative risk reductions and 95% CIs of the 
estimates and the number needed to treat to prevent diabetes in one person were 
calculated. A p value <0.05 was considered significant. The statistical package SPSS (PASW 
Statistics 18) was used for analyses (Paper 4). 
2.8 Ethical Considerations 
2.8.1 Ethical Clearance 
The study protocols of the epidemiological survey in Lyari Town and the Primary prevention 
study in Karachi city were approved by the institutional review board of the Baqai Institute 
of Diabetology and Endocrinology (BIDE).  
The study protocols  had also been sent to the Norwegian Ethics Committee for approval. 
2.8.2 Informed Consent 
Informed consent is a prerequisite for all research involving human subjects. Verbally and in 
writing, subjects were informed about the purpose and scope of both the studies 
independently, the benefits and risks of the studies, how the results will be used and 
reported and the method of confidentiality that will be used in reports. Since all the subjects 
were interviewed from a structured questionnaire; questions did not probably change from 
subject to subject.   
All participants in both the studies were required to give their informed consent voluntarily 
and the study was carried out in accordance with the Declaration of Helsinki as revised in 
2000.  
All participants reserved the right to withdraw from the study at any time, even if they have 
previously given consent to be part of study. The findings were treated with highest possible 
degree of confidentiality. Each subject was given a unique identity number. 
After data collection was completed and the subjects had received their results the data was 
anonymized. Names were deleted and the data could not be traced back to any specific 
individual.  
 
 
 
 
 
 
 
 
 
 
 
3 Results 
 
3.1 Synopsis of Paper 1 
 
Reference: 
Prevalence of Metabolic Syndrome in Urban Pakistan (Karachi): Comparison of Newly 
Proposed International Diabetes Federation and Modified Adult Treatment Panel III Criteria. 
M. Zafar Iqbal Hydrie, A. Samad Shera, Asher Fawwad, Abdul Basit and Akhtar Hussain.  
METABOLIC SYNDROME AND RELATED DISORDERS, Volume 7, Number 2, 2009. 
 
Title: Prevalence of Metabolic Syndrome in Urban Pakistan (Karachi): Comparison of Newly 
Proposed International Diabetes Federation and Modified Adult Treatment Panel III Criteria 
Abstract: 
The clustering of central obesity, dyslipidemia, hypertension, and hyperglycemia known as 
metabolic syndrome has been associated with a two- to three-fold increase in type 2 
diabetes (T2DM) and cardiovascular disease (CVD). It is recognized that the features of the 
metabolic syndrome can be present 10 years preceding T2DM and CVD. The objective of our 
study was to determine the prevalence of metabolic syndrome in adults aged 25 years and 
older from an urban population of Karachi, Pakistan, according to the International Diabetes 
Federation (IDF) definition and modified Adult Treatment Panel III (ATP III) criteria. This 
study involved a survey conducted from July, 2004, to December, 2004, by generating a 
computerized random sample of households in Lyari Town using a geographical imaging 
system (GIS). Out of the 85,520 households, 532 households were randomly selected and 
867 adults ш25 years old consented to take part in the survey; 363 of these subjects gave 
blood samples. The prevalence of diabetes was 9.4%, whereas 5.6% had impaired fasting 
glucose (abnormal glucose tolerance 15%). The prevalence of metabolic syndrome 
according to the IDF definition and modified ATP III criteria was 34.8% and 49%, 
respectively. Inclusion of modified waist circumference and specifi c body mass index (BMI) 
cut offs for Asians may help predict metabolic syndrome at an early stage. High prevalence 
of metabolic syndrome was identified irrespective of the definition applied in this 
population. This may call for immediate action to halt the accelerating risk of diabetes and 
CVD that would lead to a possible unparalleled rise in the cost of health care and human 
suffering. 
 
 
3.2 Synopsis of Paper 2 
 
Reference: 
Dietary Patterns Associated with Risk for Metabolic Syndrome in Urban Community of 
Karachi Defined by Cluster Analysis.  
M. Zafar Iqbal Hydrie, Abdul Basit, A. Samad Shera, Rubina Hakeem and Akhtar Hussain. 
Pakistan Journal of Nutrition 9 (1): 93-99, 2010. ISSN 1680-5194. 
 
Title: Dietary Patterns Associated with Risk for Metabolic Syndrome in Urban Community of 
Karachi Defined by Cluster Analysis.  
Abstract: Dietary trends have been found to be related with metabolic syndrome in various 
studies. To identify dietary patterns and study associations between the dietary patterns of 
subjects with high and low risk of metabolic syndrome in a Karachi population. A group of 
871 men and women were selected randomly from 532 households. Data about  
consumption of specific foods was available for 867 adults. Participants completed a health 
and lifestyle questionnaire and 363 subjects provided fasting blood samples for glucose and 
lipids. Dietary intake was assessed by a questionnaire to identify consumption of 33 specific 
food items and the dietary patterns categorized into 6 food groups was assessed by cluster 
analysis. Five dietary patterns were identified through cluster analysis. Cluster 1 had the 
lowest proportion of persons with metabolic syndrome i.e. 42.7% while cluster 2 had the 
highest percentage of metabolic syndrome subjects (56.3%) (p = 0.09). Consumption of fat 
and caloric dense foods was significantly higher among highest risk group (cluster 2) 
compared to lowest risk group (cluster 1) (p = 0.0001). The consumption of food groups 
containing fruit, milk and meat was also more than twice in high risk compared to low risk 
group (p = 0.0001). Even within the same population there are marked differences in dietary 
patterns and these apparently contribute to the risk of developing metabolic syndrome. 
Dietary pattern studies will help elucidate links between diet and disease and contribute to 
developing healthy eating guidelines. 
 
 
 
 
 
 
 
3.3 Synopsis of Paper 3 
 
Reference: 
Detecting Insulin Resistance in Pakistani Subjects by Fasting Blood Samples.  
M. Zafar Iqbal Hydrie, Abdul Basit, Asher Fawwad, Muhammad Yakoob Ahmedani, A Samad 
Shera and Akhtar Hussain. 
Accepted in The Open Diabetes Journal. 
 
Title:   Detecting Insulin Resistance in Pakistani Subjects by Fasting Blood Samples 
 
ABSTRACT:  
Background: Insulin Resistance has been identified as an independent risk factor for a 
number of chronic diseases such as diabetes and cardiovascular diseases (CVD).   
Objective : To identify a simple indirect method for detecting insulin resistance (IR) in our 
population.  
Methods: Geographical Imaging Systems (GIS) was used for randomly selecting the subjects. 
For visiting the 532 households selected by GIS, 9 field teams were developed. A total of 871 
subjects older than 25 years were approached by these teams out of which 867 agreed to 
participate in the survey. IR was assessed in 227 normal subjects by fasting insulin, HOMA-
IR, QUICKI and McAuley Index.  
Results:  IR was defined at 75th percentile cut off of insulin levels (9.25 U/mL) and HOMA-IR 
(1.82). The 25th
Conclusion: A common approach towards managing subjects with metabolic risk factors will 
help identify IR earlier and using IR reference values identified from simple indirect methods 
would be of value in such cases. However larger population based studies are needed to 
further define and validate these cutoff values for insulin resistance.  
 percentile cut off was used for defining IR in QUICKI (0.347) and McAuley 
Index (6.77).  
 
 
 
 
 
 
 
 
3.4 Synopsis of Paper 4 
 
Reference: 
Effect of intervention in subjects with high risk of Diabetes Mellitus in Pakistan. 
M. Zafar Iqbal Hydrie, Abdul Basit, A Samad Shera and Akhtar Hussain. 
To be submitted. 
 
Title: Effect of intervention in subjects with high risk of Diabetes Mellitus in Pakistan. 
Abstract: 
Aims:  The aim of  the study was to observe the rate of conversion from impaired glucose 
tolerance (IGT) to diabetes following lifestyle modification program and a combination of 
lifestyle modification and oral hypoglycaemic agent (metformin) compared to a control 
population with 18 months follow up.  
Methods: Around 40 screening camps were organized following a series of awareness 
lectures at various places in the city. Nearly 5000 people attended these lectures  offices, 
organizations, factories, health care centres and visited the screening camps. Around 1825 
subjects over 30 years of age were identified as high risk on the basis of a questionairre and 
requested to undertake an oral glucose tolerance test (OGTT). Out of these1739 subjects 
took the OGTT and 317 subjects were identified as having impaired glucose tolerance (IGT). 
They  were randomized into three groups. First group was given standard medical advice 
(Control Group), second group was given intensive lifestyle modification advice (LSM Group) 
while third group was given intensive lifestyle modification advice and metformin 500mg 
twice daily (LSM+Drug Group). 
Results: At the end of the study 273 subjects completed the study giving a compliance rate 
of 86%. A total of 47 incident cases of diabetes were diagnosed during the study. The overall 
incidence of diabetes was 4 cases per 1000 person-months with the incidence of diabetes as 
8.6 cases  in the control group, 2.5 cases  in the Life Style Modification (LSM) group and 2.3 
cases in the LSM+drug group.  
Conclusions:  This study showed that lifestyle intervention had a major impact in preventing 
diabetes among IGT subjects in this region. However, addition of drug in the intervention 
did not show any improved results. Resource constrain societies are challenged with the 
additional burden of diabetes cost on their already ailing economy. Therefore, we 
recommend that lifestyle modification advice and follow-up should be incorporated in 
primary health care.  
 
3.5 Summary of the Results 
In the epidemiological survey of lyari the overall prevalence of metabolic syndrome was 
34.8% and 49% according to IDF and modified ATP III classifications respectively (Table 9).  
Tabell 9: Prevalence and 95 % CI of MS using modified ATP III and IDF definition by age and sex.  
Age group n ATP III % (95%CI) IDF % (95%CI)
Overall 363 49 (43.8 - 54.1) 34.8 (29.65 -39.94)
Male
25 – 34 37 54.1 (37.98-70.21) 31.3 (15.18-47.41)
35 – 44 30 56.7 (38.8-74.59) 21.4 3.50-39.29)
45 – 54 15 53.3 (27.99-78.6) 46.7 (21.39-72.00)
> 55 35 57.2 (40.80-73.6) 34.4 (18.66-50.13)
Total 117 55.6 (46.53-64.66) 31.8 (22.73-40.86)
Female
25 - 34 107 27.1 (17.62-36.57) 14.9 (5.42-24.37)
35 - 44 68 51.5 (39.61-63.38) 37.3 (25.41-49.18)
45 - 54 31 58.1 (40.49-78.7) 60.0 (42.39-77.6)
> 55 40 76.8 (63.71-89.88) 69.05 (54.72-83.37)
Total 246 45.9 (39.65-52.14) 36.1 (29.85-42.34)
 
The prevalence rates of the metabolic syndrome increased with increasing age. Significant 
differences in the prevalence of metabolic syndrome with respect to age groups were found 
only in females (P values <0.05) (Table 9 ). Fairly good agreement between the two 
definitions of metabolic syndrome was seen with a kappa value of 0.67. All of those (n = 
120) who were classified as having metabolic syndrome following IDF criteria were 
sustained according to the modified ATP III criteria. 
Female subjects were younger, but had higher BMI values and total cholesterol, low-density 
lipoprotein (LDL), and high-density lipoprotein (HDL) levels compared to males. Males were 
older, had higher waist circumference, blood pressure and triglyceride values. Overall 30% 
of the subjects had higher total cholesterol, triglycerides, and LDL levels, as shown in Table 
10.  
 Tabell 10: Percentage of biochemical risk factors for Metabolic Syndrome 
Variable Males n (%) 
95 %CI
Female n (%) 
95% CI
Total n (%) 
95 %CI
Cholesterol > 200 mg/dl 26/95   (26.8%)
(17.9 - 35.6)
68/216    (31.5%)
(25.3 - 37.7)
94/313   (30.0%)
(24.9 - 54.9)
Triglycerides > 150 mg/dl 35/94  (37.2%)
(27.6 - 47.0)
57/208   (27.4%)
(21.3 - 33.5)
92/302   (30.5%)
(25.3 - 55.8)
Low Density Lipoprotein (LDL) 
>130 mg/dl
25 / 97   (25.8%)
(17.1 - 34.5)
63 / 216   (29.2%)
(64.8 - 35.2)
88 / 313   (28.1%)
(23.1 - 51.2)
High Density Lipoprotein (HDL) 
< 40 mg/dl for males &    
< 50 mg/dl for females
63 / 96   (65.6%)
(56.1 - 75.1)
153 / 216   (70.8%)
(64.8 - 76.9)
216 / 312   (69.2%)
(64.1 - 133.3)
 
Around 70% had low HDL levels, which is similar to that found in South Asian subjects 
residing in Europe (53). The prevalence of diabetes was found to be 9.4%, while 5.6% had 
impaired fasting glucose (Total abnormal glucose tolerance around 15%). 
We used cluster analysis to look at the diet data of the Lyari epidemiological survey and we 
identified five distinct groups in this population on the basis of cluster analysis. A total of 75 
subjects (20.7%) were in cluster one, 71(19.6%) in cluster two, 64(17.8%) in cluster three,  
85 (23.5%) in cluster four and 67 (18.5%) in cluster five. Frequency of consumption of each 
food group in all the clusters is shown in Table 11. 
Tabell 11: Frequency of Consumption of food groups in Clusters 
 Clusters 
 1 2 3 4 5 
milk group 24 69 32 57 29 
meat group 35 79 61 61 56 
fat group 13 70 20 42 44 
cereal group 76 91 90 92 81 
vegetables group 72 94 83 93 82 
fruit group 34 74 45 59 46 
While looking for the proportion of subjects with metabolic syndrome in each cluster we 
observed that cluster one had the lowest while cluster two had the highest percentage of 
subjects with the metabolic syndrome (42.7% vs. 56.3%), with a p value of 0.09 as shown in 
Figure 8.  
Figur 8: Metabolic syndrome in five Clusters according to Modified ATP III Definition 
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The dietary pattern in cluster 2 was loaded with both healthy (milk, legumes, vegetables and 
fruits) and unhealthy (refined grains, potatoes, meat and meat products , high fat dairy 
products, snacks, sweet items and fruit juices) foods.  Although healthy foods are reported 
to be protective against the metabolic syndrome, the cluster's unhealthy diet constituents 
had adverse effects on the metabolic markers which might have lead to the increased 
prevalence of metabolic syndrome as seen in this study.  
For analyzing the insulin resistance cutoff values, only those subjects with a fasting blood 
glucose of < 100 mg/dl were included to ensure that our study population only had normal 
glucose tolerance subjects. A total of 227 normoglycemic subjects (70 men and 157 women) 
were selected from the lyari epidemiological survey. General characteristics of this group of 
subjects are shown in Table 12.  
Tabell 12: General characteristics of the study subjects
* P-value < 0.001 ** P-value < 0.005 *** P-value < 0.05  
Females were significantly younger than males with lower waist circumference but higher 
Body Mass Index (BMI). Mean fasting insulin and HOMA-IR was also higher in females while 
other indices of insulin resistance were not much different in males and females.  
The 75th percentile cut off was used as a value for defining insulin resistance for fasting 
insulin levels (9.25 U/mL) and for HOMA-IR (1.82) while the 25th percentile was taken as cut 
off for defining insulin resistance according to QUICKI (0.347) and for McAuley Index (6.77) 
as shown in Table 13. These were taken as cutoff reference values for defining insulin 
resistance in the normal population.  
 
Tabell 13: Quartiles of fasting serum insulin, HOMA-IR, QUICKI and McAuley Index. 
 P25 P50 P75 
Insulin 5.95 7.8 9.25 
HOMA-IR 1.087 1.454 1.823 
QUICKI 0.347 0.359 0.376 
McAuley Index 6.77 7.046 7.33 
 
Subject
Male     n = (70) 
Mean ± SD
Female  n = (157) 
Mean ± SD
Total  n = (227) 
Mean ± SD
Age (years)* 43.10 ± 12.95 36.87 ± 11.40 38.79 ± 12.21
Body Mass Index (kg/m2 22.35 ± 4.10) ** 25.09 ± 6.27 24.27 ± 6.07
Waist Circumference (cm) 87.42 ± 12.84 85.31 ± 14.09 85.96 ± 13.72
Systolic Blood Pressure (mmHg) 127.94 ± 19.95 121.73 ± 17.14 123.59 ± 19.55
Diastolic Blood Pressure (mmHg)* 84.70 ± 12.11 77.70 ± 12.87 79.79  ± 13.02
Cholesterol (mg/dl) 175.06 ± 44.02 178.72 ± 44.85 177.61 ± 44.53
Triglyceride (mg/dl)*** 160.58 ± 123.27 128.90 ± 66.33 138.39 ± 88.25
Low Density Lipoprotein (mg/dl) 108.22 ± 30.15 114.48 ± 32.56 112.59 ± 31.91
High Density Lipoprotein (mg/dl)*** 38.65 ± 11.52 43.48 ± 12.52 42.04 ± 12.40
Glucose (mg/dl) 80.80 ± 8.82 79.94 ± 10.63 80.21 ± 10.10
,QVXOLQȝ8P/ 7.60 ± 2.78 8.40 ± 4.50 8.15 ± 4.05
HOMA 1.48 ± 0.58 1.61 ± 0.90 1.57 ± 0.81
QUICKI 0.36 ± 0.02 0.36 ± 0.03 0.36 ± 0.03
McAuley 7.09 ± 1.33 7.37 ± 1.48 7.29 ± 1.44
In the second study which was the primary prevention program, an estimated 5000 people 
attended the diabetes prevention lectures and visited the screening camps. Around 2300 
people filled in the high risk questionnaire. Around 1825 were identified as high risk and 
1739 of these subjects agreed to undertake a standardized oral glucose tolerance test 
(OGTT).  
 
Figur 9:   Flowchart with recruitment of persons for the oral glucose tolerance test (OGTT) and screening and 
randomisation. 
Non-diabetic subjects selected for screening (July 2006 – April 2008) 
2 hrs Oral Glucose Tolerance Test (OGTT) done in 1739 subjects (men = 1252 : women =487) 
 
 
  
  
 
 
 
 
 
 
 
 
Of the 1739 subjects undergoing OGTT, the majority (72%) were males; while 10.4% were 
found to have diabetes while 18% were having impaired glucose tolerance (IGT). The 
baseline characteristics of the 1739 subjects showed an increasing trend of age, BMI, and 
blood pressure from NGT to DM as shown in table 14 below.  
 
Tabell 14: Baseline Characterstics of 1739 identified high risk subjects by questionnaire 
 NGT IGT DM p-value 
N 1241 317 181  
Age of patient (years) 40.1 ± 8.9 43.6 ± 9.9 44.4 ± 9.7 <0.0001 
Body Mass Index (kg\m2 25.8 ± 5.3 ) 27.1 ± 5.0 27.3 ± 5.2 <0.0001 
Systolic BP (mmHg) 118.3 ± 16.5 121.5 ± 16.8 124.3 ± 17.7 <0.0001 
Diastolic BP(mmHg) 82.5 ± 11.0 84.6 ± 10.9 85.4 ± 13.1 0,001 
 
The 317 IGT subjects were randomized into three groups is shown in table 15. More than 
half (56%) of the subjects were young between 30-44 years of age in this IGT cohort. 
Positive family history of diabetes, hypertension, cardiovascular disease and stroke was 
present in 49%, 38%, 31% and 17% of the subjects while 25% had hypertension at start of 
study.  
 
Control Group 
(n = 108) 
ILSM Group 
(n = 114) 
Normoglycaemia 
n = 1241, (71.4%) 
(Excluded) 
IGT 
n = 317, (18.2%) 
men : women 237:80 
Diabetes 
n = 181, (10.4%) 
(Excluded) 
Metformin 500mg BD 
ILSM + Drug Group 
(n = 95)
Tabell 15: Baseline anthropometric and biochemical characteristics of the Randomized Groups 
  Control Lifestyle Lifestyle+ Met 
N 108 114 95 
Age in years 44.2 ± 10.9 43.1 ± 10.1 43.5 ± 8.4 
Body Mass Index (kg\m2 27.0 ± 5.7 )* 26.1 ± 4.7 28.1 ± 4.3 
Systolic BP (mmHg) 121 ± 17 123 ± 19 120 ± 14 
Diastolic BP(mmHg) 84 ± 11 86 ± 12 84 ± 9 
Cholesterol (mg/dl) 179.1 ± 37 178.6 ± 34 180.0 ± 36 
Triglycerides (mg/dl) 153.4 ± 109 147.3 ± 86 171.5 ± 119 
HDL-C (mg/dl)* 37.8 ± 4.3 37.4 ± 4.5 37.8 ± 7.8 
LDL-C (mg/dl) 117.2 ± 25.1 116.5 ± 22.7 117.0 ± 24.6 
 
At the end of the study 273 subjects completed the study giving a response rate of 86%. A 
total of 47 incident cases of diabetes were diagnosed during the study; 19 cases at 9 months 
and 28 cases at 18 months or closure of the study. The incidence of diabetes was 8.6 cases 
in the control group, 2.5 cases  in the Life Style Modification (LSM) group and 2.3 cases per 
1000 person-months in the LSM+drug group as shown in table 16. The numbers to be 
treated to prevent one incident case of diabetes was 9 and 8 in lifestyle and LSM+Drug 
groups respectively. 
The absolute and relative risk reduction was also significantly lower in the lifestyle and 
ILSM+Drug groups compared to control group. The numbers to be treated to prevent one 
incident case of diabetes was 9 and 8 in lifestyle and ILSM+Drug groups. 
 
Tabell 16: Comparision of the outcome at 18 months in the four groups 
  Control Lifestyle Lifestyle+ Met 
n 82 107 85 
cases per 1000 person-months 8.6 2.5 2.3 
Absolute risk reduction %  10.7 11.5 
Relative risk reduction %  (95% CI) 71(13.7-90.3) 76.5(19.7-93.1) 
NNT for 18 months to prevent DM in one case 9 8 
 
 
 
 
 
 
 
 
4 Discussion 
4.1 Methological Issues 
 
4.1.1 Choice of Study design 
We undertook two studies and we had two separate study designs for them. A cross 
sectional design was chosen for the first study which was an epidemiological survey. Cross 
sectional studies are done for determining the prevalence of a disease and to study the 
association of risk factors with the occurrence of disease.  The aim is to describe individuals 
in the population at a particular point in time and their history of exposure at that time. 
Cross sectional studies do not present clear evidence on the relationship between risk 
factors and disease since both are measured at the same time, making it difficult to 
determine whether the risk factors are truly risk factors for the outcome or if they are 
influenced by the outcome.  However in terms of chronic diseases such as diabetes where 
the causation of disease has been fairly well established, data from cross sectional survey 
helps to develop or strengthen the hypothesis about the related risk factors.  Thus this study 
design was used for our survey as has also been done in majority of surveys to determine 
the prevalence of chronic diseases, both in Pakistan and in other countries (12,23,26-29).  
For our second study which was an intervention we used a randomized control trial (RCT) 
design to study the effect of intervention in subjects with high risk of developing type 2 
diabetes. We had three arms or groups with two intervention groups and one control group. 
The groups had to be randomly selected from the target population, in this case IGT subjects 
who had taken an OGTT. Similarity between the groups was needed to ensure that the only 
difference between them at the outcome would be the effect of intervention we are trying 
to observe. For this purpose we stratified the groups according to age to ensure similar age 
distribution between the subjects in all the groups.  Since the intervention included 
counselling and motivating the subjects for lifestyle modification it could not be blinded as a 
drug and placebo trial and the subjects as well as the researchers knew which individual was 
enrolled in which group. This study design has been used in studies to observe the effect of 
intervention of subjects at risk of developing diabetes (82).  
4.1.2 Sample size 
For the lyari study we assumed that the lower limit prevalence of T2DM to be 11% in this 
population.  The size of the population from which the study sample was to be selected 
(persons 25 years and older in Lyari Town) was 244,000, the worst acceptable result would 
be ±1.5% from the true population value. Thus our study would require a sample of at least 
713 individuals to have 80% power to detect the true population value. Based on the same 
assumptions as used for T2DM (11%); hypertension (10% prevalence) and proteinuria (5%), 
our study would have 80% power to detect the true value in a sample size of 727 and 778, 
respectively. 
If the sample size is insufficient, the statistical power would be low and we would not be 
ĂďůĞƚŽĚĞƚĞĐƚĂŶĂƐƐŽĐŝĂƚŝŽŶĞǀĞŶŝĨŝƚŝƐƉƌĞƐĞŶƚůĞĂĚŝŶŐƚŽɴ-error. The precision of the 
estimate would also be low. In the field we were able to interview more than the required 
sample size (n = 867) but people’s reluctance to have the blood tests left us with less than 
the desired sample size (n = 363) at the end of the study. However since the prevalence of 
metabolic syndrome is between 30 -45% in the general population the sample size enabled 
us to analysis and interprets the results on most of the occasions. 
For the intervention study nearly 2000 suspected high risk cases identified by a high risk 
questionnaire were to be invited to participate. Considering 30% IGT cases in the high risk 
individuals around 600 would likely to have IGT. The IGT cases will be randomly allocated on 
three different arms, two preventive groups and one control group, all with 200 
participants. With an expected conversion rate of  nearly 30% T2DM in the control group (n 
= 60) and an reduction of 15-20 % in the intervention group (n = 9 -12) the sample size will 
be adequate considering ß = 0.20 and ɲсϬ͘Ϭϱ  ͘
 
4.1.3 Error 
Systemic error that modifies the result towards one direction is called bias. While random 
error does not influence the results in only one direction, the effects of random error can go 
either of the two ways. If a sample is large enough, the effect of random error will be 
balanced. Type 1 error occurs when data leads us to believe that something is true when in 
reality it is not. While type 2 error occurs when data leads us to believe that the null 
hypothesis is not rejected, when in reality it is.  
4.2 Bias 
4.2.1 Selection bias         
Systematic introduction of error may occur during subject selection for the study and is 
termed selection bias. This occurs when inclusion into a study is influenced by the 
characteristics of the subjects which might also affect the outcome. By using a random 
selection procedure we can minimize the selection bias by giving everybody the equal 
chance to be selected. According to statistical point of view all observational studies have 
built in bias but the challenge is to interpret how they affect the outcome of the research. 
In our epidemiological study in Lyari, we recruited subjects by using Geographical 
Information System (GIS). Lyari Town Geographical Information System was made by 
Population Census Office, Statistics Bureau Sindh and National Database and Registration 
Authority (NADRA) to define the geopolitical boundaries and population density of Lyari 
Town (estimated 2004 population of 700,000). A year-long, detailed physical survey of Lyari 
Town was undertaken using available plot maps. All household structures were given a 
unique identification number, along with all health, education and other civic facilities 
available to its residents. The new maps were finally digitized using a geo-referenced 
satellite image of Lyari town. The Lyari Town GIS was used to assess indicators that may be 
of interest to researchers, such as determining the community-based prevalence of chronic 
diseases among adults as has been done by our group. Computerized random selection of 
households by GIS removes the selection bias to  an extend as we visited the specified 
households instead of setting a camp in the locality to invite participants. Although we had 
over representation of women since the survey was done on weekdays compared to males 
as most of the men went to work on weekdays and were not home at the time of the 
survey.  
As for our intervention study, the IGT subjects were selected on the basis of the OGTT 
results. This made selection specific to high risk subjects and we tried to ensure that all the 
subjects in the groups had similar baseline characteristics. For this purpose we stratified 
them according to age to try to ensure that all subjects had similar characteristics and ages 
in all the groups.  
4.2.2 Information bias 
Systematic error in collecting information from the subjects is termed information bias. By 
asking questions differently and interpreting or coding information in different ways could 
lead to information bias. In both our studies, all the team members and the field workers 
were trained before the start of the studies as regards filling the questionnaires as well as 
been checked periodically during the study to ensure that proper data entries were been 
done according to protocol. The field workers in the epidemiological survey were from the 
local community and they knew the local dialect and had an understanding of the cultural 
norms. While for the intervention study the same prevention team followed all the subjects 
to ensure the same quality of care and understanding throughout the study. 
4.2.3 Measurement bias 
Since most of the survey form was in a structured interview questionnaire and subject to 
response by participants, if a question was not answered a variable would be missing in the 
final analysis. Thus variables had missing data in the interview section of the questionnaire if 
the answer was not given.  
As regards the anthropometry measurements certification course was arranged for the field 
team of the lyari study for measuring height, weight and blood pressure at the National 
Institute of Cardiovascular Diseases while for the intervention study it was done by health 
professionals.  
4.3 Confounding 
Confounding refers to the issue when a part of or the entire effect of a variable is influenced 
by another supposedly causal variable. Controlling for confounding can be done either by 
multivariate analysis or stratifying the data. In our epidemiological study we tried 
minimizing confounding by using randomized computer based selection of the households 
and study subjects. The effect of age and gender was minimized by doing stratified analysis. 
However, some confounders might have not been controlled due to lack of data collection, 
for example the diet section which was not very extensively covered in the form. In the 
intervention study confounding between the groups was controlled by stratifying by age 
during the randomization phase to ensure similar baseline characteristics in all subjects.  
4.4 Internal validity 
If the results of a study are true for those who participated in the study, the results are 
considered internally valid. 
Internal validity is increased by reducing bias and controlling for confounding. We tried to 
secure the internal validity of the survey by reducing the confounding effects and 
measurement bias as mentioned above. To reduce confounding we also stratified some of 
the results for age and gender where appropriate. 
4.5 External validity 
In terms of generalization or external validity the findings of this study reflected the 
scenario of urban Population. Lyari was chosen as it is one of the oldest, most densely 
populated part of the city with its residents having a diverse community representing every 
ethnic group found in Pakistan. The sex ratio was similar as for the country (male/female 
ratio of 1.034 males for lyari vs.1.045 males for the country). The mean age for males in lyari 
was 23.5 vs. 20.7 years for the country while for females it was 24.5 in lyari vs. 21 years for 
the country; suggesting similar age and gender distribution for both populations. Given this 
we believe that the findings of the study can be inferred on the general population and is 
more likely to be externally valid for the population of Pakistan.  
As regards the intervention study this was a selected high risk IGT group which can be 
compared with the same high risk population of Pakistan. 
4.6 Strengths of the study 
Lyari Town Geographical Information System was made to dynamically link the national 
census database to a purpose built geographical information system (GIS) to define the 
geopolitical boundaries and population density of Lyari Town. We generated a 
computerized random sample of 532 households from among the 85,520 households in 
Lyari Town. There were 11 union councils or subdivisions of Lyari Town where the samples 
were taken from ensuring that each union council had equal opportunity to be represented 
in the sample selection. We expected approximately 1000 adult men and women above 24 
years of age in the selected households in Lyari. If members of a household that had been 
selected refused to consent to household interviews, we followed a predefined protocol 
until we had enrolled a household from the neighbourhood of the original household 
selected. 
Individual members within households also reserved the right to refuse participation in the 
study. Assuming a 10% refusal rate (by members within the household at the time of 
interview) and another 20% refusal rate by those who decline to provide consent for a blood 
test, we expected at least 854 individuals to participate in this study. 
As for the intervention study, this was from a high risk population which was selected based 
on the results of the OGTT. Thus we had certain criteria for selection of subjects for the 
study and we also tried to ensure uniformity within all the groups by stratifying for age in all 
groups. 
4.7 Limitations of the study 
Looking at the limitations of the study, the study design was cross sectional for the 
epidemiological research survey, which is not the ideal design as cross sectional studies do 
not present clear evidence on the relationship between risk factors and disease since both 
are measured at the same time, making it difficult to determine whether the risk factors are 
true factors for the outcome or if they are influenced by the outcome themselves. Also 
despite being randomized by computer based GIS it was conducted in one selected area of 
the city and had low number of subjects in the final analysis making us to state that the 
results of the survey which is urban based needs to be interpreted with caution when 
generalizing for the whole population of Pakistan.  
As regards the prospective intervention study it was difficult to evaluate the compliance of 
all the subjects during the follow up period. The specific target goals were recorded but the 
diet and physical activity diaries were based on participants recall and subjective in nature. 
The comprehensive follow up of the participants was made more difficult by the participants 
being aware of their glycaemic status and maybe discussing this with other health 
professionals. 
4.8 Discussion of the main results 
The objective of the epidemiological study was to determine the prevalence of metabolic 
syndrome and related risk factors in a representative sample of  25 years  and older adults 
from an urban population of Karachi. This study also helped to define some baseline values 
for insulin levels in the normal population and try to assess insulin resistance which is a new 
entity in Pakistan. This also helped to lay the foundation for the second study by showing 
the poor dietary habits of our population and the need to have a intervention program in 
our population; and thus leading to a intervention trial of primary prevention of Type 2 
diabetes. 
4.8.1 Prevalence of Abnormal Glucose Tolerance  
The overall prevalence of abnormal glucose tolerance was 15% in our lyari epidemiological 
study, with the prevalence of diabetes to be 9.4%. The national survey conducted by the 
Diabetic Association of Pakistan (DAP) in collaboration with the World Health Organization 
(WHO) during the 1990s reported 11% prevalence of type 2 diabetes, with an overall 
abnormal glucose tolerance of 22% (26–29). Conducted in both urban and rural areas of all 
the four provinces of Pakistan, the national survey used WHO guidelines for the diagnosis of 
T2DM and impaired glucose tolerance (IGT) in over 5,600 persons 25 years and older while 
we used only the fasting criteria. By doing OGTT we might have yielded a higher prevalence 
of abnormal glucose tolerance since more cases of IGT compared to 5.6% of IFG cases might 
have been reported. Nearly 72% of the newly diagnosed subjects did not know they had 
diabetes  before the survey, a finding reported also in the national survey (12,26).  The 
mean age was highest in the subjects with diabetes followed by IFG and than normal 
population, also seen in the national survey (26-29).  
4.8.2 Prevalence of Metabolic syndrome – Different Definitions  
The prevalence of metabolic syndrome ranged from 8.2– 49% according to the definition 
used in this survey. The prevalence of Metabolic Syndrome according to WHO and EGIR 
criteria was low as compared to the other definitions probably due to both definitions using 
a two stage screening process. Thus fewer subjects were classified as having the metabolic 
syndrome. The percentage of subjects classified as having Metabolic Syndrome by ACE and 
IDF modified criteria for Asians was high, similar to as reported in other studies (57,67,68).  
When stratified by gender the prevalence was 2-3 folds higher in females by most of the 
definitions, such as WHO definition (6.9% for males; 13.9% for females), by EGIR definition 
(3.1% for males; 10.7% for females) and by IDF definition (31.8% for males; 36.1% for 
females), while by modified ATP III it was more in males (55.6% for males; 45.9% for 
females).  
Each component of the risk cluster defining metabolic syndrome has variability because of 
its regulation through genetic and acquired factors. The differences in the prevalence of the 
various component of the metabolic syndrome were because of the difference in the cut-off 
values used by the different definitions. The EGIR and ACE definitions did not include 
diabetes while ATP III, WHO and modified IDF definitions included diabetes and IGT as one 
of the components of MS. The EGIR in addition suggested fasting hyperinsulinemia (upper 
25th percentile) as the necessary component of metabolic syndrome.  
4.8.3 Prevalence of Metabolic syndrome according to modified ATP and IDF Definition 
The prevalence rate was relatively higher following modified ATP III criteria in our study 
population. Other studies in the region have also showed high prevalence rates ranging 
from 35.2% to 41% (68,116). Our study showed an alarming prevalence of 49% of the 
metabolic syndrome in an urban Pakistani population according to modified ATP III criteria, 
whereas hospital-based studies have shown a prevalence of 44% using the original ATP III 
criteria (73,74,116). One reason for the observed higher rate of metabolic syndrome in this 
study might be the use of modified cut-off criteria for BMI in Asians (115).  Our study is 
probably the first community-based study in an urban population on metabolic syndrome 
with modified ATP III definitions of metabolic syndrome. Our study also showed a 
prevalence of 34.8% of the metabolic syndrome according to the IDF definition compared to 
26% in the Chennai Urban Rural Epidemiology Study done in India (67). A study conducted in 
older subjects in Pakistan (aged 40 years and above) showed a prevalence rate of 45.9% in 
males and 57.2% in females (117).  
Differences by gender in subjects with metabolic syndrome are also evident from different 
ethnic-based studies (48,67,118). The high prevalence of low HDL-C and obesity, as seen in 
our women, has also been reported among Indian women and other South Asian women 
(67,119,120). This may indicate similar lifestyle factors, such as food habits and less physical 
activity, which may have influenced the outcome in women of Indian subcontinent. 
The prevalence of metabolic syndrome increased with advancing age in both genders using 
ATP III and IDF definitions, a trend seen in other studies done in South Asian and U.S. 
populations (56,57,65,68). The study also shows that there is greater prevalence of 
hypertension, obesity and low HDL in subjects with metabolic syndrome. Thus leading to the 
conclusion that the contributing causes of this syndrome are similar everywhere. There 
appears to be a very high prevalence of low HDL cholesterol in men and women in our 
metabolic syndrome group (> 85%). A similarly high prevalence of low HDL cholesterol in 
women was also seen in Indian studies (63).  
The present study results are not comparable with any previous Pakistani study as metabolic 
syndrome is a new entity and the modified IDF definition has only recently been introduced. 
Thus we observed a high rate of metabolic syndrome in the urban population of Lyari Town 
in the city of Karachi.  
4.8.4 Dietary Trends in South Asians leading to Metabolic Syndrome  
The interaction between different components of diet as well as the consumption of 
different food items contributes to the risk for metabolic syndrome and not one single 
dietary component which is responsible for the association of diet with metabolic 
syndrome. Thus overall dietary trends need to be observed in individuals as they consume a 
mixture of different food items in a single meal, rather than isolated groups. 
In the dietary section of our study low MS risk group (cluster 1) had lowest consumption of 
all the food groups while the high MS risk group (cluster 2) had the highest consumption in 
most of the food groups. This high food consumption seems to contribute to the high 
prevalence of MS as seen in cluster 2. Looking at the food groups individually it appears that 
the food items which were the most energy-dense had the highest consumption in cluster 2, 
and probably influencing in creating an unhealthy dietary pattern which leads to increased 
prevalence of MS. 
It has been observed in other studies that the consumption of traditional food (low in 
saturated fat, low in simple sugars and high in fibre) has declined recently and energy-dense 
food (high in calories, carbohydrates and saturated fats and low in fibre) and non-traditional 
energy-dense fast food are being increasingly consumed in South Asia (59,75). 
Studies have also shown that South Asians have a high consumption of dairy products and 
sugar compared to other populations  (75,124). Although dairy consumption has been 
inversely related to MS in some studies (125-127) more than twice dairy consumption was 
seen in the high risk group. Looking further at the individual food items in the milk group it 
was observed that the highest consumption was in cream\custard and ice cream\sweet 
lassi; items which have a high fat and sugar content. Coincidently a high intake of fat, milk 
products and sugars in various regions of India have shown to be associated with increased 
cardiovascular mortality (128). Thus a combination of dairy products, with high fat and 
sugars may influence the individual properties of food and produce a positive association 
with metabolic syndrome. In our study these factors probably made dairy consumption lose 
its protective effect in our subjects as documented elsewhere (127).  
Red meat, organ meat and prawns from the meat group were consumed 3 to 5 times more 
in cluster 2 compared to cluster 1. All of these food items are known to be high in saturated 
fat, which has been adversely associated with cholesterol, blood pressure, obesity and 
diabetes risk (129-131).  
Similarly all the food items in fat & sweet group were consumed five times more in cluster 2 
compared to cluster 1. Sweet products were consumed an alarming 13 times more in cluster 
2 and they probably influenced the increased prevalence of MS in cluster 2 with their load of 
empty calories in the diet.  
South Asians consume more carbohydrates compared to Europeans and this may lead to 
hyperinsulinemia, postprandial hyperglycaemia, hypertriglyceridemia and low HDL 
cholesterol levels, all of which is probably due to insulin resistance (87). Processed cereals, 
such as refined grains have been shown to be associated with an increased risk of the 
components of the metabolic syndrome in The Malmö Diet and Cancer Study (132). In our 
study refined grains were also consumed nearly twice in the high MS risk group (cluster 2). 
Although nearly double consumption of raw vegetables was seen in cluster 2 compared to 
cluster 1 and while double consumption of the fruit group was also seen in cluster 2, looking 
at the individual food items in the fruit group it seems that the consumption of fruit juices 
was 8 times more in cluster 2 compared to cluster 1 which would lead to extra empty 
calories. Despite the fact that an inverse association between prevalent MS and intakes of 
fruit and vegetables has been reported previously, the extra empty calories leads to 
increased prevalence of MS undermining the protective effect of vegetables and fruits on 
cluster 2 (130,133-134).    
4.8.5 Defining Insulin Resistance  
Insulin Resistance (IR) is an acronym for a wide range of metabolic derangements with 
convincing evidence that it is an independent risk factor for a number of chronic diseases 
such as diabetes and cardiovascular diseases (CVD).  Insulin resistance has also been 
suggested as the primary cause leading to the clustering of risk factors such as glucose 
intolerance, hypertension, elevated serum triglycerides, low serum HDL cholesterol and 
central obesity which together have been labeled as the Metabolic syndrome (MS) (37).  
Thus diagnosis of insulin resistance at the initial stages of a disease could be used as a 
effective measure to prevent unfavourable outcome.  
Researchers have suggested that a fasting insulin level at 75th percentile cutoff is accurate at 
predicting insulin resistance in normal non diabetic population in some studies (135,136). 
Fasting insulin levels at 75th percentile was also used as a cut off value in this study and this 
value lies within the range observed in other studies (135,142,143).  
Insulin resistance indices have been developed based on fasting blood samples (serum 
insulin and glucose levels) which can be used as reference cutoffs defined for various 
populations (135). The homeostasis model for insulin resistance (HOMA-IR), the quantitative 
insulin sensitivity check index (QUICKI) and McAuley Index are commonly used surrogate 
measures from these fasting values and have proven to be a reliable alternative to the 
glucose clamp studies (136-138). Many studies using these simple indirect methods for 
detecting insulin resistance have been reported (139-141).  
4.8.5.1  Insulin resistance indices  
In 1985 Matthews was one of the pioneers to define homeostasis model for insulin 
resistance (HOMA-IR) as a simple and reliable method for estimating insulin sensitivity from 
fasting plasma glucose and insulin levels (138). The non-linearity of the model precludes an 
exact algebraic solution, but estimations are possible by using mathematical 
approximations: 
HOMA-B = Insulin (mU/ml) × 20/ glucose (mmol/l) - 3.5 
HOMA-R      =      Insulin      (mU/ml)        ×         glucose      (mmol/l)/22.5 
Low HOMA values indicate high insulin sensitivity, whereas high HOMA values indicate low 
insulin sensitivity.  
HOMA-IR values between 1.21 and 1.45 were reported for normal subjects by Matthews 
(138). Many large population-based studies have used HOMA-IR to assess insulin sensitivity 
and reported HOMA-IR to be around 2.6 on the basis of the 75th percentile (137, 140-142).  
However lower HOMA-IR values have been observed in south asians with an Indian study 
reporting HOMA-IR to be 1.93 at the 75th
Taking 75th percentile of HOMA-IR as a cut-off for insulin resistance we compared insulin 
resistance group (HOMA-IR > 1.82) with non insulin resistance group (HOMA-IR < 1.82) and 
observed that age, hypertension (systolic and diastolic blood pressure), being overweight (as 
assessed by waist circumference or Body Mass Index), triglycerides and urinary micro-
albuminuria were increased in insulin resistant group compared to normal group while HDL 
was decreased in the insulin resistant group. A large number of other epidemiological and 
clinical studies have firmly established consistent correlations between anthropometric, 
metabolic and homodynamic variables of insulin resistance. These variables include obesity, 
unfavourable body fat distribution, glucose intolerance or type2 diabetes, hyperinsulinemia, 
 percentile while in our study it was observed to be 
even lower at 1.82 (144).  
low levels of HDL hypertriglyceridemia, high levels of LDL and hypertension; some of which 
were also seen in our study.  
Other researchers suggested QUICKI to be a better surrogate measure of insulin resistance 
than HOMA-IR (139). The 25th percentile value of QUICKI was 0.347 in our study which lies 
within the range reported for normal populations (0.33-0.372) by other researchers (142).  
It has been suggested by some researchers that incorporating triglycerides in asian subjects 
increases the likelihood of identifying insulin resistance (144). The index proposed by 
McAuley for the diagnosis of insulin resistance does this by incorporating triglycerides in its 
formula (135). We calculated  McAuley index on the basis of the 25th percentile and in our 
study the cutoff of McAuley index was 6.77.  
Although determining insulin resistance by indirect methods is difficult due to the variability 
of results, but the cut off values of IR determined can be used as a measure of insulin 
resistance in Pakistani adults. It is hoped that a common approach towards managing 
subjects with metabolic risk factors by using a single cutoff value will help save time and 
improve clinical assessment by identifying such cases of insulin resistance earlier. Secondly 
the clinical focus may shift from identifying the various risk factors separately towards 
identifying insulin resistance by using reference values measured from these simple indirect 
methods.   
4.8.6 Primary Prevention Study 
Our results suggest that lifestyle intervention is highly effective in preventing high risk 
individuals (IGT) from conversion to diabetes in this population. Adding oral hypoglycaemic 
agent (metformin) in addition to lifestyle modification was not found to be advantageous 
for prevention. These results are in line with previous studies done in other populations 
(145-149).  
The progression rate of  IGT to diabetes in our control group was lower compared to Indian 
and Chinese controls (8.2% per 12 months compared to 18.3% and 11.3% per 12 months 
respectively) (145,146). But it was still significantly higher than seen in the Finnish (6% per 
year)  and DPP (11 per 100 person-years) studies (147-149). All subjects in the control group 
also received general health advice about diet, nutrition and exercise at baseline and at 
subsequent follow-up visits. This might have increased their diabetes risk awareness and 
some subjects may have benefited from this advice. A absolute reduction of 10.7/100 was 
seen in the intensive lifestyle group, which was greater than seen in IDPP (15.7/100) (145). 
More number of subjects were needed to treat in order to prevent one case of diabetes in 
the intensive group in our study (9 vs 6.4) compared to IDPP (145).  
The baseline characteristics appear to be similar in our subjects compared to other Asian 
studies (Mean age Indian 45.9±5.7 years, Chinese 45±9.1 years vs. our mean age 43.6±9.9 
years)  but had comparatively higher BMI (kg/m2) (Indian 25.8±3.5 kg/m2, Chinese 25.8±3.8 
kg/m2 and ours 27.1±5.0 kg/m2) (145,146). Our subjects were younger and leaner 
compared to the Finnish (age 55±7.0 years, BMI 31±4.6 kg/m2) and the American subjects 
(age 50.6±10.7 years, BMI 34±6.7 kg/m2) (6;8). The follow-up period in our study was half in 
duration (only 18 months) compared to the Indian, American and Finnish studies (145-149). 
In our study the progression of IGT to diabetes was comparable to other Asian studies and 
showed the effectiveness of lifestyle modification involving moderate physical activity and 
diet modification to prevent diabetes in this population. Adding metformin had a slight 
additional benefit but its impact was quite small with relative risk reduction decreasing by 
5.5%, from 71% to 76.5% in the lifestyle modification+drug group. This difference was not 
found to be statistically significant.     
Our findings showed that in order to reduce the burden of  diabetes epidemic, effective 
primary prevention can be achieved through lifestyle modification. Therefore, it is suggested 
that necessary policy development on the prevention of diabetes should emphasize on 
lifestyle modification. The main motivation for the prevention of type 2 diabetes is that it 
can prevent or delay the onset of diabetes and its complications, thereby reducing the life 
entrenched financial burden and unnecessary human sufferings of diabetes on both the 
individual and on the society at large. Developing countries have to face this additional 
burden on their already ailing economy (150,151); therefore, primary prevention 
programmes need to become a integral part of Primary Health Services and strategies for 
reducing the diabetes burden at all levels.  
 
 
 
 
 
 
 
 
 
 
5 Implications of the results 
 
The prevalence of the metabolic syndrome was found to be between 12% - 49% using the 
various definitions of metabolic syndrome. We focused on the modified ATP III and IDF 
definitions as they provide an accessible diagnostic tool which is suitable for use and 
establish a list of potential additional criteria that could be included in epidemiological 
studies and other research into the metabolic syndrome. 
 
The prevalence of metabolic syndrome increases with advancing age for both males and 
females The study showed greater prevalence of hypertension, obesity and low HDL in 
subjects with metabolic syndrome.  
 
More than half of our study population does not do any sort of physical exercise and lead a 
sedentary lifestyle. Similar contributing factors of this syndrome have been observed 
elsewhere with obesity and sedentary lifestyle in the forerun. Bearing this in mind we 
designed a diabetes prevention program to be implemented in our local population.  
In several randomized trials, drug therapy has proven effective in the prevention of type 2 
diabetes. However, drug intervention has been shown to be less effective than therapeutic 
lifestyle interventions. Our study shows the efficacy of lifestyle modifications as a means of 
primary prevention in a population having distinctive environmental conditions and genetic 
propensity as was seen in the Indian Diabetes Prevention Programme for the Indian 
population.  
 
Our studies have helped to compile population based data, monitor disease trends, and 
create an environment that will be conducive to promoting healthy lifestyles through multi-
sectorial, inter-disciplinary collaborations. 
 
Recent Updates from the China DaQing Prevention Study, the Finnish Diabetes Prevention 
Study, the American Diabetes Prevention Programme Outcome Study and the Look Ahead 
Study have all shown that the most efficient way to manage diabetes and its complications 
is to prevent diabetes in the first place. This in turn has lead to policy documents from 
expert organizations such as The Disease Control Priorities project (DCP-2), the European 
Society of Cardiology and European Association for the Study of Diabetes, the Canadian 
Diabetes Association, the American Diabetes Association, and the International Diabetes 
Federation, all recommending lifestyle changes such as weight loss and increased physical 
activity for the prevention of T2DM among those with pre-diabetes (82,145,152-156).  
 
Policy changes and community mobilization schemes need to be initiated. Lifestyle 
modification programmes with particular emphasis on increasing physical activity (30 
minutes of brisk walking), adhering to a balanced diet (high in fibre and low in fat), and 
losing 5% body weight which has shown to reduce the risk of progression from impaired 
glucose tolerance to diabetes need to be initiated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Conclusion 
 
Based on the findings of the epidemiological survey we implemented the primary 
prevention trial since the metabolic syndrome should be considered as a prime target for 
preventive medicine; and as the emerging global epidemic of metabolic and vascular disease 
has significant implications for the development of population based health policies. 
 
Despite the challenges involved in day-to-day life, the non-pharmacological lifestyle 
modification approach to prevention of the metabolic syndrome is shown to be effective in 
our study. A large number of lifestyle-related risk factors are associated with the metabolic 
syndrome and diabetes as seen in the lyari survey. Therefore we need to increase people’s 
awareness about these risk factors by seminars and public events and to highlight the 
significant of a healthy lifestyle.  
 
IDF and WHO have made recommendations for the development of nationwide surveillance 
and prevention programmes against non-communicable diseases, including diabetes. The 
results from our study can be used as a pilot project for launching such programs within the 
communities making them relevant to our cultural needs, and help the government and 
advocacy groups within the country to translate this evidence into culturally accepted 
clinical practice to initiate a national diabetes prevention and control program.  
 
In order to reduce the diabetes burden and stop treating the majority of the cases when 
they reached the steeper extreme of the road a nationwide community based diabetes 
primary prevention program needs to be started. This is important, particularly at a time 
when the global epidemic of metabolic and vascular disease is emerging as a significant 
public health challenge, with its consequences for diabetes and CVD. 
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8 Appendix I(Questionnaire of First Study) 
 
Informed Consent
Diabetic Association of Pakistan and World Health Organization Collaborating Center
CONSENT FORM
Title of Research Project: 
Prevalence of Type 2 Diabetes and Associated Risk Factors among Adults 25 Years 
and Above in Urban Karachi
Explanation of Research Project:
PURPOSE OF STUDY
The doctors and health workers here are working with researchers at
• Diabetic Association of Pakistan and World Health Organization 
Collaborating Centre;
• Interactive Communications Research and Development Division;
• Baqai Institute of Diabetology and Endocrinology
• Lyari Community Development Project
to find out about diabetes and heart disease in adults. Your household has been selected randomly 
from a list of all households in Lyari / North Nazimabad. The researchers undertaking this survey 
would like to ask you to participate in this study.
PROCEDURES
If you agree we will ask you questions about 
• your household and members of your household. 
• your lifestyle (e.g. diet, exercise) and existing conditions related to diabetes 
and heart disease. 
We will take measurements of your height, weight, hips, waist, abdomen and blood pressure. 
The doctors would like to take a blood sample from you after you have fasted overnight to 
test for high levels of glucose, lipids and liver enzymes.  You will be informed of the glucose 
test results within 3 days but the results of some of the other tests will take longer. 
Do you agree to provide blood to test for glucose, lipids and liver enzymes: Yes __; No ___ 
We would also like to store your blood sample to test for infections that might cause liver 
disease. The blood sample may be stored for up to 10 years.  The samples will be stored in a 
manner that will not identify you by name. The results from these future tests may not be 
available to you. 
Do you agree to let the blood sample be stored for up to 10 years for future research?  
Yes ____; No _____
The data from the study will be kept in an office in Karachi. Information about your child 
will be available only to people working on the study. We will keep the study information 
private to the extent possible by the laws of Pakistan. People responsible for making sure that 
the research is done properly may review your study records.  This might include people from 
the Baqai Institute of Diabetology and Endocrinology and the Lyari Community 
Development Project. 
RISKS AND DISCOMFORTS
If blood is taken the needle stick may cause some discomfort and bruising. 
BENEFITS
The test results will be given to you.  Any doctors that you visit will benefit by finding out if 
you have diabetes or risk factors for diabetes and heart disease. This information will also 
help researchers and doctors in understanding the causes of diabetes and heart disease in 
adults in Lyari / North Nazimabad and to plan programs to prevent these diseases. If you do 
not have diabetes or risk factors for diabetes and heart disease, you will be able to continue 
your lifestyle knowing that you are at low risk. You will not receive any payment for 
participating in this study. 
You are not forced to be in this study. You may leave the study at any time.  If you decide not 
to be in the study, your care or relations with your doctors will not be changed in any way. 
You should ask the project coordinator any questions you may have about this study. You 
may ask him/her questions in the future if you do not understand anything. The researchers 
will tell you any new information that they may find out while you are in this study.
If you think being in the study has hurt you, you have not been treated fairly you can call the 
Principal Investigator Dr. A Samad Shera at 661-6890 (Karachi). You can also call the 
Project Coordinator Dr. Aamir Khan at 439-6254 (Karachi). You can also call Dr. Abdul 
Basit at the Baqai Institute of Diabetology and Endocrinology at 661-7234 (Karachi) and Mr. 
Abdur Rahim Moosvi at the Lyari Community Development Project at 752-1687 (Karachi).
If you agree to participate in this study please sing your name below.
Void One Year From Above Date
No. ___________________________
Approved From ___________ to ___________
                               
____________________________________________
Signature 
____________________________________
Witness to Consent Procedures*
____________________________________________
Signature of Investigator
____________________________________________
Date
*Optional unless subject is illiterate, or unable to sign
Note: Signed copies of this form must be a) retained in file by the Principal 
Investigator, b) given to the participant and c) put in the patient’s medical record (when applicable).
Structured Interview Questionnaire (11 Pages)
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• Consent Form in Local Language ‘Urdu’. 
Date of IRB Approval: June 9, 2004
Dr. Shakil Baig
Chairman,
             Institutional Review Board
INSTITUTIONAL REVIEW BOARD MEMBERS
Name Profession Address/Ph # 
• Dr. Shakil Baig M.B.B.S., M.R.C.P. Consultant Rheumatologist
• Dr. Abdul Basit M.B.B.S., M.R.C.P. Consultant Diabetologist & Endocrinologist Baqai Institute of 
• Dr. Yakoob Ahmedani M.B.B.S.,FCPS Consultant Physician Diabetology and 
• Dr.Mohiuddin Waseem M.B.B.S,D.A.B.I.M.Consultant Diabetologist & Endocrinologist Endocrinology
• Dr M Zafar Iqbal Abbasi Administrator BIDE Ph.: 6617234-5
• Mufti Fazal Karim Non-Organizational Member / Non-Medical Member
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Diabetes Prevention Study
Diabetic Association of Pakistan
Baqai Institute of Diabetology and Endocrinology 
University of Oslo
Questionnaire 
1.1 Date:       1.2 : Registration No:   
                               
1.3  Name:                    S/o, W/o, D/o  
 
1.4 Date of Birth     1.5 Age: (in years) 
 
1.6 Sex:  Male=  1, Female=  2.        1.7  Marital Status: Married=1, Single =2, Widow=3 
1.8 Address: 
              
District 
 
1.9   Phone Number                            Home: 
 
                            Mobile:    
 
Date of visit Type of visit Advisor Focus
d d m m y y
1. Individual
2. Group
3. Short contact (phone, 
letter, e-mail etc.)
1. Nurse
2. Physician
3. Physiotherapist
4. Dietitian
5. Psychologist
6. Other
1. Diet / weight loss   
2. Exercise 
3. Smoking withdrawal
4. Other
 1.10 Occupation:    
Administrative/Professional =1, Business=2, Skilled Labour=3,   Manual Labour=4   
Home Duties =5,Unemployed=6, Pensioner=7, Others =8 
1.11 Education :   
Illiterate =1 Only Read & Write=2 Primary  =3 Secondary =4, Matric/ SSC =5 , Inter/HSC=6, 
Graduate=7,   Specialty=8 (specify) 
1.11b Education in Number of Years  
1.12 Socio-economic History:   Are you Earner = 1             or   Dependent  =  2 
Total family monthly income from all sources    
Rs.< 5000/- =1.  Rs. 5000 – 10,000/- =2,  Rs. 10,000 – 20,000/- = 3,   Rs. 20,000 – 30,000/- = 4, 
  > Rs. 30,000/- = 5 
       
            No. of Earners   No. of Dependents  
1.13 Community: 
 Mohajir = 1,  Punjabi = 2,  Sindh = 3,  Pathan = 4,  Balochi = 5,  Makrani=6, 
 Memon = 7,  Others (Specify) = 8 
2 Personal History
Serial 
Family History in first degree relative (Parents, Siblings & Children) 
Disease Subjects No =1, Yes =2, 
1 Diabetes   
2 Hypertension   
3 Ischemic Heart Disease   
4 Stroke   
5 Others   
 
2.2 Any addiction: Niswar = 1,   Cigarettes = 2,    Biri = 3,    Chews 
Tobacco = 4,   Huqqa = 5,   Alcohol = 6,   Other = 7 
3 History of past illness:
 Please circle correct response 
3.1 Has a doctor ever told you that you have;  If yes are you currently, Medicine name 
 taking any medications  
High blood pressure. Yes No  Yes No     
Angina    Yes No  Yes No     
Heart Attack  Yes No  Yes No     
Stroke.    Yes No  Yes No    
Foot ulceration.  Yes No  Yes No    
Hyperlipidemia  Yes No  Yes No    
Claudation  Yes No  Yes No    
Depression  Yes No  Yes No    
Others Specify  Yes No  Yes No    
 
Obstetric History (Women Only) 
 
Number of Live Births           Number of Still Births     
 
Number of miscarriages            Number of abortions     
4 Blood Glucose Result Lab Serial No
4.1 How many hours since last food or drink, except water? Hours = 
4.2 Fasting Blood Glucose Levels =
4.3
Time of Glucose Drink =                    Hours, minutes.Time of  2nd Sample
4.4 Two hours Blood Glucose levels =                           
Initials
 
 
B Physical Examination
5.1 Height (cm) 5.2 Weight (kg) 5.3. BMI  (kg/m2)
5.4 Waist circumference (cm) 5.5. Hip circumference (cm) 5.6 WHRatio
cm
6. Blood pressure (mmHg)
6.1 First measurement (systolic/diastolic) 
/
6.2 Second measurement (systolic/diastolic) 
/
6.3 Third measurement (systolic/diastolic) 
 
Right   Left   
7 Visual Acuity                           
8 Eye Examination (Fundoscopy)
 
                                
(Code of 8.1 & 8.2:  Nil=0,  1 to 5=1, 6 to 10=2, 11+ =3,  Retina not visible=9)               
8.1 Microdots                         
                                                       
8.2 Blot Haemorrhages   
         
 (Code of 8.3, 8.4 & 8.5 :  Absent = 0,   Present = 1,  Retina not visible = 9) 
8.3 Exudates (hard)        
 
8.4 Exudates (soft)        
 
8.5 Vitreous Haemorrhage       
  
(Code of 8.6:  Nil=0, Peripheral=1,  Disc=2,  RP=3,  Retina not seen=9) 
 
8.6 New vessels       
  
(Code of 8.7 :  Nil=0,  mild=1, Retina not seen clearly=2 ,lens removed=3) 
             
8.7 Cataracts       
9 Limb Examination
9.1 Pulses    
(Code of 9.1: normal =0,  diminshed =1, absent =2, amputation = 9) 
 
9.1a  Femoral    0    1   2   9  0    1   2   9 
 
 9.1b  Popliteal    0    1   2   9  0   1   2   9 
 
 9.1c  Dorsalis pedis    0    1   2   9  0   1   2   9 
 
 9.1d  Tibialis posterior   0    1   2   9  0   1   2   9 
 
9.2 Sensation  
(Code of 9.2: normal=0, diminshed=1, absent=2,  amputation=9) 
 
9.2a Touch with 10gm monofilament   0   1   2   9  0   1   2   9 
 
9.2b Vibration with 128 Hz tuning fork   0   1   2   9  0   1   2   9 
 
9.3 Reflexes  
(Code of 9.3 : present =0,diminshed = 1, absent=2,amputation = 9) 
 
9.3a    Knee      0   1   2   9  0   1   2   9 
 
 9.3b    Ankle     0   1   2   9  0   1   2   9 
 
cm , kg ,
,cm
/
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Physical Activity 
Questions Response Code 
Activity at work 
1 
Does your work involve vigorous-intensity activity that causes 
large increases in breathing or heart like [carrying or lifting 
heavy loads, digging or construction work] for at least 10 
minutes continuously? 
       Yes       1 
        No        2  
 
 If No, go to P 4 
P1 
2 
In a typical week, on how many days do you do vigorous-
intensity activities as part of your work? 
Number of days P2 
3 
How much time do you spend doing vigorous-intensity activities 
at work on a typical day? 
Hours : minutes 
                                
P3 
(a-b) 
4 
Does your work involve moderate-intensity activity that causes 
small increases in breathing or heart rate such as brisk walking 
[or carrying light loads] for at least 10 minutes continuously? 
      Yes     1 
      No       2     If 
No, go to P  7 
P4 
5 
In a typical week, on how many days do you do moderate-
intensity activities as part of your work? 
Number of days P5 
6 
How much time do you spend doing moderate-intensity 
activities at work on a typical day? 
Hours : minutes 
                                
P6 
(a-b) 
Travel to and from places 
7 
Do you walk or use a bicycle (pedal cycle) for at least 10 
minutes continuously to get to and from places? 
     Yes     1 
      No       2    If 
No, go to P10 
P7 
8 
In a typical week, on how many days do you walk or bicycle 
for at least 10 minutes continuously to get to and from 
places? 
Number of days 
 
 
P8 
9 
How much time do you spend walking or bicycling for 
travel on a typical day? 
Hours : minutes 
                                
P9 
Recreational activities 
10 
Do you do any vigorous-intensity sports, fitness or recreational 
(leisure) activities that cause large increases in breathing or 
heart rate [running or football,] for at least 10 minutes 
continuously? 
    Yes     1 
     No       2     If 
No, go to P13 
 
P10 
11 
In a typical week, on how many days do you do vigorous-
intensity sports, fitness or (leisure) activities? 
Number of days P11 
12 
How much time do you spend doing vigorous-intensity sports, 
fitness or recreational activities on a typical day? 
Hours : minutes 
                                
P12 
13 
Do you do any moderate-intensity sports, fitness or recreational 
(leisure) activities that causes a small increase in breathing or 
heart rate such as brisk walking, (cycle, swimming, volleyball) for 
at least 10 minutes continuously? 
      Yes     1 
       No       2     If 
No, go to P16 
 
P13 
14 
In a typical week, on how many days do you do moderate-
intensity sports, fitness or recreational (leisure) activities? 
Number of days P14 
15 
How much time do you spend doing moderate-intensity sports, 
fitness or recreational (leisure) activities on a typical days? 
Hours : minutes 
                                
P15 
Sedentary behaviour 
16 
How much time do you usually spend sitting or 
reclining on a typical day? 
 Hours : minutes 
                              
P16 
 
 
Physical Activity 
Questions Response Code 
Activity at work 
1 
Does your work involve vigorous-intensity activity that causes 
large increases in breathing or heart like [carrying or lifting 
heavy loads, digging or construction work] for at least 10 
minutes continuously? 
       Yes       1 
        No        2  
 
 If No, go to P 4 
P1 
2 
In a typical week, on how many days do you do vigorous-
intensity activities as part of your work? 
Number of days P2 
3 
How much time do you spend doing vigorous-intensity activities 
at work on a typical day? 
Hours : minutes 
                                
P3 
(a-b) 
4 
Does your work involve moderate-intensity activity that causes 
small increases in breathing or heart rate such as brisk walking 
[or carrying light loads] for at least 10 minutes continuously? 
      Yes     1 
      No       2     If 
No, go to P  7 
P4 
5 
In a typical week, on how many days do you do moderate-
intensity activities as part of your work? 
Number of days P5 
6 
How much time do you spend doing moderate-intensity 
activities at work on a typical day? 
Hours : minutes 
                                
P6 
(a-b) 
Travel to and from places 
7 
Do you walk or use a bicycle (pedal cycle) for at least 10 minutes 
continuously to get to and from places? 
     Yes     1 
      No       2    If 
No, go to P10 
P7 
8 
In a typical week, on how many days do you walk or bicycle for 
at least 10 minutes continuously to get to and from places? 
Number of days 
 
 
P8 
9 
How much time do you spend walking or bicycling for travel on a 
typical day? 
Hours : minutes 
                                
P9 
Recreational activities 
10 
Do you do any vigorous-intensity sports, fitness or recreational 
(leisure) activities that cause large increases in breathing or 
heart rate [running or football,] for at least 10 minutes 
continuously? 
    Yes     1 
     No       2     If 
No, go to P13 
 
P10 
11 
In a typical week, on how many days do you do vigorous-
intensity sports, fitness or (leisure) activities? 
Number of days P11 
12 
How much time do you spend doing vigorous-intensity sports, 
fitness or recreational activities on a typical day? 
Hours : minutes 
                                
P12 
13 
Do you do any moderate-intensity sports, fitness or recreational 
(leisure) activities that causes a small increase in breathing or 
heart rate such as brisk walking, (cycle, swimming, volleyball) for 
at least 10 minutes continuously? 
      Yes     1 
       No       2     If 
No, go to P16 
 
P13 
14 
In a typical week, on how many days do you do moderate-
intensity sports, fitness or recreational (leisure) activities? 
Number of days P14 
15 
How much time do you spend doing moderate-intensity sports, 
fitness or recreational (leisure) activities on a typical days? 
Hours : minutes 
                                
P15 
Sedentary behaviour 
16 
How much time do you usually spend sitting or 
reclining on a typical day? 
 Hours : minutes 
                              
P16 
PHYSICAL ACTIVITY RECOMMENDATION
 
          Registration No. 
 
 
Date      
1)      
2)      
3)      
4)      
 
 
 
PHYSICAL ACTIVITY RECOMMENDATION
 
          Registration No. 
 
 
Date      
1)      
2)      
3)      
4)      
 
 
 
PHYSICAL ACTIVITY RECOMMENDATION
 
  Registration No. 
 
 
Date      
1)      
2)      
3)      
4)      
 
¾ FLEXIBILITY EXERCISE: 
¾ STRENGTH TRAINING: 
¾ CARDIO RESPIRATORY EXERCISES: 
 
Lab Investigations      Registration No:     
 
B
Last Visit 
Physical Examination
5.1 Height (cm) 5.2 Weight (kg) 5.3. BMI  (kg/m2)
5.4 Waist circumference (cm) 5.5. Hip circumference (cm) 5.6 WHRatio
cm
6. Blood pressure (mmHg)
6.1 First measurement (systolic/diastolic) 
/
6.2 Second measurement (systolic/diastolic) 
/
6.3 Third measurement (systolic/diastolic) 
 
 
 
Last Visit         Right      Left 
7 Visual Acuity                           
8 Eye Examination (Fundoscopy)
 
                                
(Code of 8.1 & 8.2:  Nil=0,  1 to 5=1, 6 to 10=2, 11+ =3,  Retina not visible=9)               
8.1 Microdots                         
                                                       
8.2 Blot Haemorrhages   
         
 (Code of 8.3, 8.4 & 8.5 :  Absent = 0,   Present = 1,  Retina not visible = 9) 
8.3 Exudates (hard)        
 
8.4 Exudates (soft)        
 
8.5 Vitreous Haemorrhage       
  
(Code of 8.6:  Nil=0, Peripheral=1,  Disc=2,  RP=3,  Retina not seen=9) 
 
8.6 New vessels       
  
(Code of 8.7 :  Nil=0,  mild=1, Retina not seen clearly=2 ,lens removed=3) 
             
8.7 Cataracts       
9 Limb Examination
Date 0 months 9 months* 18 months Remarks
OGTT – Fasting BS mg/dl
OGTT – 2 Hrs Postprandial BS mg/dl
Fasting Total Lipids mg/dl
Total Cholesterol mg/dl
Triglyceride mg/dl
HDL mg/dl
LDL mg/dl 
Fasting Insulin Levels
HbA1c %
cm , kg ,
,cm
/
0 1 2 3 9 0 1 2 3 9
0 1 2 3 9 0 1 2 3 9
0 1 90  1  9 0  1  9 
0  1  9 0  1  9 
0  1  9 0  1  9 
0    1   2  3  9 0    1   2  3  9 
0    1   2  3   0    1   2  3   
9.1 Pulses    
(Code of 9.1: normal =0,  diminshed =1, absent =2, amputation = 9) 
 
9.1a  Femoral    0    1   2   9  0    1   2   9 
 
 9.1b  Popliteal    0    1   2   9  0   1   2   9 
 
 9.1c  Dorsalis pedis    0    1   2   9  0   1   2   9 
 
 9.1d  Tibialis posterior   0    1   2   9  0   1   2   9 
         
9.2 Sensation  
(Code of 9.2: normal=0, diminshed=1, absent=2,  amputation=9) 
 
9.2a Touch with 10gm monofilament   0   1   2   9  0   1   2   9 
 
9.2b Vibration with 128 Hz tuning fork   0   1   2   9  0   1   2   9 
 
9.3 Reflexes  
(Code of 9.3 : present =0,diminshed = 1, absent=2,amputation = 9) 
 
9.3a    Knee      0   1   2   9  0   1   2   9 
 
 9.3b    Ankle     0   1   2   9  0   1   2   9 
 
Date Weight  
B.P Pulse 
Treatment 
Diet  
 
Date Weight  
B.P Pulse 
Treatment 
Diet  
 
Date Weight  
B.P Pulse 
Treatment 
Diet  
 
 
 
 
 
 
Informed Consent Form 
                                                                                                                                          
You are being invited to participate in a research study (PPS). This Form is designed to 
provide you with information about the study. The investigators or representative describes 
this study to you and answer any of your questions. 
 
Title of project: Impact of intervention for the prevention of Type 2 diabetes: (a randomized 
high-risk population based study in Pakistan and Bangladesh) 
 
Investigator(s):_________________________________________________ 
 
Address: ______________________________________________________ 
 
Phone No.__________________ CO-Investigator(s)   __________________ 
 
This is to certify that I, ______________________________________, hereby agree to 
participate as a volunteer in an authorized research project. 
 
I understand the purpose of this research as mentioned above. The procedure involves 
evaluating subjects for impaired glucose tolerance according to Oral Glucose Tolerance test 
and enrolling them in an intervention study to prevent them from diabetes in the future. The 
duration of participation will be 18 months. 
I understand that I will be provided physical activity and dietary advice during this period. 
Also my weight and dietary habits will be continuously monitored during follow-ups. 
I may be given “Metformin” for the duration of the study according to selection criteria. 
Benefits of participating in project may include: Obtaining optimal control of Blood Sugars 
and trying to prevent from progression to diabetes. Reduction in weight and increase in 
physical activity under professional supervision will also be achieved.  
I understand that all the information which is obtained from me will be confidential in an 
appropriate manner. 
Participation is voluntary and I understand that I am free to refuse to participate in a 
procedure or to refuse to answer any question at any time without prejudice to me. I 
understand that I am free to withdraw my consent and to withdraw from the study any time 
without prejudice to me. 
I understand that the research investigators named above will answer any of my questions 
about the research procedures, my rights as a subject and research-related injuries time.  
 
I understand that I will be given a copy of this consent form if I so request. 
 
 
Name and signature of participant or responsible Agent / Date.  
  
 
Note:-If you have any questions or complaints about the informed consent process or policy, 
please contact investigator(s). THANK YOU! 
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Prevalence of Metabolic Syndrome in Urban Pakistan 
(Karachi): Comparison of Newly Proposed International 
Diabetes Federation and Modified Adult Treatment 
Panel III Criteria
M. Zafar Iqbal Hydrie, M.Phil.,1,* A. Samad Shera, F.R.C.P.,2 Asher Fawwad, M.Phil.,3 
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Abstract
The clustering of central obesity, dyslipidemia, hypertension, and hyperglycemia known as metabolic syndrome 
has been associated with a two- to three-fold increase in type 2 diabetes (T2DM) and cardiovascular disease 
(CVD). It is recognized that the features of the metabolic syndrome can be present 10 years preceding T2DM and 
CVD. The objective of our study was to determine the prevalence of metabolic syndrome in adults aged 25 years 
and older from an urban population of Karachi, Pakistan, according to the International Diabetes Federation 
(IDF) defi nition and modifi ed Adult Treatment Panel III (ATP III) criteria. This study involved a survey con-
ducted from July, 2004, to December, 2004, by generating a computerized random sample of households in Lyari 
Town using a geographical imaging system (GIS). Out of the 85,520 households, 532 households were randomly 
selected and 867 adults ≥25 years old consented to take part in the survey; 363 of these subjects gave blood 
samples. The prevalence of diabetes was 9.4%, whereas 5.6% had impaired fasting glucose (abnormal glucose 
tolerance 15%). The prevalence of metabolic syndrome according to the IDF defi nition and modifi ed ATP III cri-
teria was 34.8% and 49%, respectively. Inclusion of modifi ed waist circumference and specifi c body mass index 
(BMI) cut offs for Asians may help predict metabolic syndrome at an early stage. High prevalence of metabolic 
syndrome was identifi ed irrespective of the defi nition applied in this population. This may call for immediate 
action to halt the accelerating risk of diabetes and CVD that would lead to a possible unparalleled rise in the cost 
of health care and human suffering.
Introduction
The modern era has seen the rise of computerization and mechanization, with improved transport result-
ing in changes in lifestyle from active to sedentary and thus 
making an enormous impact on human health.1 The rise in 
metabolic syndrome has been partly related to the achieve-
ments in public health during the 20th century, with people 
living longer owing to elimination of many of the commu-
nicable diseases.2
Over the last 20 years, focus on the metabolic syndrome 
has gradually increased, and studies have shown that the 
prevalence of metabolic syndrome is steadily increasing in 
all populations worldwide, recognizing this as one of the 
major global public health challenges of recent times.3 The 
1
 Department of International Health, Institute of General Practice and Community Medicine, Faculty of Medicine, University of Oslo, 
Norway.
2
 World Health Organization Collaborating Centre, Diabetic Association of Pakistan, Nazimabad, Karachi, Pakistan.
3
 Research Department, Baqai Institute of Diabetology and Endocrinology, Nazimabad, Karachi, Pakistan.
4
 Department of Medicine, Medical Unit-IV, Baqai Medical University and Baqai Institute of Diabetology and Endocrinology, 
Nazimabad, Karachi, Pakistan.
5
 Faculty of Medicine University of Oslo, Institute of General Practice and Community Medicine, Department of International Health, 
Oslo, Norway.
*
 Present address: Baqai Institute of Diabetology and Endocrinology, Nazimabad, Karachi, Pakistan.
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in Pakistan to identify the potential for prevention of life-
threatening diseases like diabetes and CVD. However, a 
few small-scale studies have been conducted. Such studies 
conducted in hospital patients have shown a prevalence rate 
of 44%4; another study conducted amongst diabetic patients 
showed a prevalence of metabolic syndrome of 46%.14
These studies were all specifi c, high-risk group-based 
studies. To the best of our knowledge, only one community-
based epidemiological study on the prevalence of metabolic 
syndrome has been reported from a rural area of Pakistan.15 
According to International Diabetes Federation (IDF) and 
Adult Treatment Panel III (ATP III) defi nition, 40% and 31% 
had metabolic syndrome, respectively. Hence the study 
reported here is the fi rst community-based prevalence 
survey of metabolic syndrome in an urban population of 
Pakistan. Furthermore, we have also examined the concor-
dances between the IDF defi nition and modifi ed ATP III cri-
teria for metabolic syndrome.
high prevalence of metabolic syndrome and cardiovascu-
lar disease (CVD) risk factors have been reported in South 
Asians.4–8 Although more than one fi fth of the world popu-
lation lives in South Asia, very few studies have been done 
on metabolic syndrome in this part of the world. Amongst 
those in India, the prevalence rates of metabolic syndrome 
were reported to be higher than 40%.4 It is estimated that a 
population with metabolic syndrome is three times as likely 
to have and twice as likely to die from a heart attack or stroke 
compared to people without the syndrome.9 In addition, peo-
ple with metabolic syndrome have a fi ve-fold greater risk of 
developing type 2 diabetes (T2DM).10 We looked at the prev-
alence of Metabolic Syndrome according to International 
Diabetes Federation (IDF) and Modifi ed Adult Treatment 
Panel III (ATPIII) criterions as given in Table 1.10,11
Studies have shown a high prevalence of T2DM and CVD 
in South Asians.7,8,12,13 Very few studies have looked at the 
prevalence of metabolic syndrome in the general population 
Table 1. Diagnostic Criteria for the Metabolic Syndrome from the International Diabetes Federation (IDF)10 
and American Heart Association (AHA)/National Heart, Lung, and Blood Institute (NHLBI)11
  AHA/NHLBI diagnostic criteria for metabolic
 IDF clinical criteria for metabolic syndrome syndrome
Measure (central   
obesity plus any two  Measure (any three 
of fi ve other criteria  of the fi ve criteria 
constitute a diagnosis  below constitute a 
of metabolic  diagnosis of 
syndrome) Categorical cut points metabolic syndrome) Categorical cut points
Central obesity Waist circumference Elevated waist General U.S. population:
   ethnicity specifi c   circumference   ≥102 cm (≥40 in.) in men,
 For South Asians:      ≥88 cm (≥35 in.) in women;
   ≥90 cm in men,      lower cut points for insulin-
   ≥80 cm in women      resistant individuals or ethnic
         groups (for South Asians:
         ≥90 cm in men, ≥80 cm in
         women)
Raised triglycerides >150 mg/dL Elevated triglycerides ≥150 mg/dL (1.7 mmol/L) or
   (1.7 mmol/L) or on      on drug treatment for
   specifi c treatment for this      elevated triglycerides
   lipid disorder      
Reduced high- <40 mg/dL Reduced high-density <40 mg/dL (1.03 mmol/L) in
  density lipoprotein   (1.03 mmol/L) in men,   lipoprotein   men, <50 mg/dL
  cholesterol   <50 mg/dL   cholesterol   (1.29 mmol/L) in women
   (1.29 mmol/L) in women      
   or on specifi c treatment      
   for this lipid abnormality      
Raised blood ≥130 mmHg systolic Elevated blood ≥130 mmHg systolic blood
  pressure   blood pressure or   pressure   pressure or ≥85 mmHg
   ≥85 mmHg diastolic      diastolic blood pressure or on
   blood pressure or on      drug treatment for
   treatment for previously      hypertension
   diagnosed hypertension      
Raised fasting Fasting plasma glucose Raised fasting Fasting plasma glucose
  glucose   ≥100 mg/d1L   glucose   ≥100 mg/dL (5.6 mmol/L) or
   (5.6 mmol/L) or    previously diagnosed type 2
   previously diagnosed type    diabetes
   2 diabetes  
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(BMI) was calculated as a ratio of weight (kg) to height in 
meters squared. Waist circumference was measured at the 
minimum circumference between the lower border of the 
ribs and iliac crest on the midaxillary line, and hip cir-
cumference was measured at the greatest protrusion of the 
buttocks just below the iliac crest The measurements were 
taken in centimeters, and the waist-to-hip ratio (WHR) was 
calculated as waist/hip circumference.
Blood pressure was measured with a special precaution 
to reduce the variation of blood pressure value with resting 
values: individuals were requested to take 10 minutes rest at 
a sitting position before measuring the blood pressure. We 
used standard cuffs for an adult-fi tted mercury sphygmo-
manometer for all individuals to minimize the difference. 
Two blood pressure readings were taken, and a mean value 
was used for the fi nal measurements.
Laboratory assays
At the end of the household visit, all adults 25 years and 
older were asked to undertake an 8-hour fast for blood tests 
(fasting blood glucose and lipid profi le) that was collected 
at home on weekends. Within 1 hour of blood collection, 
the samples were centrifuged and separated. All selected 
parameters of blood lipids (total cholesterol, triglycerides, 
high-density lipoprotein cholesterol [HDL-C] and low-den-
sity cholesterol [LDL-C]) and blood glucose estimation were 
performed using a Vitalab Selectra autoanalyzer. Fasting 
blood glucose and lipid profi les were done by the glucose 
oxidase GOD PAP method and cholesterol CHOD PAP 
method, respectively. Fasting insulin levels were measured, 
but these will be presented elsewhere.
Criteria for metabolic syndrome
Diagnostic criteria for the metabolic syndrome were from 
the IDF10 and American Heart Association (AHA)/National 
Heart, Lung, and Blood Institute (NHLBI) (Table 1).11
Statistical analysis
All data were recorded on forms developed using 
TeleForm® Version 6.01, an optical character recognition 
software. Later this data was converted into the software 
package Statistical Package for Social Sciences (SPSS, version 
11.5) for analysis. The prevalence of metabolic syndrome was 
determined by simple percentages and with 95% confi dence 
intervals (CIs). For group comparisons, the chi-square test 
was performed; the Student t-test was performed for contin-
uous variables. A P value of <0.05 was considered statisti-
cally signifi cant. The age-specifi c distribution of prevalence 
of metabolic syndrome was calculated for men and women 
separately and described in percentages. A kappa test was 
done to examine the agreement among the defi nitions. All 
P values presented are two tailed.
Results
Description of anthropometric and biochemical param-
eters are provided in Table 2. Female subjects were younger 
but had higher BMI values and total cholesterol, low-density 
lipoprotein (LDL), and high-density lipoprotein (HDL) lev-
els. Males were older and had higher waist circumference, 
Materials and Methods
Study area and population
The survey activities were conducted over a period of 6 
months from July, 2004, to December, 2004. The Lyari Town 
Geographical Information System (GIS) was made by the 
Population Census Offi ce, Statistics Bureau Sindh, and a 
research organization to defi ne the geopolitical boundaries 
and population density of Lyari Town (estimated 2004 pop-
ulation, 700,000). This was done by dynamically linking the 
national census database to a purpose-built GIS. This GIS 
ascribed unique identifi cation numbers to 85,520 house-
holds, which was the initial criteria for studying the prev-
alence of metabolic syndrome among randomly selected 
households in Lyari.
The rationale for choosing Lyari Town for this study was 
that its residents comprise a multiethnic community that 
includes the major ethnic groups found in Pakistan. There 
is similarly a wide spectrum of socioeconomic groups in 
the area that could possibly be representative of the general 
population.
Methodology
The ethical approval for this survey was given by 
Institutional Review Board (IRB) of Baqai Institute of 
Diabetology and Endocrinology. The survey activities were 
divided into two phases, the household interview plus phys-
ical examination and blood sample collection. Amongst the 
initial households selected, 532 households were randomly 
selected through the GIS software and maps. These house-
holds were then generated into nine fi eld segments, which 
were the responsibility of nine fi eld teams. A fi eld team 
comprised of one or two medical students, a female health 
worker, and a male health worker. All teams and survey-
ors were supervised by a medical doctor acting as the fi eld 
coordinator.
If members of a selected household were absent or 
refused to participate, then the third door to the right of that 
house (while standing facing the door of the original house) 
was approached and consent to participate was sought. In 
case of further denial or absence, the next consecutive door 
to the right was selected. All adults 25 years and older were 
invited to participate after providing signed consent. In the 
case of illiterate participants, the consent form was read out 
to them and a thumbprint was procured in the presence of a 
household member or neighbor as witness.
By following this procedure, a total of 871 persons >25 
years were approached, out of which 867 persons partic-
ipated in the survey (response rate, 99.5%). These people 
were interviewed by the fi eld teams, and their anthropo-
metric measures were performed and blood samples were 
collected. Of these, 363 persons gave blood, producing a 
response rate of 42% for blood collection.
Anthropometry
Anthropometric and demographic information was 
collected during interview. Weight, height, waist, and hip 
circumference were measured with the participants in 
standing position wearing light clothes and no shoes. The 
weight was taken to the nearest 0.1 kg by a digital bathroom 
scale and height was taken to the 0.1 cm. Body mass index 
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classifi cations in this population. The prevalence increased 
with age for both sexes using both defi nitions in our pop-
ulation. This trend was also seen in other studies done in 
South Asian and U.S. populations.4,16–18 One possible reason 
for the observed higher rate of metabolic syndrome in this 
population is the high rate of obesity following the Asian 
cut-off criteria.19
In addition, lower waist circumference applied with 
modifi ed ATP III criteria instead of the original cut off in our 
study may have also increased the prevalence of metabolic 
syndrome. However, our data are consistent with studies 
done in Indian, Bangladeshi, and Chinese populations.4,17,20 
The prevalence rate was relatively higher following modi-
fi ed ATP III criteria in our study population. Other studies 
in the region also showed higher prevalence rates ranging 
from 35.2% to 41%.4,21 A study conducted in older subjects in 
Pakistan (aged 40 years and above) showed a prevalence rate 
of 45.9% in males and 57.2% in females.22
The reported prevalence rate from Chennai, India, was 
26% compared to our prevalence of 34.8% following IDF 
criteria,23 whereas a study done in rural Pakistan showed a 
prevalence of 40%.5 The prevalence of metabolic syndrome 
was also seen to increase with advancing age. This was also 
blood pressure, and triglyceride values. Approximately 30% 
of the subjects had higher total cholesterol, triglycerides, and 
LDL levels, as shown in Table 3. A total of 70% had low HDL 
levels, which are typical of the data presented in Europe 
from the Indian subcontinent. The revalence of diabetes was 
9.4%, whereas 5.6% had impaired fasting glucose (abnormal 
glucose tolerance 15%).
The overall prevalence of metabolic syndrome was 34.8% 
and 49% according to IDF and modifi ed ATP III classifi ca-
tions, respectively (Table 4). The prevalence rates of the met-
abolic syndrome increased with increasing age. Signifi cant 
differences in the prevalence of metabolic syndrome with 
respect to age groups were found only in females (P values 
<0.05) (Table 4). There was fairly good agreement between 
the two defi nitions of metabolic syndrome, with a kappa 
value of 0.67. All of those (n = 120) who were classifi ed as 
having metabolic syndrome following IDF criteria were sus-
tained according to the modifi ed ATP III criteria.
Discussion
Our study showed a very high prevalence of the met-
abolic syndrome according to IDF and modifi ed ATP III 
Table 2. Means of Anthropometric and Biochemical Parameters of Subjects (N = 363)
 Male Female Total
 mean ± SD mean ± SD mean ± SD
Age (years) 45.1 ± 15.7 38.8 ± 12.8 40.8 ± 14.1
BMI (kg/m2) 23.9 ± 7.2 26.0 ± 7.1 25.4 ± 7.2
Waist-to-hip ratio 0.94 ± 0.11 0.91 ± 0.16 0.92 ± 0.15
Waist circumference (cm) 89.5 ± 16.0 87.8 ± 15.8 88.4 ± 15.8
Systolic blood pressure (mmHg) 127.4 ± 18.6 124.3 ± 19.6 125.2 ± 19.3
Diastolic blood pressure (mmHg) 84.3 ± 11.8 79.9 ± 13.7 81.2 ± 13.3
Fasting plasma glucose (mg/dL) 86.7 ± 21.7 86.6 ± 23.2 86.6 ± 22.7
Cholesterol (mg/dL) 175.9 ± 42.6 180.7 ± 44.6 179.2 ± 43.9
Triglycerides (mg/dL) 158.9 ± 105.2 135.2 ± 70.2 142.6 ± 83.3
Low-density lipoprotein (mg/dL) 110.7 ± 28.8 116.2 ± 33.0 114.5 ± 31.8
High-density lipoprotein (mg/dL) 37.1 ± 10.4 43.2 ± 12.4 41.3 ± 12.2
Abbreviations: SD, standard deviation; BMI, body mass index.
Table 3. Percentage of Biochemical Risk Factors for Metabolic Syndrome
 Males Females Total
 n (%) n (%) n (%)
Variable 95% CI 95% CI 95% CI
Cholesterol >200 mg/dL 26/95 (26.8) 68/216 (31.48) 94/313 (30.0)
 (17.99–35.62) (25.28–37.67) (24.92–54.92)
Triglycerides >150 mg/dL 35/94 (37.23) 57/208 (27.4) 92/302 (30.5)
 (27.46–47.00) (21.34–33.46) (25.30–55.80)
Low-density lipoprotein 25/97 (25.77) 63/216 (29.16) 88/313 (28.1)
  >130 mg/dL (17.06–34.47) (64.77–35.22%) (23.12–51.22)
High-density lipoprotein 63/96 (65.62) 153/216 (70.83) 216/312 (69.2)
  <40 mg/dL for males, (56.12–75.12) (64.77–76.89) (64.07–133.27)
  <50 mg/dL for females 
Abbreviation: CI, confi dence interval.
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it is suggested that inclusion of modifi ed waist circum-
ference and BMI cut offs as done in the modifi ed ATP III 
criteria and IDF defi nition would probably help identify 
metabolic syndrome at an earlier stage.
Despite the debate regarding metabolic syndrome as a 
clinical entity in recent scientifi c communications, it is clear 
that defi nition of the syndrome has relevance only if it iden-
tifi es individuals at risk both for T2DM and CVD. Thus, the 
signifi cance of metabolic syndrome should be appraised in 
relation to its appropriateness for the identifi cation of the 
individuals at risk. Our study showed that the prevalence of 
diabetes was 9.4%, whereas 5.6% had impaired fasting glu-
cose (abnormal glucose tolerance 15%). The National Diabetes 
Survey of Pakistan, using study protocols and standardized 
World Health Organization (WHO) defi nitions showed the 
overall glucose intolerance (diabetes and impaired glucose 
tolerance [IGT] combined) was present in 22–25% of the sub-
jects, whereas the overall prevalence of IGT in these surveys 
ranged from 5.39% to 11.2%.31–33
Our study showed an alarming prevalence of 49% of 
the metabolic syndrome in an urban Pakistani population 
according to the modifi ed ATP III criteria, whereas hospi-
tal-based studies have shown a prevalence of 44% using 
the original ATP III criteria. Our study is probably the fi rst 
community-based study in an urban population on meta-
bolic syndrome with modifi ed ATP III defi nitions of meta-
bolic syndrome.
We observed a high rate of metabolic syndrome in the 
urban population of Lyari Town in the city of Karachi. Its 
residents comprise a diverse community including every 
major ethnic group found in Pakistan. Furthermore, the 
residents also have a mixed socioeconomic personal history. 
This may help to comprehend the spectrum of the metabolic 
syndrome in the general population. However, there are 
some limitations to this study. Despite the use of computer-
ized random selection of households by GIS to minimize the 
selection bias, the sample size is small. It cannot be general-
ized for the Pakistani population as a whole, and thus the 
results have to be interpreted with caution.
Our study may suggest that the burden of noncommu-
nicable diseases such as CVDs and diabetes in our region 
will be increased as a consequence of higher rate of meta-
bolic syndrome seen in this population. Every effort should 
be made for the management of the metabolic syndrome to 
reduce the risks of diabetes and CVDs in this population. 
This is important, particularly at a time when the global epi-
demic of metabolic and vascular disease is emerging as a 
signifi cant public health challenge, with its consequences for 
diabetes and CVD.
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Abstract: Dietary trends have been found to be related with metabolic syndrome in various studies. To
identify dietary  patterns  and  study  associations  between  the  dietary  patterns  of  subjects  with  high
and low risk of metabolic syndrome in a Karachi based community. A group of 871 men and women were
selected randomly from 532 households. Data about consumption of specific foods was available for 867
adults. Participants completed a health and lifestyle questionnaire and 363 subjects provided fasting blood
samples for glucose and lipids. Dietary intake was assessed by a questionnaire to identify consumption of
33 specific food items and the dietary patterns categorized into 6 food groups was assessed by cluster
analysis. Five dietary patterns were identified through cluster analysis. Cluster 1 had the lowest proportion
of persons with metabolic syndrome i.e. 42.7% while cluster 2 had the highest percentage of metabolic
syndrome subjects (56.3%) (p = 0.09). Consumption of fat and caloric dense foods was significantly higher
among highest risk group (cluster 2) compared to lowest risk group (cluster 1) (p = 0.0001). The
consumption of food groups containing fruit, milk and meat was also more than twice in high risk compared
to low risk group (p = 0.0001). Even within the same population there are marked differences in dietary
patterns and these apparently contribute to the risk of developing metabolic syndrome. Dietary pattern
studies will help elucidate links between diet and disease and contribute to developing healthy eating
guidelines.
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INTRODUCTION
High prevalence of metabolic syndrome and
Cardiovascular Disease (CVD) risk factors have been
reported worldwide especially in South Asians
(Ramachandran et al., 2003; Wierzbicki et al., 2005;
Basit et al., 2002; Jafar et al., 2005). Metabolic Syndrome
(MS) has been shown to be a good marker of future
disease risk and it is estimated that subjects with
metabolic syndrome are three times more likely to have
and twice as likely to die from a heart attack or stroke
compared to people without the syndrome (Sarkar et al.,
2006). Similarly, people with metabolic syndrome have
a five-fold increased risk of developing type 2 diabetes.
Although dietary intake has been linked to individual
components of MS or the outcome diseases such as
diabetes and cardiovascular diseases, the dietary
patterns which may lead to the development of
metabolic syndrome have not been specified. In recent
years there has been increasing interest in the
identification of dietary patterns as consumed by
populations to better understand the association of diet
with chronic diseases (Schwerin et al., 1982; Randall et
al., 1990). During the last two decades, there has been
significant changes in society’s life style habits with
increase in unhealthy eating, sedentary activities and
smoking (Panagiotakos et al., 2003). These habits have
fueled the epidemic of obesity, which is an important risk
factor for diabetes, cardiovascular diseases,
hypertension and dyslipidemia all of which may be
preceded by metabolic syndrome (Basit and Shera,
2008).
The 1990-1994 National Health Survey of Pakistan
showed that overall 25% of the population was
overweight or obese. The factors significantly associated
with obesity were increasing age, being female, higher
education, urban residence, high economic status and
a high intake of meat (Jafar et al., 2006). Knowledge of
specific food patterns is important for relating diet to
nutritional status and for the identification of groups at
risk of under-or over consumption of specific food items
(Tucker et al., 1992). 
Several studies have shown that adopting a dietary
pattern characterized by high intake of red meat, refined
grains, snacks, sweets and fried foods contribute to the
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increased prevalence of type 2 diabetes (Song et al., Diabetology and Endocrinology. The survey activities
2004; Schulze et al., 2003; Van et al., 2002). Whilst were divided into two phases, the household interview
adopting a dietary pattern characterized by high based on questionnaire and blood sample collection.
consumption of non-refined cereals, fruits and The questionnaire included demographical details, diet
vegetables, a moderate intake of dairy products, poultry and physical activity questions and anthropometric
and fish and a low intake of red meat contribute towards measurements.
a reduced prevalence of type 2 diabetes, metabolic Around 532 households were randomly selected
syndrome and cardiovascular disease (Kris-Etherton et
al., 2001; Trichopoulou et al., 2003; Chrysohoou et al.,
2004).
Thus understanding the food patterns around which
diets are formed is important for meal planning and
nutritional counseling. Cross-sectionally, dietary intake
rich in whole-grain foods have been linked to a lower
prevalence of metabolic syndrome (Sahyoun et al., 2006;
McKeown et al., 2004; Esmaillzadeh et al., 2005). Dairy
intake has been inversely associated with metabolic
syndrome (Azadbakht et al., 2005; Mennen et al., 2000;
Pereira et al., 2002). Greater intakes of fruit and
vegetables have been associated with a lower
prevalence of metabolic syndrome (Esmaillzadeh et al.,
2006). No association has been found between
metabolic syndrome and intakes of meat and fish
(Mennen et al., 2000).
In cross-sectional dietary pattern analysis, a greater
prevalence of MS was found among consumers of
empty calorie dietary patterns, whereas a lower
prevalence was found among those consuming a
healthy dietary pattern (Esmaillzadeh et al., 2007;
Sonnenberg et al., 2005). 
There are no clear recommendations regarding dietary
guidelines for the prevention of metabolic syndrome in
persons at risk. The present study will help to evaluate
the relationship between dietary intake and the risk of
developing MS. Cluster analysis offers advantages over
the alternative quantitative approaches as it aims to
identify distinct, relatively homogeneous groups based
upon selected attributes (the dietary variables) (Hu,
2002).
The aim of the present study is to identify dietary patterns
within a general population sample of urban Pakistani
subjects. We also aim to report the associations
between dietary patterns and prevalence of metabolic
syndrome which is a precursor for the development of
Cardiovascular Disease (CVD) and glucose intolerance.
MATERIALS AND METHODS
The survey was conducted from July 2004 to December
2004 over a period of 6 months. The Lyari Town
Geographical Information System (GIS) was used in this
survey which ascribed unique identification numbers to
85,520 households in Lyari, where the study on
prevalence of metabolic syndrome amongst selected
households   was   undertaken   (Hydrie   et   al.,   2009).
The ethical approval for the Lyari survey was given by the
Institutional Review Board (IRB) of Baqai Institute of
through the GIS software and maps. All adults older than
25 years were invited to participate after providing signed
consent. By following this procedure, a total of 871
persons were approached, out of which 867 persons
participated in the survey (response rate: 99.5%). These
people were interviewed by the field teams and their
anthropometric measures taken. Of these, 363 persons
gave blood samples, producing a response rate of 42%
for blood collection.
Anthropometry: Weight, height, waist, and hip
circumference were measured with the subjects in
standing position wearing light clothes and no shoes.
The weight was taken to the nearest 0.1 kg by a digital
bathroom scale and height was taken to the 0.1 cm.
Body Mass Index (BMI) was calculated as a ratio of
weight (kg) to height in meters squared. Waist
circumference was measured at the minimum
circumference between the lower border of the ribs and
iliac crest on the midaxillary line and hip circumference
was measured at the greatest protrusion of the buttocks
just below the iliac crest The measurements were taken
in centimeters and the Waist-to-Hip Ratio (WHR) was
calculated as waist/hip circumference. Blood pressure
was measured twice by using a mercury
sphygmomanometer, with individuals requested to sit
for 10 min before measuring the blood pressure as a
special precaution to minimize blood pressure
variations and a mean value taken for the final
measurements.
Laboratory assays: All subjects were asked to
undertake an 8 h fast for blood tests (fasting blood
glucose and lipid profile) that were collected at home on
weekends (Hydrie et al., 2009). All selected parameters
of blood lipids (total cholesterol, triglycerides, High
Density Lipoprotein Cholesterol [HDL-C] and Low-
Density Cholesterol [LDL-C]) and blood glucose
estimation were performed using a Vitalab Selectra
autoanalyzer. Fasting blood glucose and lipid profiles
were done by the glucose oxidase GOD PAP method
and cholesterol CHOD PAP method, respectively.
Criteria for metabolic syndrome: Diagnostic criteria for
the metabolic syndrome were taken from the American
Heart Association (AHA)/National Heart, Lung and Blood
Institute (NHLBI) (Table 1) (Grundy et al., 2005).
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Table 1: AHA/NHLBI diagnostic criteria for metabolic syndrome
Measure (any three of the five criteria below
constitute a diagnosis of metabolic syndrome) Categorical cut points 
Elevated waist circumference U.S. population: >102 cm in men, >88 cm in women; lower cut points for insulin-
resistant individuals or ethnic groups. For South Asians: >90 cm in men, >80 cm in
women
Elevated triglycerides >150 mg/dl (1.7 mmol/l) or on drug treatment for elevated triglycerides
Reduced HDL cholesterol <40 mg/dl (1.03 mmol/l) in men, <50 mg/dl (1.29 mmol/l) in women
Elevated blood pressure >130 mmHg systolic blood pressure or >85 mmHg diastolic blood pressure or on drug
treatment for hypertension
Raised fasting glucose Fasting plasma glucose >100 mg/dl (5.6 mmol/l) or previously diagnosed type 2
diabetes
Dietary data: Dietary consumption was assessed by a
33 food items interviewer-administered semi
quantitative food-frequency questionnaire. The food
items were categorized into 6 major food groups: Dairy,
meat, fat and sweet, cereals, vegetables and fruits
groups. Out of the 363 subjects assessed for metabolic
syndrome 362 completed the food-frequency
questionnaire.
Statistical analysis: We used cluster analysis to identify
dietary patterns and to segregate subjects based on the
similarity of diet. We chose food variables because we
wanted to identify food patterns clusters. K-means
cluster analysis was used to define clusters of subjects
using the cluster analysis option in SPSS. This
procedure attempts to identify relatively homogeneous
groups of cases based on selected characteristics.
In K-means cluster analysis, the homogeneity of cases
within a cluster is measured by the total within-cluster
sum of squares. Cluster memberships are determined
by sequentially moving cases from one cluster to
another so that the total within-cluster sum of squares is
minimized.
The algorithm requires the number of clusters to be
specified prior to analysis. It is possible to identify seeds
using information derived from previous research. 
Five clusters were defined. We investigated metabolic
syndrome prevalence for each cluster and compared the
dietary patterns of the clusters with the lowest and
highest prevalence of metabolic syndrome. 
RESULTS
We identified five distinct groups in this population on
the basis of cluster analyses. A total of 75 participants
(20.7%) were in cluster 1, 71 (19.6%) in cluster 2, 64
(17.8%) in cluster 3, 85 (23.5%) in cluster 4 and 67
(18.5%) in cluster 5. Frequency of consumption of each
food group in all the clusters is shown in Table 2. 
Analyzing for proportion of subjects with metabolic
syndrome in each cluster it was observed that cluster 1
had the lowest proportion of persons with metabolic
syndrome while cluster 2 had the highest percentage of
metabolic syndrome subjects (42.7% vs. 56.3%) with a
p value of 0.09 compared to the other clusters as shown
in Fig. 1.
Table 2: Frequency of consumption of food groups in clusters (%)
Clusters
--------------------------------------------------------
1 2 3 4 5
Milk group 24 69 32 57 29
Meat group 35 79 61 61 56
Fat group 13 70 20 42 44
Cereal group 76 91 90 92 81
Vegetables group 72 94 83 93 82
Fruit group 34 74 45 59 46
Fig. 1: Metabolic syndrome in five clusters according to
modified ATP III definition
Comparing the food items in milk group it was observed
that the consumption in cluster 2 (high risk group) was
twice compared to cluster 1 (low risk group), the greatest
consumption was in cream\custard (7.6 times) and ice
cream\sweet lassi (5 times) as shown in Fig. 2. 
In meat group the consumption of red meat, organ meat,
prawns and eggs in cluster 2 was 3-5 times compared
to cluster 1 as shown in Fig. 3. 
There was five times increased consumption of the
sweet and fat group in cluster 2 compared to cluster 1
as shown in Fig. 4. 
In the cereal group there was not much difference in the
consumption of legumes and fried rice in both the
clusters but around 1.6 times more consumption of
naans (refined grain) was seen in cluster 2 compared to
cluster 1 (Fig. 5). 
In the vegetable group there was also not much
difference in the consumption of cooked vegetables and
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Fig. 2: Comparison of groups with regards to milk group
Fig. 3: Comparison of groups with regards to meat
group
Fig. 4: Comparison of groups with regards to fat and
sweet group
cooked potatoes in both clusters but the consumption of
raw vegetables was almost double in cluster 2
compared to cluster 1 (Fig. 6). 
In the fruit group both clusters showed high Fig. 7: Comparison of groups with regards to fruit group
consumption of fruits but 8 times more consumption of
fruit  juices was seen in cluster 2 compared to cluster 1 its components. Rather it is the interaction between
as shown in Fig. 7. different components of diet as well as the consumption
DISCUSSION
Metabolic Syndrome (MS) has been identified as a
precursor of predicting future disease and
understanding how MS can be influenced by overall
dietary pattern as an entity is valuable. 
No individual dietary component is wholly responsible
for the association of diet with metabolic syndrome and
Fig. 5: Comparison of groups with regards to cereal
group
Fig. 6: Comparison of groups with regards to vegetable
group
of different food items which contribute to the risk for
metabolic syndrome. Thus overall dietary trends needs
to be observed as individuals consume a mixture of
different food items in a single meal, rather than isolated
groups.
To our knowledge, this is the first investigation to look
into major dietary patterns and its association with the
metabolic syndrome by cluster analysis. 
Pak. J. Nutr., 9 (1): 93-99, 2010
97
In this study low MS risk group (cluster 1) had lowest to insulin resistance (Burden et al., 1994). Processed
consumption of all the food groups while the high MS cereals, such as refined grains have been shown to be
risk group (cluster 2) had highest consumption in most associated with an increased risk of the components of
of the food groups. This high food consumption may the metabolic syndrome in The Malmö Diet and Cancer
also contribute to the high prevalence of MS as seen in Study (Wirfalt et al., 2001). Similarly in our study refined
cluster 2. grains were consumed nearly twice in the high MS risk
Looking at the food groups individually it appears that group (cluster 2).
the  food items which were the most energy-dense had Almost double consumption of raw vegetables was
the highest consumption in cluster 2 and this probably seen in cluster 2 compared to cluster 1. Similarly the
had the most influence in creating an unhealthy dietary overall double consumption of the fruit group was seen
pattern which may lead to increased prevalence of MS. in cluster 2. An inverse association between prevalent
It has been observed in other studies that the MS and intakes of fruit and vegetables has been
consumption of traditional food (low in saturated fat, low reported previously (Esmaillzadeh et al., 2006). Also
in simple sugars and high in fibre) has declined recently consumption of diets high in fruit and vegetables has
and energy-dense food (high in calories, carbohydrates been associated with lower blood pressure (Appel et al.,
and saturated fats and low in fibre) and non-traditional 2006) and a better lipid profile (Lichtenstein et al., 2006).
energy-dense fast food are being increasingly Looking at the individual food items in the fruit group it
consumed in South Asia (Misra et al., 2009; Misra and was observed that the consumption of fruit juices which
Khurana, 2008). accounts to empty calories was 8 times more in cluster
Studies have shown that South Asians have a high 2 compared to cluster 1. As mentioned earlier empty
consumption of dairy products and sugar compared to calories in diet may lead to increased prevalence of MS;
other populations (Misra et al., 2009; Popkin, 2001). the increased consumption of fruit juices probably
Although dairy consumption has been inversely related undermined the protective effect which vegetables and
to MS in some studies (Azadbakht et al., 2005; Mennen fruits may have in cluster 2.
et al., 2000; Pereira et al., 2002) more than twice dairy In summary the dietary pattern in cluster 2 was loaded
consumption was seen in the high risk group. Looking with both healthy (milk, legumes, vegetables and fruits)
further at the individual food items in the milk group it and unhealthy (refined grains, potatoes, meat and meat
was observed that the highest consumption was in products, high fat dairy products, snacks, sweet items
cream\custard and ice cream\sweet lassi; items which and fruit juices) foods. Although the healthy foods have
have a high fat and sugar content. Coincidently a high been reported to be protective against the metabolic
intake of fat, milk products and sugars in various regions syndrome, the cluster's unhealthy diet constituents have
in India has also shown to be associated with increased adverse effects on metabolic markers which may lead to
cardiovascular mortality (Gupta et al., 2006). Thus a increased prevalence of MS. 
combination of dairy products, with high fat and sugars A limitation to consider in the interpretation of our results
may influence the individual properties of the food and
produce a positive association with metabolic
syndrome. In our study these factors probably made
dairy consumption lose its protective effect in our
subjects as documented elsewhere. 
Red meat, organ meat and prawns from the meat group
were consumed 3-5 times more in cluster 2 compared
to cluster 1. All of these food items are known to be high
in saturated fat, which has been adversely associated
with cholesterol (Schaefer, 2002), blood pressure (Appel
et al., 2006), obesity and diabetes risk (Parillo and
Riccardi, 2004). 
Similarly all the food items in fat and sweet group were
consumed five times more in cluster 2 compared to
cluster 1. Sweet products were consumed at an
alarming 13 times more in cluster 2 and they probably
influenced the increased prevalence of MS in cluster 2
with their load of empty calories in the diet. 
South Asians consume more carbohydrates compared
to Europeans and this may lead to hyperinsulinemia,
postprandial hyperglycemia, hypertriglyceridemia and
low HDL cholesterol levels, all of which is probably due
is the use of an FFQ containing only 33 items, thus
restricting the number of food items needed to
characterize usual dietary intake. Furthermore, for some
food groups such as dry fruits, low consumption and a
narrow range of values among consumers may have
prevented us from detecting a relationship if one was
present. Moreover, reporting biases may have occurred.
Although we acknowledge these limitations, other
studies have indicated that there is reasonable validity
and reliability of food groups and major dietary patterns
obtained from FFQs. 
Another limitation of our study is its cross-sectional
nature. Thus, the association observed between these
dietary patterns and the metabolic syndrome needs to
be confirmed in prospective analyses. Furthermore we
cannot generalize our findings to Pakistani populations,
since only one area within an urban city was used for the
sample population.
However, participants in the current study reflected
almost all major ethnic groups of Pakistan so that a
broad range of dietary habits were represented. Most
previous studies relating MS to diet have focused on a
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single food group. Thus, a major strength of our study is Esmaillzadeh, A., M. Kimiagar, Y. Mehrabi, L. Azadbakht,
that all six major food groups have been covered in the
FFQ.
Thus we need to further explore the development of a
method which accurately measures an individual’s
overall diet quality and quantity and this is a prerequisite
for further research regarding the relationship between
diet and metabolic syndrome. Further research is
required in larger prospective populations to be able to
validate the findings of this study and improve our
understanding of the association of diet with MS.
ACKNOWLEDGEMENTS
We acknowledge the support of Merck Pakistan Pvt Ltd
for lab tests. We acknowledge the hard work and
dedicated commitment of the medical students and
social workers of Lyari community development project
which made this study possible. Finally we acknowledge
the Norwegian Research Council for financing.
REFERENCES
Appel, L.J., M.W. Brands, S.R. Daniels, N. Karanja, P.J.
Elmer and F.M. Sacks, 2006. Dietary approaches to
prevent and treat hypertension: A scientific
statement from the American Heart Association.
Hypertension, 47: 296-308.
Azadbakht, L., P. Mirmiran, A. Esmaillzadeh and F. Azizi,
2005. Dairy consumption is inversely associated
with the prevalence of the metabolic syndrome in
Tehranian adults. Am. J. Clin. Nutr., 82: 523-530. 
Basit, A. and A.S. Shera, 2008. Prevalence of Metabolic
syndrome in Pakistan. J. Metabolic Syndrome and
Related Disorder, 6: 171-175.
Basit, A., M.Z.I. Hydrie, K. Ahmed and R. Hakeem, 2002.
Prevalence of diabetes, impaired fasting glucose
and associated risk factors in a rural area of
Baluchistan province according to new ADA criteria,
J. Pak. Med. Assoc., 52: 357-360.
Burden, M.L., A. Samanta, D. Spalding and A.C. Burden,
1994. A comparison of the glycaemic and
insulinaemic effects of an Asian and a European
meal. Pract Diabetes Int., 11: 208-211. 
Chrysohoou, C., D.B. Panagiotakos, C. Pitsavos, U.N.
Das and C. Stefanadis, 2004. Adherence to the
Mediterranean diet attenuates inflammation and
coagulation process in healthy adults: The ATTICA
Study. J. Am. Coll. Cardiol., 44: 152-158. 
Esmaillzadeh, A., P. Mirmiran and F. Azizi, 2005. Whole-
grain consumption and the metabolic syndrome: A
favorable association in Tehranian adults. Eur. J.
Clin. Nutr., 59: 353-362.
Esmaillzadeh, A., M. Kimiagar, Y. Mehrabi, L. Azadbakht,
F.B. Hu and W.C. Willett, 2006. Fruit and vegetable
intakes, C-reactive protein and the metabolic
syndrome. Am. J. Clin. Nutr., 84: 1489-1497. 
F.B. Hu and W.C. Willett, 2007. Dietary patterns,
insulin resistance and prevalence of the metabolic
syndrome in women. Am. J. Clin. Nutr., 85: 910-918.
Grundy, S., J. Cleeman, S. Daniels, K. Donato, R. Eckel
and B. Franklin, 2005. Diagnosis and management
of the metabolic syndrome: An American Heart
Association/National Heart, Lung and Blood
Institute scientific statement. Circulation, 112: 2735-
2752.
Gupta, R., A. Misra, P. Pais, P. Rastogi and V.P. Gupta,
2006. Correlation of regional cardiovascular
disease mortality in India with lifestyle and
nutritional factors. Int. J. Cardiol., 108: 291-300. 
Hu, F.B., 2002. Dietary pattern analysis: A new direction
in nutritional epidemiology. Current Opinion in
Lipidology, 13: 3-9.
Hydrie, M.Z.I, A.S. Shera, A. Fawwad, A. Basit and A.
Hussain, 2009. Prevalence of metabolic syndrome
in urban Pakistan: (Karachi): Comparison of newly
proposed IDF and modified ATP III Criterions. J.
Metabolic Syndrome Related Disorder, 7: 119-124.
Jafar, T.H., F.H. Jafary, S. Jessani and N. Chaturvedi,
2005. Heart disease epidemic in Pakistan: Women
and men at equal risk. Am. Heart J., 150: 221-226.
Jafar, T.H., N. Chaturvedi and Pappas Gregory, 2006.
Prevalence of overweight and obesity and their
association with hypertension and diabetes
mellitus in an Indo-Asian population. Can. Medical
Assoc. J., Vol. 175.
Kris-Etherton, P., R.H. Eckel and B.V. Howard, 2001.
AHA Science Advisory: Lyon Diet Heart Study.
Benefits of a Mediterraneanstyle, National
Cholesterol Education Program/American Heart
Association Step I Dietary Pattern on Cardiovascular
Disease. Circulation, 103: 1823-1825.
Lichtenstein, A.H., L.J. Appel, M. Brands, M. Carnethon,
S. Daniels, H.A. Franch, B. Franklin, P. Kris-
Etherton, W.S. Harris, B. Howard, N. Karanja, M.
Lefevre, L. Rudel, F. Sacks, L. Van Horn, M. Winston
and J. Wylie-Rosett, 2006. Diet and lifestyle
recommendations revision 2006: A scientific
statement from the American Heart Association
Nutrition Committee. Circulation, 114: 82-96.
McKeown, N.M., J.B. Meigs, S. Liu, E. Saltzman, P.W.
Wilson and P.F. Jacques, 2004. Carbohydrate
nutrition, insulin resistance and the prevalence of
the metabolic syndrome in the Framingham
Offspring Cohort. Diabetes Care, 27: 538-546.
Mennen, L.I., L. Lafay, E.J.M. Feskens, M. Novak, P.
Lepinay and B. Balkau, 2000. Possible protective
effect of bread and dairy products on the risk of
metabolic syndrome. Nutr. Res., 20: 335-347. 
Pak. J. Nutr., 9 (1): 93-99, 2010
99
Misra, A., L. Khurana, S. Isharwal and S. Bhardwaj, Schwerin, H.S., J.L. Stanton, J.L. Smith, A.M. Riley Jr. and
2009. South Asian diets and insulin resistance. Br.
J. Nutr., 101: 465-473. 
Misra, A. and L. Khurana, 2008. Obesity and the
metabolic syndrome in developing countries. J.
Clin. Endocrinol. Metab., 93 (11 suppl 1): S9-30.
Panagiotakos, D.B., C. Chrysohoou and C. Pitsavos,
2003. The prevalence of Clinical and Biomedical
Markers Related to Cardivascular Disease: Design
a Preliminary Results from the ATTICA Study.
Hellenic J. Cardiol., 44: 308-316.
Parillo, M. and G. Riccardi, 2004. Diet composition and
the risk of type 2 diabetes: Epidemiological and
clinical evidence. Br. J. Nutr., 92: 7-19.
Pereira, M.A., D.R. Jacobs Jr., L. Van Horn, M.L. Slattery,
A.I. Kartashov and D.S. Ludwig, 2002. Dairy
consumption, obesity and the insulin resistance
syndrome in young adults: The CARDIA Study.
JAMA., 287: 2081-2089.
Popkin, B.M., 2001. The nutrition transition and obesity
in the developing world. J. Nutr., 131: 871-3S.
Ramachandran, A., C. Snehalatha, K. Satyavani, S.
Sivasankari and V. Vijay, 2003. Metabolic syndrome
in urban Asian Indian adults- a population study
using modified ATP III criteria. Diab. Res. Clin.
Pract., 60: 199-204.
Randall, E., J.R. Marshall, S. Graham and J. Brasure,
1990. Patterns in food use and their associations
with nutrient intakes. Am. J. Clin. Nutr., 52: 739-745.
Sahyoun, N.R., P.F. Jacques, X.L. Zhang, W. Juan and
N.M. McKeown, 2006. Whole-grain intake is
inversely associated with the metabolic syndrome
and mortality in older adults. Am. J. Clin. Nutr., 83:
124-131.
Sarkar, S., M. Das, B. Mukhopadhyay, C.S. Chakrabarti
and P.P. Majumder, 2006. High prevalence of
metabolic syndrome and its correlates in two tribal
populations of India and the impact of urbanization.
In. J. Med. Res., 123: 679-686.
Schulze, M.B., J.E. Manson, W.C. Willett and F.B. Hu,
2003. Processed meat intake and incidence of Type
2 diabetes in younger and middle-aged women.
Diabetologia, 46: 1465-1473.
B.E. Brett, 1982. Food, eating habits and health: A
further examination of the relationship between food
eating patterns and nutritional health. Am. J. Clin.
Nutr., 35 (Suppl. 5): 1319-1325.
Schaefer, E.J., 2002. Lipoproteins, nutrition and heart
disease. Am. J. Clin. Nutr., 75: 191-212.
Song, Y., J.E. Manson, J.E. Buring and S. Liu, 2004. A
prospective study of red meat consumption and
type 2 diabetes in middle-aged and elderly women:
the women's health study. Diabetes Care, 27: 2108-
2115.
Sonnenberg, L., M. Pencina, R. Kimokoti, P. Quatromoni,
B.H. Nam, R. D’Agostino, J.B. Meigs, J. Ordovas, M.
Cobain and B. Millen, 2005. Dietary patterns and the
metabolic syndrome in obese and non-obese
Framingham women. Obes. Res., 13: 153-162.
Trichopoulou, A., T. Costacou, C. Bamia and D.
Trichopoulos, 2003. Adherence to a Mediterranean
diet and survival in a Greek population. N. Engl. J.
Med., 348: 2599-2608.
Tucker, K.L., G.E. Dallal and D. Rush, 1992. Dietary
patterns of elderly Boston-area residents defined by
cluster analysis. J. Am. Diet. Assoc., 92: 1487-1491.
Van Dam, R.M., W.C. Willett, E.B. Rimm, M.J. Stampfer
and F.B. Hu, 2002. Dietary fat and meat intake in
relation to risk of type 2 diabetes in men. Diabetes
Care, 25: 417-424.
Wierzbicki, A.S., S. Nishtar, P.J. Lumb, M. Lambert-
Hammill, C.N. Turner, M.A. Crook, M.S. Marber and
J. Gill, 2005. Metabolic syndrome and risk of
coronary heart disease in a Pakistani cohort. Heart,
91: 1003-1007.
Wirfalt, E., B. Hedblad, B. Gullberg, I. Mattisson, C.
Andren, U. Rosander, L. Janzon and G. Berglund,
2001. Food patterns and components of the
metabolic syndrome in men and women: A cross-
sectional study within the Malmo Diet and Cancer
cohort. Am. J. Epidemiol., 154: 1150-1159.
1Title:
Detecting Insulin Resistance in Pakistani Subjects by Fasting Blood Samples
AUTHORS:
Author for Correspondence
M. Zafar Iqbal Hydrie, M.phil
PhD student
Department of International Health
Institute of General Practice and Community Medicine
Faculty of Medicine, University of Oslo, Norway.
Email: m.z.hydrie@medisin.uio.no , research@bideonline.com
Baqai Institute of Diabetology and Endocrinology
Plot No. 1-2, II-B, Nazimabad No2, Karachi-74600
Phone: 92 21 36688897, 92 21 36608565, 92 21 36707179
Fax: 92 21 36608568
Abdul Basit, F.R.C.P.
Professor of Medicine,
Department of Medicine
Baqai Institute of Diabetology and Endocrinology
Baqai Medical University
Asher Fawwad, M.phil
Assistant Professor of Biochemistry
Research Department
Baqai Institute of Diabetology and Endocrinology
Baqai Medical University
Muhammad Yakoob Ahmedani, FCPS.
Professor of Medicine,
Department of Medicine
Baqai Institute of Diabetology and Endocrinology
Baqai Medical University.
A Samad Shera, F.R.C.P.
Honorary President (IDF), Secretary General (DAP),
Director WHO Collaborating Centre.
Diabetic Association of Pakistan
5-E / 3, Nazimabad, Karachi-74600, Pakistan.
Akhtar Hussain, D.Sc
Professor
University of Oslo, Faculty of Medicine
Institute of General Practice and Community Medicine
Department of International Health
P.O Box 1130 Blindern
N- 0317 Oslo – Norway
2ABSTRACT:
Background
Insulin Resistance has been identified as an independent risk factor for a number of chronic 
diseases such as diabetes and cardiovascular diseases (CVD).
Objective
To identify a simple indirect method for detecting insulin resistance (IR) in our population. 
Methods: 
Geographical Imaging Systems (GIS) was used for randomly selecting the subjects. For 
visiting the 532 households selected by GIS, 9 field teams were developed. A total of 871 
subjects older than 25 years were approached by these teams out of which 867 agreed to 
participate in the survey. IR was assessed in 227 normal subjects by fasting insulin, HOMA-
IR, QUICKI and McAuley Index.
Results:
IR was defined at 75th percentile cut off of insulin levels (9.25 U/mL) and HOMA-IR (1.82).
The 25th percentile cut off was used for defining IR in QUICKI (0.347) and McAuley Index
(6.77).
Conclusion: 
A common approach towards managing subjects with metabolic risk factors will help identify
IR earlier and using IR reference values identified from simple indirect methods would be of 
value in such cases. However larger population based studies are needed to further define and 
validate these cutoff values for insulin resistance. 
Key words: Insulin Resistance, Fasting Blood Levels, Metabolic Syndrome, Pakistani,
HOMA, QUICKI, McAuley Index
INTRODUCTION
Insulin Resistance (IR) is an acronym for a wide range of metabolic derangements with 
convincing evidence that it is an independent risk factor for a number of chronic diseases such 
as diabetes and cardiovascular diseases (CVD). Insulin resistance has also been suggested as 
the primary cause leading to the clustering of risk factors such as glucose intolerance, 
hypertension, elevated serum triglycerides, low serum HDL cholesterol and central obesity 
which together have been labeled as Metabolic syndrome (MS) (1). 
Elevated insulin levels are believed to accelerate the development of atherosclerosis and is
considered to be a key cause of cardiovascular pathologies in metabolic syndrome (2-3). High 
death rates from coronary heart diseases have been associated with insulin resistance and 
metabolic syndrome (4). It has also been observed that reduction in insulin resistance 
improves glycaemic control and favourably modifies other components of the metabolic
syndrome (5). Thus diagnosis of insulin resistance at the initial stages of a disease could be 
used as a effective measure to prevent unfavourable outcome, including reduction of 
cardiovascular morbidity and mortality. 
Unfortunately reliable methods for measuring insulin resistance in vivo such as the hyper-
insulinemic euglycemic clamp and minimal-model approximation of the metabolism of 
glucose (MMAMG) are time-consuming, complicated and require expensive equipment for 
epidemiological research as well as for clinical practice (6 -8).
For this purpose insulin resistance indices have been developed based on fasting blood 
samples (serum insulin and glucose levels) which are used as reference cutoffs defined for 
various populations (9). The homeostasis model for insulin resistance (HOMA-IR), the
quantitative insulin sensitivity check index (QUICKI) and McAuley Index are commonly 
used surrogate measures from these fasting values and have proven to be a reliable alternative 
3to the glucose clamp studies (8, 10-11). Many studies using these simple indirect methods for 
detecting insulin resistance have been reported (12-14).
Studies done in Pakistani population comparing hypertensive subjects with normal subjects,
showed high levels of insulin in hypertensive subjects (p<0.001), likewise children having 
family history of cardiovascular disease had higher insulin levels compared to children with 
family history of diabetes, while fasting insulin and cholesterol levels was significantly higher 
in diabetic subjects compared to controls in another Pakistani study with a p value of <0.01.
(15-17).
Although the prevalence of metabolic syndrome has been reported in Pakistani population, no 
population based study measuring insulin resistance in Pakistani adults have been reported to 
our knowledge (18-20). Because of the lack of information on insulin resistance in our local 
population we decided to determine the reference cut off values of IR indices from our 
community based epidemiological study done previously (20).
MATERIALS AND METHODS
Study area and population
The survey was conducted from July 2004 to December 2004. Geographical Imaging Systems 
(GIS) was developed for Lyari Town with unique identification numbers ascribed to 
households and the prevalence of metabolic syndrome was studied by random selection of 
these households (20).
Methodology
The ethical approval for this survey was given by Institutional Review Board (IRB) of Baqai 
Institute of Diabetology and Endocrinology. The survey activities were divided into two 
phases - the household interview plus physical examination and blood sample collection, both 
have been described in detail previously (20). Nine field teams visited the 532 households 
which were selected by GIS and approached a total of 871 subjects > 25 years of age out of 
which 867 agreed to participate in the survey. Anthropometric and demographic information 
was collected during the interview. Waist and hip circumference was measured and blood 
pressure taken twice by using mercury sphygmomanometer. 
Laboratory assays
All adults > 25 years were asked to undertake a 10 hours fast for blood tests (fasting blood 
glucose, lipid profile and insulin levels) for which blood samples were collected on weekends. 
Blood samples were given by 363 persons out of the 867 adults who took part in the survey.
All selected parameters of blood lipids (total cholesterol, triglycerides, HDL- cholesterol and 
LDL-Cholesterol) and blood glucose estimation was done using auto-analyzer Vitalab 
Selectra. Fasting blood glucose and lipid profile were done by GOD PAP method and CHOD 
PAP method respectively. 
Insulin
Fasting insulin was measured by enzyme linked immunosorbent assay (ELISA) based on the 
sandwich principle. The specificity of antibodies or cross reactivity of the kit to the proinsulin 
was zero percent. The analytical sensitivity of the assay was found to be 1.76 uIU/ml. 
Assessing insulin resistance
Insulin resistance was assessed in 227 normal subjects by calculating HOMA, QUICKI and 
McAuley Index indices as follows:
HOMA-R = Insulin (Iu/ml) × glucose (mmol/l)/22.5
QUICKI = 1/ [log (fasting insulin) + log (fasting glucose)]
McAuley Index = Exp [2.63-028 ln (Insulin in Mu/l)-0.31ln (triglyceride in mmol/l) 
4STATISTICAL ANALYSIS
Characteristics of the subjects according to gender were analyzed using an independent 
sample t-test. Data was presented as quartiles of fasting insulin, HOMA-IR, QUICKI and 
McAuley index to observe the various percentiles of insulin sensitivity and determine insulin 
resistance according to defined standard protocols.
The statistical analysis was conducted using SPSS for Windows (version13, SPSS Inc., 
Chicago, IL, U.S.A.), and p<0.05 was considered statistically significant.
RESULTS
Subjects with fasting blood sugars < 100 mg/dl were taken as having normal glucose 
tolerance. A total of 227 normoglycemic subjects (70 men and 157 women) were selected 
from the survey population.
General characteristics of the study participants are shown in Table 1. Females were 
significantly younger than males with lower waist circumference but higher Body Mass Index 
(BMI). Mean total cholesterol and LDL cholesterol was higher in females compared to males.
Mean fasting insulin and HOMA-IR was also higher in females while other indices of insulin 
resistance were not much different in males and females. Males had significantly higher blood 
pressure compared to females.
The 75th percentile cut off was used as a value for defining insulin resistance for fasting 
insulin levels (9.25 U/mL) and for HOMA-IR (1.82) while the 25th percentile was taken as cut 
off for defining insulin resistance according to QUICKI (0.347) and for McAuley Index (6.77)
as shown in Table 2.
DISCUSSION
In this study females had higher fasting insulin levels compared to males; internationally there 
are contrasting studies about gender based insulin differences with some showing higher 
insulin resistance in one gender compared to the other (21).  
Researchers have suggested that a fasting insulin level at 75th percentile cutoff is accurate at 
predicting insulin resistance in normal non diabetic population in some studies (4,9). Fasting 
insulin levels at 75th percentile was thus used as a cut off value in this study and this value 
lies within the range observed in other studies (4,9,22). 
In 1985 Matthews was one of the pioneers to define HOMA-IR as a simple and reliable 
method for estimating insulin sensitivity from fasting plasma glucose and insulin levels (11). 
HOMA-IR values between 1.21 and 1.45 were reported for normal subjects by Matthews (11).
Many large population-based studies have used HOMA-IR to assess insulin sensitivity and 
reported HOMA-IR to be around 2.6 on the basis of the 75th percentile (4,10,13,14). 
However lower HOMA-IR values have been observed in south asians with an Indian study 
reporting HOMA-IR to be 1.93 at the 75th
Other researchers suggested QUICKI to be a better surrogate measure of insulin resistance 
than HOMA-IR (12). The 25th percentile value of QUICKI was 0.347 in our study which lies 
within the range reported for normal populations (0.33-0.372) by other researchers (4, 24). 
percentile while in our study it was observed to be 
even lower at 1.82 (23).
It has been suggested by some that incorporating triglycerides in asian subjects increases the 
likelihood of identifying insulin resistance (25). The index proposed by McAuley for the 
diagnosis of insulin resistance incorporates triglycerides in its formula (9). Thus we calculated  
McAuley index on the basis of the 25th percentile and in our study the cutoff of McAuley 
index was 6.77. Thus we calculated the cut off values for defining insulin resistance in our 
population by using simple fasting blood levels of insulin and glucose.
5However our study had a few limitations. Firstly, the diagnosis of insulin resistance was based 
only on a single test of fasting blood glucose and insulin levels. Hyperinsulinemic euglycemic
clamp studies were not performed to correlate the findings of indirect methods of insulin
resistance with the gold standard test in this case. However, WHO has suggested that the 75th
percentile cutoff of insulin can be used for epidemiological studies, which was done in this 
study (26). Although the sample size was small and generalizing the cutoff values for 
Pakistani population have to be taken with caution, the randomization of the sample was done 
by GIS which reduces bias in sample selection. Thirdly, although insulin assays can vary
considerably depending on cross-reaction with proinsulin, in this study human insulin-specific 
radioimmunoassay was used which has no significant cross-reactivity with proinsulin thereby 
minimizing the interference by proinsulin (27).
Determining cutoff values of IR by indirect measures could help in identifying insulin 
resistant subjects in clinical practice on account of their simplicity and clinicians may be able 
to use this simple test as an initial screening tool to identify such subjects. Thus clinicians 
may intervene earlier in insulin resistant subjects to prevent the development of type 2 
diabetes, hypertension and cardiovascular diseases in such subjects. However since the values 
are not universally applicable because of the variability of values studied in different 
populations we need to have specific population based studies and this was such an attempt in 
the Pakistani population. Studies have shown that when compared with the insulin sensitivity 
value obtained by the MMAMG method the sensitivity of McAuley was observed to be 
significantly higher than that of HOMA-IR or QUICKI (4,9). However HOMA-IR has been 
most widely studied as an indirect method for IR and has been considered by many 
researchers to be a good measure of IR (4,7).
Although determining insulin resistance by indirect methods is difficult due to the variability 
of results, but the cut off values of IR determined can be used as a measure of insulin 
resistance in Pakistani adults.
It is hoped that a common approach towards managing subjects with metabolic risk factors by 
using a single cutoff value will help save time and improve clinical assessment by identifying 
such cases of insulin resistance earlier. Secondly the clinical focus may shift from identifying 
the various risk factors separately towards identifying insulin resistance by using reference 
values measured from these simple indirect methods.
However larger population based studies are needed to further define and validate these cutoff 
values for insulin resistance in this south asian population.
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8Table 1: General characteristics of the study subjects
* P-value < 0.001 ** P-value < 0.005 *** P-value < 0.05
Table 2: Quartiles of fasting serum insulin, HOMA-IR, QUICKI and McAuley Index.
P25 P50 P75
Insulin 5.95 7.8 9.25
HOMA-IR 1.087 1.454 1.823
QUICKI 0.347 0.359 0.376
McAuley Index 6.77 7.046 7.33
Subject Male
Mean ± SD
n = (70)
Female
Mean ± SD
n = (157)
P value Total
Mean ± SD
n = (227)
Age (yr)* 43.10 ± 12.95 36.87 ± 11.40 < 0.000 38.79 ± 12.21
Body Mass Index (kg/m2) ** 22.35 ± 4.10 25.09 ± 6.27 0.002 24.27 ± 6.07
Waist Circumference  (cm) 87.42 ± 12.84 85.31 ± 14.09 0.288 85.96 ± 13.72
Systolic Blood Pressure (mmHg) 127.94 ± 19.95 121.73 ± 17.14 0.033 123.59 ± 19.55
Diastolic Blood Pressure (mmHG)* 84.70 ± 12.11 77.70 ± 12.87 < 0.000 79.79 ± 13.02
Cholesterol (mM/L) 175.06 ± 44.02 178.72 ± 44.85 0.581 177.61 ± 44.53
Triglyceride (mM/L)*** 160.58 ± 123.27 128.90 ± 66.33 0.018 138.39 ± 88.25
Low Density Lipoprotein (mM/L) 108.22 ± 30.15 114.48 ± 32.56 0.181 112.59 ± 31.91
High Density Lipoprotein (mM/L)*** 38.65 ± 11.52 43.48 ± 12.52 0.009 42.04 ± 12.40
Glucose (mM/L) 80.80 ± 8.82 79.94 ± 10.63 0.556 80.21 ± 10.10
,QVXOLQȝ8P/ 7.60 ± 2.78 8.40 ± 4.50 0.178 8.15 ± 4.05
HOMA 1.48 ± 0.58 1.61 ± 0.90 0.258 1.57 ± 0.81
QUICKI 0.36 ± 0.02 0.36 ± 0.03 0.889 0.36 ± 0.03
McAuley 7.09 ± 1.33 7.37 ± 1.48 0.138 7.29 ± 1.44
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Abstract:
Aims: The aim of  the study was to observe the rate of conversion from impaired glucose 
tolerance (IGT) to diabetes following lifestyle modification program and a combination of 
lifestyle modification and oral hypoglycaemic agent (metformin) compared to a control 
population with 18 months follow up. 
Methods: Around 40 screening camps were organized at places such as organizations, 
factories and health care centre.  Nearly 5000 people attended lectures and visited the 
screening camps. Of these 2300 filled a high risk questionairre and 1825 subjects over 30 
years of age were identified as high risk. They were requested to undertake an oral glucose 
tolerance test (OGTT). Out of these 1739 subjects took the OGTT and 317 subjects were 
identified as having impaired glucose tolerance (IGT). They were randomized into three 
groups. First group was given standard medical advice (Control Group), second group was 
given intensive lifestyle modification advice (LSM Group) while third group was given 
intensive lifestyle modification advice and metformin 500mg twice daily (LSM+Drug 
Group).
Results: At the end of the study 273 subjects completed the study giving a compliance rate of 
86%. A total of 47 incident cases of diabetes were diagnosed during the study. The overall 
incidence of diabetes was 4 cases per 1000 person-months with the incidence of diabetes as 
8.6 cases  in the control group, 2.5 cases  in the Life Style Modification (LSM) group and 2.3
cases in the LSM+drug group.
Conclusions This study showed that lifestyle intervention had a major impact in preventing 
diabetes among IGT subjects in this region. However, addition of drug in the intervention did 
not show any improved results. Resource constrain societies are challenged with the
additional burden of diabetes cost on their already ailing economy. Therefore, we recommend 
that lifestyle modification advice and follow-up should be incorporated in primary health care.
Keywords: IGT, primary prevention, diabetes, lifestyle intervention, metformin.
Introduction:
The prevalence of diabetes is increasing globally and the burden of the disease is making it 
one of the most challenging public health problem of the 21st century with Asia as the 
epicentre (1;2). It is increasing in epidemic proportions with one person developing  diabetes 
every five seconds globally (1;2). Once diabetes develops it causes disability, increased health 
costs to the person and reduced life expectancy with somebody dying from diabetes every ten 
seconds in the world (2). Thus diabetes is a chronic debilitating disease causing life long 
complications such as heart disease, blindness, kidney damage and foot amputations. The 
most dramatic increase in type 2 diabetes is occuring in genetically predisposed populations 
where rapid and major lifestyle changes are taking place. These include changes in diet and 
reduction in physical activity, with consequent increase in the prevalence of obesity leading to 
increased burden of diabetes (2;3). Diabetes leads to increased morbidity and mortality, with 
the only way to reduce this is to prevent it from developing.
Randomized controlled trials have shown that progression to diabetes can be reduced in 
people at identifiable risk through interventions (2-4). Thus evidence from clinical trials 
suggest that subjects at risk of developing diabetes can prevent or delay the onset of type 2 
diabetes by lifestyle modification or medication (2;3). A number of studies done in China, 
Finland, USA and India have demonstrated the importance of healthier lifestyle in preventing
or reducing the occurrence of diabetes (3;5-9). The collective results of such prevention 
studies showed an average reduction of 51% in new cases of diabetes (4). Studies from 
Finland and USA showed that the most powerful way to prevent the occurrence of diabetes 
was to modify lifestyle condusive to improved metabolic health (6-8).
Most intervention studies targeted diabetes prevention by achieving and maintaining a healthy 
body weight through a combination of dietary measures and physical activity in high risk 
subjects (2). However, based on genetics and defining cardio-metabolic state including level 
of obesity, fat deposition pattern and dietary habits in different populations, this intervention 
strategy may need to be revised. For example, different ethnic groups have different body 
mass index (BMI) cutoffs which may have a varied effect on intervention as evident in the 
Indian study where risk reduction rate of 28% was seen compared to 58% risk reduction of 
diabetes in the Finnish and USA studies (7-10).
One limitation of the study in India was that the subjects were recruited from the local railway 
company and most of them were vegeterians. South Asians are a heterogenous group based on
different religious and cultural practices including food habits and they are genetically 
different. Studies have also noted dietary differences within the ethnic groups in South Asians
(11;12). For example, the diet of South Asians (mainly Punjabi) studied in Scotland was 
found to have large differences between Muslim and non-Muslim groups, with Muslims more 
likely to eat meat and less likely to eat fruit and cooked vegetables than non-Muslims (13).
This difference was also seen in another study between Muslims and Hindus (probably due to 
their vegetarianism) (14). This difference in diet due to ethnicity and religion may have a 
effect on intervention strategies and needs to be further explored to better understand the 
effect of intervention programs in these communities.
Therefore we conducted this intervention study in the largest city (Karachi) of Pakistan 
amongst the general population where most of the people were muslim and non vegeterian.
The main aim of  the study was to observe the rate of conversion from IGT to diabetes 
following lifestyle modification program and a combination of lifestyle modification and oral 
hypoglycaemic agent (metformin) compared to a control population with 18 months follow 
up.
Methodology:
Location:
Karachi is the largest and most populous city of Pakistan. All the major ethnic groups of the 
country are represented here with Muhajirs forming the dominant ethnic group in Karachi.
Our primary prevention team visited different primary health care centres within the city to
generate awareness and distributed educational leaflets about our primary prevention 
program.
Study Procedure
A number of strategies starting with opportunistic screening at 2 different out patient clinics 
was adopted to secure participation of the general population and create awareness about 
diabetes prevention. With the aim to reach a larger audience our diabetes prevention team 
arranged a series of 2-days awareness lectures at various places in the city by going to offices, 
service organizations, factories and visiting health care centres. Lectures on diabetes and its 
prevention were delivered by the prevention team in local language to the audience on the 
first day. The audience were asked to fill  a risk questionnaire at the end of the first day. On 
the second day, screening of high risk subjects was done according to results of the 
questionnaire and all high risk subjects were invited for an OGTT. During the time OGTT 
was done, all the subjects underwent a detailed anthropometric and medical examination as 
well as been asked about their socio-demographic, physical activities and dietary habits 
including information on quantity and quality of meals by a dietician and physical trainer.  
Design of the study:
This was a randomized clinical trial (RCT) conducted in subjects over 30 years of age who 
were diagnosed as having IGT according to World health Organization criteria (15). The IGT 
subjects were followed for a period of 18 months prospectively.
A questionnaire was filled as the first step to identify subjects from the overall population 
who may be at an increased risk of developing type 2 diabetes. . This standardized 
questionnaire included (a) family history (parents or siblings with  diabetes), (b) high body 
mass index, (c) low physical activity, (d) age, (e) hypertension, (f) high cholesterol or 
triglycerides (g) history of gestational diabetes or birth weight > 3.5 Kgs. Those identified as 
high risk (n=1825) were requested to undergo an Oral Glucose Tolerance Test (OGTT). Of 
these 1739 came for the OGTT giving a response rate of 95.3%. Subjects with 2 hour glucose 
levels between 140 to 199 mg/dl were identified as having impaired glucose tolerance (IGT)
and were requested to participate in the study. Those who were diagnosed with diabetes 
(n=181) were referred to respective hospitals for further medical care. 
After taking informed consent, the participants were randomized by age stratas (31- 40 years, 
41–50 years, 51–60 years and > 60 years) into three different arms. This was to ensure equal 
age representation in all the arms of the intervention. The three groups as shown in the 
flowchart were followed for 18 months (Figure 1). First group was given standard medical 
advice (Control Group), second group was given intensive lifestyle modification advice (LSM 
Group) while third group was given intensive lifestyle modification advice and metformin
(LSM+Drug Group).
Subjects
An estimated 5000 people attended the diabetes prevention lectures and visited the screening 
camps. Of these 2300 filled a high risk questionairre and 1825 were identified as high risk 
subjects which were requested to undertake a standardized oral glucose tolerance test 
(OGTT). Around 1739 agreed and out of these 317 subjects were identified as having 
impaired glucose tolerance (IGT group).
Of the 1739 subjects who underwent OGTT, 72% were males, 10.4% were found to have 
diabetes and 18% were having impaired glucose tolerance (IGT). The baseline characteristics 
of the 1739 subjects showed an increasing trend in terms of age, BMI, and blood pressure 
from NGT to DM as shown in table 1 below.
Investigations
All IGT subjects had fasting lipid profile, fasting insulin levels, OGTT and HbA1c done at 0, 
9 and 18 months. At the interim 9-month visit, confirmation of diabetes was made with 
OGTT. Plasma glucose was measured using the glucose oxidase–peroxidase method. The 
fasting serum lipid profile was estimated using standard enzymatic procedures. HbA1c was 
measured by HPLC using Biorad, a procedure certified by the National Glycohemoglobin 
Standardization Program. Weight, height, waist circumference and blood pressure were 
measured at each scheduled visit. All the subjects in the IGT cohort were seen after the OGTT 
tests and randomized into one of the three groups at baseline (0 week). They were followed 
according to their assigned groups and seen every two months by the primary prevention 
team. At 9 and 18 months blood tests were done to confirm their glucose status and assess 
their biochemical parameters. Weight and height was measured with the subjects minimally 
clothed, without shoes, in a standing position. Waist circumference was measured at the mid-
point between the iliac crest and the costal arch. Blood pressure was measured twice, 5 min 
apart, in a sitting position, and the average of the two readings were recorded.
Intervention and Randomization
All subjects who agreed to participate in the study were randomized into three groups as 
shown in figure 1. The subjects assigned to their respective groups were followed till the end
of the study. 
Subjects in the intervention group were given detailed advice about how to achieve the 
intervention goals, which included reduction of > 5 % of body weight loss via diet control 
and physical exercise, total fat intake less than 30% of energy consumed, fiber intake of 
15g/1000 kcal, and moderate exercise for minimum 30 min/day. Frequent ingestion of 
wholemeal products, vegetables and fruits, low-fat milk and meat products, and vegetable oils 
rich in monounsaturated fatty acids was recommended. The subjects had sessions with a 
dietician and physical trainer at each visit and they were individually counselled to increase 
their level of physical activity. Endurance exercises such as walking, jogging and cycling 
were recommended to improve fitness. Supervised, individually tailored training advice was 
also offered to improve the physical fitness of each individual. These interventions were 
based on reinforcing behaviour modification via diet change and encouraging physical 
activity in each subject.
Subjects in the control group were given general diet and exercise information at baseline and 
followed at subsequent visits but no specific individual counselling was done. While subjects 
in the intervention+drug groups were also seen every 2 months by a medical doctor for their 
drug adherence. 
Follow-up
Reinforcement and counselling was done every 2 months in all groups with the intensive 
groups seen by the medical officer, dietician and physical trainer, while the control group seen 
only by the medical officer as described in detail elsewhere (16).
Primary Outcome:
The primary outcome was defined as developing diabetes indicated by either fasting plasma 
glucose of (> 125 mg\dl) and \or 2-hours plasma glucose of (>199 mg\dl) confirmed at 9 & 18 
months follow-up by an OGTT (15). Subjects identified as having diabetes were excluded 
from the study and given medical advice with referral to physicians for further follow-up.
Ethics
The project was approved by BIDE ethics committee and the Norwegian Research Council.
All high risk subjects gave written informed consent at the start of the study. Records were 
kept for any adverse effects occurring during the course of the study.
Statistics
Mean and standard deviation were reported for continuous variables and inter-group 
comparisons were tested by two tailed $129$&RPSDULVRQRISURSRUWLRQVZDVE\Ȥ
analysis. The proportion of subjects developing diabetes in each group and their comparison 
ZDVE\ȤDQDO\VLV
For the intervention measures, the absolute and relative risk reductions and 95% CIs of the 
estimates and the number needed to treat to prevent diabetes in one person were calculated. A 
p value <0.05 was considered significant. The statistical package SPSS (PASW Statistics 18) 
was used for analyses.
Results:
The  IGT subjects (317) were randomized into three groups as shown in table 2. More than 
half (56%) of the subjects were between 30-44 years of age in the IGT cohort while 36% of 
the subjects were unskilled\skilled manual labourers. Positive family history of diabetes, 
hypertension, cardiovascular disease and stroke was present in 49%, 38%, 31% and 17% of 
the subjects respectively while 25% had hypertension at the start of the study.
During the course of the study, the mean body weight and waist circumference decreased in 
the LSM and LSM+Drug groups while it increased in the control group as shown in figure 2 
and 3.
At the end of the study 273 subjects completed the study giving a response rate of 86%. A
total of 47 incident cases of diabetes were diagnosed during the study; 19 cases at 9 months 
and 28 cases at 18 months or closure of the study. The overall incidence of diabetes was 4
cases with 8.6 cases in the control group, 2.5 cases  in the Life Style Modification (LSM) 
group and 2.3 cases per 1000 person-months in the LSM+drug group as shown in table 3. The 
numbers to be treated to prevent one incident case of diabetes was 9 and 8 in lifestyle and 
LSM+Drug groups respectively.
Adverse Events:
Overall 44 subjects dropped out or were lost to follow up. In the control group there were 2 
deaths while 24 subjects dropped out during the study. In the lifestyle modification group 8 
subjects refused to continue the study and dropped out. In the LSM+Drug group 5 subjects 
stopped taking the drug either due to side effects of the drug such as gastrointestinal problems 
or complaining of weakness probably due to hypoglycemia while 5 subjects refused to follow 
due to personal reasons and were lost to follow up.
Discussion: 
Our data suggest that lifestyle intervention is highly effective in preventing high risk 
individuals (IGT) from conversion to diabetes in this population. Adding oral hypoglycaemic 
agent (metformin) in addition to lifestyle modification was not found to be advantagious for 
the prevention. Our data is in line with the previous studies done in other population (6-9).
The progression rate of IGT to diabetes in our control subjects was lower compared to Indian 
and Chinese controls (8.2% per 12 months compared to 18.3% and 11.3% per 12 months
respectively) (5;9). But this was significantly higher than seen in the Finnish (6% per year)
and DPP (11 per 100 person-years) studies (5;7;8). All subjects in the control group also 
received general health advice about diet, nutrition and exercise at baseline and at subsequent 
follow-up visits. This may have helped to increase their awareness about their diabetes risk 
and some subjects may have benefited from the advice or made subsequent lifestyle 
modifications due to this. A absolute reduction of 10.7/100 was seen in the intensive lifestyle 
group, which was greater than seen in IDPP (15.7/100) (9). More number of subjects were 
needed to treat in order to prevent one case of diabetes in the intensive group (9 vs 6.4) in our 
study compared to IDPP (9).
Looking at the baseline characteristics it appears that our subjects were similar in age as other 
Asian studies (Mean age Indian 45.9±5.7 years, Chinese 45±9.1 years and ours 43.6±9.9
years) but had comparatively higher BMI (kg/m2) (Indian 25.8±3.5, Chinese 25.8±3.8 and 
ours 27.1±5.0) (5;9). However our subjects were still younger and leaner compared to the 
Finnish (age 55±7.0 years, BMI 31±4.6) and the American subjects (age 50.6±10.7 years, 
BMI 34±6.7) (6;8). The follow-up period in our study was nearly half in duration (only 18 
months) compared to the Indian, American and Finnish studies (6-8).
In our study the progression of IGT to diabetes was comparable to other Asian studies and it 
showed the effectiveness of lifestyle modification involving moderate physical activity and 
diet modification to prevent diabetes in this population. Adding metformin had an additional 
benefit but its impact was quite small with the relative risk reduction of 5.5%, from 71% to 
76.5% in the lifestyle modification+drug group. This difference was not found to be 
statistically significant. 
Our results showed that to reduce the burden of diabetes epidemic, effective primary 
prevention can be achieved through lifestyle modification. Therefore, it is suggested that 
necessary policy development on the prevention of diabetes should emphasis on the lifestyle
modification. Recent Updates from the China DaQing Prevention Study, the Finnish Diabetes 
Prevention Study, the American Diabetes Prevention Programme Outcome Study and the 
Look Ahead Study have all shown that the most efficient way to manage diabetes and its 
complications is to prevent diabetes in the first place. This in turn has lead to policy 
documents from expert organizations such as The Disease Control Priorities project (DCP-2), 
the European Society of Cardiology and European Association for the Study of Diabetes, the 
Canadian Diabetes Association, the American Diabetes Association, and the International 
Diabetes Federation, all recommending lifestyle changes such as weight loss and increased 
physical activity for the prevention of T2DM among those with pre-diabetes (2;9;17-21).
The main motivation for the prevention of type 2 diabetes is that it can prevent or delay the 
onset of diabetes and its complications, thereby reducing the life entrenched financial burden 
and unnecessary human sufferings of diabetes on both the individual and on the society at 
large. Developing countries have to face this additional burden on their already ailing 
economy (22;23); therefore, primary prevention programmes need to become a integral part 
of Primary Health Services and strategies for reducing the diabetes burden at all levels.
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FIGURE 1: Flowchart with recruitment of persons for the oral glucose tolerance test
(OGTT) and screening and randomisation.
5000 subjects attended the awareness lectures 
2300 Subjects filled the High risk questionairre 
1825 Subjects were identified for screening (July 2006 – April 2008)
2 hrs Oral Glucose Tolerance Test (OGTT) undertaken in 
1739 (men = 1252 : women =487)
Control Group (n = 108) ILSM Group (n = 114)
Normoglycaemia (n = 1241)
(71.4% Excluded)
IGT n = 317, (18.2%)
men : women 237:80
Diabetes (n = 181)
(10.4% Excluded)
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Figure 2: Weight changes in 18 months 
(*p value = 0.003)
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Figure 3: Waist Circumference
Table 1: Baseline Characterstics of 1739 identified high risk subjects by questionnaire
NGT IGT DM p-value
N 1241 317 181
Age of patient (years) 40.1 ± 8.9 43.6 ± 9.9 44.4 ± 9.7 <0.0001
Body Mass Index (kg\m2) 25.8 ± 5.3 27.1 ± 5.0 27.3 ± 5.2 <0.0001
Systolic BP (mmHg) 118.3 ± 16.5 121.5 ± 16.8 124.3 ± 17.7 <0.0001
Diastolic BP(mmHg) 82.5 ± 11.0 84.6 ± 10.9 85.4 ± 13.1 0,001
Table 2: Baseline Characteristics of the 317 Subjects in the IGT Cohort
Control Lifestyle Lifestyle+ Met
N 108 114 95
Age in years 44.2 ± 10.9 43.1 ± 10.1 43.5 ± 8.4
Body Mass Index (kg\m2) 27.0 ± 5.7 26.1 ± 4.7 28.1 ± 4.3
Systolic BP (mmHg) 121 ± 17 123 ± 19 120 ± 14
Diastolic BP(mmHg) 84 ± 11 86 ± 12 84 ± 9
Cholesterol (mg/dl) 179.1 ± 37 178.6 ± 34 180.0 ± 36
Triglycerides (mg/dl) 153.4 ± 109 147.3 ± 86 171.5 ± 119
HDL-C (mg/dl)* 37.8 ± 4.3 37.4 ± 4.5 37.8 ± 7.8
LDL-C (mg/dl) 117.2 ± 25.1 116.5 ± 22.7 117.0 ± 24.6
Table 3: Comparision of the outcome at 18 months in the four groups 
Control Lifestyle Lifestyle+ Met
N 82 107 85
cases per 1000 person-months 8.6 2.5 2.3
Absolute risk reduction % 10.7 11.5
Relative risk reduction % (95% CI) 71(13.7-90.3) 76.5(19.7-93.1)
NNT for 18 months to prevent DM in one case 9 8

